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Preface
It is already quite some time ago that I started my PhD research. As my
colleagues know, the start of a PhD is challenging, exciting but most of all
abrupt. First, all the people in the lab are introduced and you get assigned
your very own desk.at desk will start to feel a little bit like home over the
years (especially since I had the luck to be assigned a spot in oce awesome).
e second announcement goes like: “Hey, you should write a grant proposal
for the IWT within 2 weeks! Could you write down what you plan to do in the
next 4 years?’. It’s only then that the PhD journey ocially starts and it starts
with the realization: “I will never be able to do this on my own”.
is is especially the case since my work is mainly an aggregating study,
combining the methods and hard work of my predecessors. As such, I con-
sider the major part of my PhD thesis as a big puzzle, bringing together
all those fruits of labour. Because the help and support of specialists in all
these dierent domains was vital, I puzzled together a long list of people that
provided me with help and guidance.
Right from the start, the four corner pieces were already dened: Patrick,
Bram, Guido and Carole. It was really astonishing how the roadmap of a
whole 4 year IWTproject was dened in the 2 week time framewith their help.
First of all, I’d like to thank Patrick for helping me every step of the way. Next
to the help with setting up the direction of the research, his help consisted of
convincing me of the importance of my own results, proofreading a lot of text
and sometimes warning me that I was making everything too complicated.
He reminded me countless times that the story is the most important part,
which led directly to the coherent story in this PhD thesis.
Bram introduced me to the basics of almost all important tools and meth-
odologies, for which I am very grateful. Furthermore, Bram tremendously
improved the literal style of basically everything I have written, thanks to the
very thorough corrections that he provided time and time again.
e Antwerp corner pieces consisted of Guido and Carole, with both
of them being essential for the successful outcome of this project.anks
to them, the whole (dicult) breeding process of the laboratory mice, was
ix
Preface
reduced to the simple question: “Can I have some mice please?”. Moreover,
their experience with histology was crucial to validate important parts of this
work. For the interpretation of the results, their dierent background and
point of view was highly valuable. Also thanks to Mandy for proofreading
the rst two chapters of this thesis.
e in vivo imaging of themice was another important piece of the puzzle.
For this part, I mainly want to thank the people from INFINITY (Benedicte,
Christian and Scharon) together with Bert and Francisco. I would not have
been able to do any FSI simulations without the help of Liesbeth, Joris, Joris,
Alessandra, Abigail and Jan. I also want to thank Mathias, Francesco and Nic
for the help with the solid mechanics.
I thank the past and present members of my oce (Gianluca, Koen,
Liesbeth, Alessandra, Darya, Margo, Wouter, Danilo, Giussepe, Daniela,
Giorgia, Hicham) for the “homemade” birthday cakes, the coee breaks, the
colour advice, brightening up the day with some Italian air, the helping
hands and the listening ears. Of course I also want to thank all the other
members of bioMMeda. Special thanks go to Annette for volunteering to
help me with the most boring part of my research. I would like to thank
Saskia for all the administrative support. My gratitude goes to Jurgen for
the technical assistance and for the nice times when we were trying to piece
together a website.
I alsowant to thankRuoyu, Kim and Frank of the ErasmusMCRotterdam
for the fruitful discussions, helpful remarks and warm welcome at the yearly
shear stress symposium. I hope the future bringsmore collaborations between
both research groups.
Uiteraard wil ik ook nog mijn vrienden en familie bedanken. Maarten
en Karel voor de (verplichte) interesse en het geduld wanneer PhD besognes
luchtigere cafépraat in de weg stonden. Mijn zussen, ouders, grootouders en
familie wil ik bedanken om in mij te geloven, me te steunen, de hulp en voor
de ludieke insteek die altijd beschikbaar was.
Maar vooral wil ik ook Soe nog bedanken. Ze vormt de laatste jaren het
belangrijkste puzzelstuk in mijn leven. Bedankt om er altijd te zijn voor mij,
geduld te hebben als het nodig was, me bij te staan met raad en daad en om
samen met mij stap voor stap aan een toekomst te bouwen.
Finally, thanks to you, my dear reader. By now you have already read two
pages of my thesis.ank You. . . (You’re almost there.)
David De Wilde
Gent, January 2016
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Inleiding
Hart- en vaatziekten zijn wereldwijd de belangrijkste doodsoorzaak. Athero-
sclerose of slagaderverkalking wordt gekenmerkt door de ontwikkeling van
plaque in de middelgrote tot grote slagaders. Gedurende het langdurende
ontwikkelingsproces zijn vele verschillende biologische processen betrokken
die uiteindelijk leiden tot de opstapeling van vetten in de slagaderwand en
de inammatie (ontsteking) van diezelfde slagaderwand.
De meeste risicofactoren zijn systemisch van aard, zoals roken, leeijd,
hoge bloeddruk en hoge concentraties van vetten in het bloed. Ze “bevoorde-
len” dus geen specieke locaties. In tegenstelling tot voorgaande risicofac-
toren ontwikkelen atherosclerotische plaques zich echter voornamelijk aan
de binnenbocht en in vertakkingen van de bloedvaten. Het wordt algemeen
aanvaard dat de bloedstroom (hemodynamica) een (mede-)oorzaak van
dit lokale karakter van plaque ontwikkeling is. De bloedstroom beïnvloedt
de ontwikkeling van atherosclerose via de wandschuifspanning (WSS, de
wrijfkracht gedeeld door de oppervlakte) die ze uitoefent op de endotheel-
cellen aan de binnenkant van de bloedvatwand. Een lage en/of oscillerende
WSS activeert en/of faciliteert de biologische processen die leiden tot plaque
ontwikkeling.
Eén van de moeilijkheden in het onderzoek naar de rol van de hemody-
namica bij plaquevorming, is dat de oorspronkelijke wandschuifspanning,
voordat enige atherosclerose was ontwikkeld, gelinkt moet worden met de
plaatsen waar de atherosclerose ontwikkelt op een later tijdstip. Om dit mo-
gelijk te maken, vergelijken de meeste beschikbare studies WSS in een eerste
groep gezonde proefpersonen/dieren (zonder plaque ontwikkeling) met de
plaque locaties, gemeten in een tweede groep proefpersonen/dieren (deze
onderzoeken vergelijken dus twee verschillende groepen in plaats van een
langdurige opvolging van de dieren). Hiertoe vergelijkt men de gemiddelde
waardes gevonden voor demetingen in beide groepen. Het gevaar van uitmid-
deling is echter dat de nale correlatie tussen WSS en atherosclerosevorming
wordt overschat. In deze PhD thesis is het dus ons doel om te onderzoeken
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of er een link bestaat tussen WSS en atherosclerose, en dit op een individuele
basis in een studie die individuele dieren opvolgt doorheen de tijd. Deze
aanpakmaakt het overbodig om demeetwaardes uit te middelen. De centrale
onderzoeksvraag is dan ook:
Bestaat er een individuele en kwantitatieve link tussen de
wandschuifspanning in een gezonde referentietoestand en de
daaropvolgende plaqueontwikkeling in muismodellen van
atherosclerose?
In dit werk maken we gebruik van muismodellen van atherosclerose
omdat deze ons toelaten om de proefdieren op te volgen gedurende de ge-
hele tijdspanne van atheroscleroseontwikkeling. Om de onderzoeksvraag te
kunnen beantwoorden, dienen er verschillende tussenliggende technische
doelen gehaald te worden. Ten eerste moet er een in vivomethode ontwik-
keld worden om de locaties van atheroscleroseontwikkeling in muizen te
kunnen bepalen. Ten tweede is het nodig dat er verscheidene (bestaande)
computermodellen en technieken aangepast en gecombineerd worden om
de bloedstroom en bloedvaten van muizen te simuleren. Ten slotte dient het
correcte statistisch model toegepast te worden om de link tussen WSS en
atherosclerose te kwanticeren.
Deel I: Het bestuderen van atherosclerose in muizen
Hoofdstuk 1: Atherosclerose
Dit eerste hoofdstuk bevat algemene achtergrondinformatie bij de anatomie
en de fysiologie van het humane cardiovasculaire systeem dat bestaat uit
het hart en de bloedvaten. Een overzicht wordt gegeven van de belangrijk-
ste slagaders in het menselijke lichaam. Daarnaast wordt ingezoomd op de
anatomische beschrijving van de bloedvaten in de hals en het hoofd. De
halsslagader (common carotid artery - CCA) vertakt in de binnenste (in-
ternal carotid artery - ICA) en de buitenste (external carotid artery - ECA)
halsslagaders. Deze drie slagaders vormen het onderwerp van deze thesis.
In een tweede deel wordt er dieper ingegaan op atherosclerose of slagader-
verkalking. Deze ziekte wordt gekenmerkt door de vorming van plaques
in de slagaderwand. De belangrijkste processen die hier een rol in spelen
zijn de inltratie van vetten in de vaatwand en inammatie (ontsteking)
van de vaatwand. Vervolgens worden de ernstige klinische complicaties van
atherosclerose kort besproken. Atherosclerotische plaques kunnen scheuren
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en zo kunnen er bloedklonters ontstaan wat kan leiden tot een hartaanval of
een beroerte, wat de belangrijkste doodsoorzaken zijn wereldwijd. Verder
worden twee verschillende classicatiesystemen overlopen om de plaques in
te delen op basis van de histologische kenmerken enerzijds en op basis van
het risico tot complicaties anderzijds. Verschillende risicofactoren voor het
ontwikkelen van hart- en vaatziekten zijn algemeen bekend. Meer speciek
voor atherosclerose zijn deze risicofactoren: geslacht, leeijd, genetische
factoren, een hoge bloeddruk, obesitas, roken en overmatig alcohol verbruik.
In tegenstelling tot wat men zou kunnen verwachten op basis van deze syste-
mische risicofactoren, ontwikkelt atherosclerose zich op specieke plaatsen
in het cardiovasculair systeem. De lokale hemodynamica is een mechanisme
dat deze speciciteit qua locaties kan verklaren. In het laatste deel van dit
hoofdstuk wordt beschreven hoe de bloedstroming het ontstaan van plaques
kan beïnvloeden. De endotheelcellen, die de grens vormen tussen het bloed
en de bloedvatwand, spelen hier een belangrijke rol in door het “voelen” van
de wandschuifspanning (WSS) die de bloedstroom uitoefent.
Hoofdstuk 2: Muismodellen van atherosclerose
Het trage tijdsverloop van de ontwikkeling van atherosclerose bij de mens
bemoeilijkt het onderzoek naar atherosclerose. Daarom zijn verschillende
diermodellen ontwikkeld die humane atherosclerose nabootsen. Dit tweede
hoofdstuk gee een overzicht van enkele diermodellen die dikwijls gebruikt
worden bij atheroscleroseonderzoek, zoals konijnen, varkens en apen. Vervol-
gens wordt het muismodel in meer detail beschreven vanwege de specieke
voordelen: ze zijn goedkoop, er is snelle ontwikkeling van atherosclerose,
er is gemakkelijke genetische manipulatie mogelijk en de atherosclerotische
plaques vertonen grote gelijkenissen met humane plaques. Daarnaast is het
bij muizen ook mogelijk om studies op te zetten met een gro(o)t(er) aantal
dieren, wat noodzakelijk kan zijn omde resultaten statistisch te onderbouwen.
Daarnaast is het ethisch meer algemeen aanvaard om muizen te gebruiken
voor preklinisch onderzoek in vergelijking met andere diermodellen. Eén
strategie om de invloed van de hemodynamica op atherosclerosevorming te
bestuderen, is om de bloedstroom te manipuleren met een chirurgische in-
greep. Het grootste nadeel vanmuizen is echter dat de normale wildtypemuis
behoorlijk resistent is tegen de ontwikkeling van atherosclerose. Er zijn echter
verschillende rassen gekweekt die gevoelig zijn aan atherosclerose wanneer
ze een vetrijk dieet voorgeschoteld krijgen. De normale, zwarte labo muis
(C57BL/6J) is het meest gebruikte ras. Om de concentratie van lipoproteïnes
in het bloedplasma nog verder te verhogen, zijn het lage-dichtheid-lipop-
roteïne-receptor knockout (LDLR−/−) ras en het ras dat apolipoproteïne E
(ApoE−/−) mist, ontwikkeld. In het ApoE−/− muismodel ontwikkelen zich
de meest vergevorderde plaques en dus wordt dit muismodel regelmatig ge-
bruikt. Aan de universiteit van Antwerpen werd vervolgens een muismodel
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ontwikkeld dat naast de apolipoproteïne E deciëntie ook een heterogene
mutatie in het brilline 1 gen hee (ApoE−/− Fbn1C1039G+/−). Bij dit muis-
model treedt spontane ruptuur op van de atherosclerotische plaques, wat
grotendeels afwezig is bij de andere muismodellen. In dit werk werden zowel
ApoE−/− als ApoE−/− Fbn1C1039G+/− muizen gebruikt om een diepgaande
studie te doen naar de invloed van hemodynamica op de vorming van deze
complexe plaques.
Hoofdstuk 3: Beeldvorming van atherosclerose bij muizen
Ultrageluid (ultrasound - US) en micro-computertomograe (µCT) zijn de
twee in vivo beeldvormingstechnieken die voornamelijk worden gebruikt
in dit onderzoek. Ultrageluid is gebaseerd op ultrasone akoestische golven
boven de hoorbare frequentie. Met behulp van deze techniek kunnen ver-
schillende soorten beelden bekomen worden, afhankelijk van de precieze
beeldverwerking van de signalen. Een weergave van de anatomische structu-
ren in 2D wordt bekomen met B-mode beeldvorming. Bij M-mode beeldvor-
ming wordt de variatie over de tijd van metingen langsheen 1 enkele scanlijn
weergegeven. Dit kan gebruikt worden om bijvoorbeeld de pulsatiliteit van
een bloedvat op te meten. Pulsed Doppler is nog een andere techniek, die de
snelheid van de bloedstroom opmeet. Meer speciek voor muizen, vormen
de hogere hartslag en de kleinere grootte van de bloedvaten een uitdagende
omgeving, vergeleken met mensen. Daarom werd een specieke scanner, de
Vevo2100, gebruikt voor dit onderzoek.
Micro-computertomograe (µCT) is gebaseerd op ioniserende röntgen-
straling. Een µCT scanner bestaat uit 3 delen: de röntgenbron, het object en
de detector. De röntgenbron genereert een kegelvormige bundel van rönt-
genstraling die doorheen het te beeldvormen object (een muis) gaat. Nadien
wordt deze straling opgevangen en geregistreerd door een detector. Een
deel van de straling wordt geattenueerd door de weefsels waardoorheen de
straling penetreert. De hoeveelheid attenuatie is afhankelijk van de lokale
attenuatie-coëciënten. Voor een µCT meting worden verschillende projec-
ties onder verschillende hoeken opgemeten. Om dit te doen, wordt zowel de
röntgenbron als de detector rond de muis geroteerd. Voor de beeldvorming
van de bloedvaten is het behalen van voldoende contrast de grootste uitda-
ging. Recent werden er echter verscheidene contrastmiddelen ontwikkeld in
verbandmet deze toepassing. In het huidige onderzoek werd gebruikgemaakt
van het goud-nanopartikel contrastmiddel Aurovist.
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Deel II: Computationele technieken voor de studie van de
arteriële hemodynamica
Hoofdstuk 4: Numerieke simulaties van de arteriële hemodynamica
Om een voldoende gedetailleerde weergave van het stromingsveld in de arte-
riën te bekomen, maaktmen dikwijls gebruik van computationele vloeistofdy-
namica (computational uid dynamics (CFD)). In dit hoofdstuk worden de
algemene principes van de numerieke technieken uitgelegd van de methodes
toegepast in hoofdstukken 8 en 9. Eerst worden de vergelijkingen opgelijst die
de stroming van onsamendrukbare vloeistoen beschrijven. Nadien volgen
de algemene principes van CFD, dat wordt gebruikt om deze vergelijkingen
op te lossen. Het buerende eect van de halsslagaders wordt in rekening
gebracht door de beweging van de bloedvatwand, onder impuls van de bloed-
stroom en de bloeddruk, in beschouwing te nemen. In het tweede deel van
dit hoofdstuk worden de vergelijkingen van de vastestofmechanica overlopen
en de oplossingsmethode van deze dierentiaalvergelijkingen (computatio-
nele vastestofmechanica - computational solid mechanics (CSM)). Als laatste
is het nog nodig om beide deelproblemen (de vloeistofmechanica en de
vastestofmechanica) aan elkaar te koppelen om tot een vloeistof-structuur
interactiemodel te komen. In het laatste stuk van het huidige hoofdstuk wordt
deze koppelingstechniek Tango kort uiteengezet.
Hoofdstuk 5: Hemodynamische wandschuifspanningsparameters
In deze PhD thesis zijn we eerder geïnteresseerd in de invloed die het bloed
hee op de endotheelcellen dan op het snelheidsveld van de bloedstroom zelf.
De endotheelcellen vormen de grens tussen de bloedstroom en de bloedvat-
wand en vormen dus het gedeelte van de bloedvatwand dat de bloedstroming
waarneemt en waar processen die leiden tot atherosclerose vorming worden
geactiveerd. Meer speciek ondervinden de endotheelcellen de wandschuif-
spanning (WSS) die de bloedstroom uitoefent. Verschillende parameters
werden reeds ontwikkeld om het atherogene eect van verschillende stroom-
patronen zo optimaal mogelijk te kwanticeren. De belangrijkste van deze
parameters worden geïllustreerd in hoofdstuk 5. In het eerste deel worden de
op de magnitude gebaseerde hemodynamische wandschuifspanningsparame-
ters opgelijst: de tijdsgemiddelde wandschuifspanning (time averaged wall
shear stress (TAWSS)), de oscillatie index (oscillatory shear index (OSI)), de
relatieve verblijijd (relative residence time (RRT)) en de zijdelingse wand-
schuifspanning (transverse wall shear stress (transWSS)). Al deze parameters
beschrijven (een combinatie van) de volgende fenomenen: de grootte van
de wandschuifspanning, het oscillerende karakter van de wandschuifspan-
ning en de multi-directionaliteit. Een tweede groep van hemodynamische
wandschuifspanningsparameters is gebaseerd op het harmonisch karakter en
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de frequentie inhoud van de wandschuifspanning. Tot deze groep behoren
de harmonische index (harmonic index (HI)) en de dominante frequentie
(dominant harmonic (DH)).
Deel III: Pathofysiologie van atherosclerose in muismodellen:
beeldvormingsresultaten
Hoofdstuk 6: Beeldvorming van de anatomie en (patho)fysiologie met
ultrageluid
Dit hoofdstuk gee een overzicht van de ultrageluid meetresultaten. In beide
muizenrassen, het ApoE−/− en het ApoE−/− Fbn1C1039G+/− ras, werd het
ultrageluid onderzoek 5 wekelijks uitgevoerd. We onderzochten de halsslag-
ader (CCA), de interne halsslagader (ICA) en de externe halsslagader (ECA)
aan zowel de linker- als de rechterzijde. Eerst werd de bloedsnelheid op-
gemeten met Pulsed Doppler ultrageluid. De belangrijkste trends waren:
(i) een stijging van de snelheid in de ECA en ICA met het verloop van tijd,
(ii) een kleine daling in de pieksnelheid van de CCA na verloop van tijd,
(iii) geen statistisch verschil tussen linker en rechter halsslagaders en (iv)
de meeste snelheidswaarden verschilden tussen de ApoE−/− en de ApoE−/−
Fbn1C1039G+/− muizen. Gebaseerd op deze snelheden werden een resistieve
index (RI) en een pulsatiele index (PI) berekend. Met uitzondering van RI
in de ECA (hoger voor het ApoE−/− Fbn1C1039G+/− ras), had het ras geen sta-
tistische invloed op beide parameters. Vervolgens werden de diameters van
dezelfde bloedvaten opgemeten met M-mode ultrageluid. Deze diameters
vertoonden geen statistisch signicante trends, behalve dat tijd een signi-
cante factor was voor de ECA diameter, waarbij de diameter gemiddeld
genomen afneemt naarmate het experiment vordert. De distensibiliteit van
de CCA was hoger dan van andere twee takken.
Hoofdstuk 7: Goud partikel contrast µCT: detectie van kwetsbare
plaques
De inltratie van macrofagen in atherosclerotische plaque is één van de
tekenen die wijzen op een kwetsbare plaque die mogelijks aanleiding gee
tot klinische complicaties. Dit hoofdstuk beschrij een nieuwe techniek om
de inltratie van macrofagen in de plaque te meten aan de hand van goud-
nanopartikels contrast µCT. Op deze manier is een functionele component
toegevoegd aan µCT dat anders beperkt blij tot anatomische beeldvorming.
In deze studie werden zowel ApoE−/− als ApoE−/− Fbn1C1039G+/−muizen
opgevolgd gedurende een vetrijk dieet van 20 weken. Op weken 10, 15 en 20
werd er een µCT scan protocol uitgevoerd. Dit protocol bestond uit een pre-
en een post-contrastinjectie beeld. Een interessante observatie was dat op
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de pre-contrastinjectie beelden van weken 15 en 20 er nog contrast zichtbaar
was in de bloedvatwand van vorige meetpunten. Histologisch onderzoek
bevestigde dat deze contrastpartikels zich op dezelfde plaats bevinden als de
macrofagen.
Nadat er een angiograsch beeld gecreëerd was, werden de halsslagaders
gesegmenteerd met het publiek beschikbare sowareplatform VMTK. De
aanwezigheid van contrast in de vaatwand werd op het lumen oppervlakte
geprojecteerd door een speciaal ontwikkeld algoritme. Daardoor werd een
grasche weergave (aan de hand van een kleurcodering) bekomen van de
macrofaaginltratie op de lumen oppervlakte.
Voor de drie takken van de bifurcatie (CCA, ECA en ICA) werd de
oppervlakte berekend van de vaatwand waar macrofaaginltratie kon wor-
den gedetecteerd (contrast-enhanced area fraction (CAF)). Deze numerieke
waarde vertoonde een duidelijke stijging van week 15 naar week 20. Boven-
dien toonde dit ook aan dat er een hogere mate van macrofaaginltratie
merkbaar was bij de ApoE−/− Fbn1C1039G+/− muizen in vergelijking met de
ApoE−/− muizen. De sterkste mate van macrofaaginltratie werd gemeten in
de ECA en de zwakste in de ICA.
Nadat de globale aanwezigheid van macrofaaginltratie was bestudeerd
aan de hand van de CAF waarden, werden de precieze locaties langsheen de
bloedvaten waar dit optrad, onderzocht. Dit toonde dat de macrofaaginl-
tratie in de CCA beperkt bleef tot de regio net proximaal van de bifurcatie.
Voor beide takken van de bifurcatie (ECA en ICA) vertoonde de macrofaag-
inltratie echter meer uitgesmeerde patronen.
Als slot van dit hoofdstuk is nog een extra sectie toegevoegd waar de mo-
gelijkheid wordt onderzocht om een angiograsch beeld van de bloedvaten
in de muizenhersenen te maken. Om dit angiograsch beeld te bekomen,
wordt het pre-contrast injectie beeld (met daarop de schedel zichtbaar) van
het post-contrastinjectie beeld (met daarop zowel de bloedvaten als de sche-
del zichtbaar) afgetrokken. Dit resulteert in een 3D-beeld waar enkel de
vasculatuur nog in overblij.
Deel IV: De rol van wandschuifspanning in de pathofysiologie van
atherosclerose in muismodellen
Hoofdstuk 8: Bestuderen van de wandschuifspanningsparameters met
behulp van muisspecieke vloeistof-structuur interactie simulaties
Dit hoofdstuk beschrij een methodologie die gebruikt kan worden om de
wandschuifspanning en afgeleide grootheden te berekenen ter hoogte van
de vertakking van de halsslagader in muizen. Dit algoritme is gebaseerd op
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vloeistof-structuur interactie (uid-structure interaction (FSI)) simulaties
van 8 verschillende halsslagaders (4 linkse en 4 rechtse) voor 4 verschillende
ApoE−/− muizen. De metingen waarop deze modellen zijn gebaseerd, zijn
uitgevoerd wanneer de muizen 10 weken op het vetrijke dieet waren. Op dat
tijdstip was er nog geen vernauwing van het bloedvat merkbaar.
Voor het opstellen van het model is er gebruik gemaakt van in vivo beeld-
vorming om de fysiologische realiteit zo dicht mogelijk te benaderen. De
snelheidsmetingen van de bloedstroom in de CCA, ECA en ICA werden
herschaald naar een massadebiet. Door beperkingen qua meetnauwkeurig-
heid, was de tijdsgemiddelde massa-instroom niet gelijk aan de gemiddelde
massa-uitstroom. Daarom werden de massadebieten van de ECA en de ICA
herschaald om te voldoen aan de massabalans, uitgemiddeld over 1 cyclus.
Nadien werd het massadebiet van zowel de CCA en de ECA aan de randen
van het model opgelegd. Voor de ICA werd de opgemeten diameter lineair
herschaald naar een drukcurve met literatuur gebaseerde diastole en systole
waarden. Samen met het massadebiet laat dit ons toe om een 3-elementen
windketelmodel aan te passen aan de metingen. Dit windketelmodel linkt
het massadebiet aan de druk aan deze rand van het model.
De geometrie was bekomen door de segmentatie van de µCT metingen.
Vervolgens werd de geometrie gekrompen naar de diastole diameter, gemeten
met M-mode ultrageluid.
De in vivo spanningstoestand onder een axiale voorspanning en een
inwendige druk werd berekend op basis van twee opeenvolgende “backwards
incremental method (BI)” stappen. De BI methode is een iteratief proces
waarbij de inwendige spanningen worden berekend onder een bepaalde be-
lasting, gegeven de vervormde geometrie. Deze interne spanningstoestand
werd opgelegd als een initiële spanningstoestand bij de numerieke simulaties.
Daarnaast werd het externe weefsel dat het bloedvat omgee gemodelleerd
met veer-elementen. Zowel de voorspanning als het externe weefsel werden
toegevoegd om de beweging en dus ook de buerende werking van het bloed-
vat zo realistisch mogelijk te benaderen. Daarnaast hebben beide modellen
een stabiliserende invloed op de berekeningen.
Met behulp van Tango werden de structuurmechanica en de vloeistofdy-
namica gekoppeld. Na het bepalen van de oplossing werden dan de wand-
schuifspanning en afgeleide grootheden bepaald.
Op basis van deze FSI resultaten kon dan de buitenkant van de sinus
van de ECA geïdenticeerd worden als regio met het meeste kans op ontwik-
keling van atherosclerose, uitgaande van de veronderstelling dat de zones
onderworpen aan lage en oscillerende wandschuifspanning hetmeest vatbaar
zijn voor de ontwikkeling van slagaderverkalking. Voor al de verschillende
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berekende bifurcaties had deze zone de meest kritische waarde van de drie
berekende grootheden: TAWSS, OSI en RRT. Bovendien toonden we ook
aan dat de buerende capaciteit van de bloedvatwand onontbeerlijk is om de
randvoorwaarden correct te kunnen opleggen.
Hoofdstuk 9: Vergelijken van verschillende numerieke methodologieën
om wandschuifspanning te berekenen
Het vloeistof-structuur interactiemodel dat beschreven is in hoofdstuk 8,
is één van de meer geavanceerde mogelijkheden om deWSS te berekenen.
Eenvoudigeremethodes zijn reedsmeermaals gebruikt. Demeest eenvoudige
zijn de CFD-simulaties waar de tijdsafhankelijkheid wordt verwaarloosd en
een constante bloedstroom wordt verondersteld (=tijdonafhankelijke CFD).
Bij deze techniek kan ofwel de gemiddelde snelheid ofwel de maximale snel-
heid worden opgelegd als randvoorwaarden. Transiënte CFD berekeningen
zijn een andere mogelijkheid. Deze modellen zijn gelijkaardig aan de FSI-
modellen in het vloeistofdomein, maar ze houden geen rekening met de
beweging en dus ook buerende werking van het bloedvat.
Voor de verschillende simulatietechnieken bekwamen we vervolgens
verschillende (tijdsgemiddelde) waardes voor de WSS van 3.25, 7.54, 3.42
en 2.85Pa voor respectievelijk de gemiddelde snelheid tijdonafhankelijke
CFD, de maximale snelheid tijdonafhankelijke CFD, de transiënte CFD en
de transiënte FSI simulaties. Wanneer de bekomen resultaten echter wer-
den genormaliseerd (door te delen door de gemiddelde waarde), waren de
bekomen patronen zeer gelijkaardig. Het oscillerend karakter van de WSS
kon niet bestudeerd worden met de tijdonafhankelijke berekeningen. De
transiënte FSI berekeningen vertoonden stromingspatronen met een hoger
oscillerende karakter in vergelijking met de transiënte CFD-berekeningen.
In het tweede deel van hoofdstuk 9 wordt onderzocht of de fysieke ac-
tiviteit van de muis een invloed hee op de bekomen resultaten. Een muis
onder verdoving zal immers een lagere hartslag, een lagere debiet van de
bloedstroom en een lagere bloeddruk hebben ten opzichte van een muis die
bij bewustzijn is. In de literatuur werd reeds de hypothese geopperd dat dit
een invloed kan hebben op de waargenomenWSS patronen∗. Wanneer de
muis fysiek actief is, zullen de fysiologische parameters nog meer toenemen
en dus nog verder weg afdrijven van de waardes opgemeten onder anesthesie.
Daarom wordt onderzocht of anesthesie en de graad van fysieke activiteit
een invloed hebben op de numerieke resultaten.
∗Z. Mohri, E. M. Rowland, L. A. Clarke, A. De Luca, V. Peier, R. Krams, S. J.
Sherwin en P. D. Weinberg, „Elevated Uptake of PlasmaMacromolecules by Regions
of Arterial Wall Predisposed to Plaque Instability in a Mouse Model”, PLoS ONE,
deel 9, nr. 12, e115728, 2014
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VanAnesthesie naar Rust en vervolgensActief nam de TAWSS telkens toe.
De genormaliseerde TAWSS patronen vertoonden echter amper verschillen.
Voor alle OSI berekeningen was dezelfde locatie blootgesteld aan de hogere
waardes. Voor de case Actief was deze zone wel meer uitgebreid. Voor de
hogere niveaus van activiteit werden zones waargenomen waar de WSS van
richting omkeerde. Dit gebeurde hoofdzakelijk aan de buitenkant van de
ECA, wat waarschijnlijk de grotere zone met een verhoogde OSI verklaart.
Hoofdstuk 10: De correlatie tussen atherosclerose en op
wandschuifspanning gebaseerde grootheden
In hoofdstuk 7 werd de macrofaaginltratieverdeling overheen het lumen
oppervlak berekend op weken 15 en 20 na de start van het vetrijke dieet.
Daarnaast werd in hoofdstuk 8 deWSS-verdeling berekend voor 8 bifurcaties
van 4 ApoE−/− muizen. Deze berekeningen waren gebaseerd op metingen
gedaan 10 weken na de start van het vetrijke dieet, voordat vernauwing van
de bloedvaten zichtbaar was. Daardoor hebben we de unieke mogelijkheid
om beide datasets te linken aan elkaar op een individuele muis basis. In
tegenstelling tot wat de meeste studies beschrijven in de wetenschappelijke
literatuur, hebben wij immers de WSS grootheden distributie en de macro-
faag distributie voor dezelfde proefdieren, wat ons toelaat om een gepaarde
statistische test uit te voeren.
Deze vergelijking werd uitgevoerd op 3 verschillende niveaus: (i) het
individuele bloedvatniveau, (ii) het individuele bifurcatieniveau en (iii) de
totale populatie (= 7 bifurcaties). Al deze vergelijkingen werden uitgevoerd
voor de macrofaaginltratie datasets van weken 15 en 20. De vergelijking
gebeurde aan de hand van de Spearman correlatiecoëciënt ρs. Deze corre-
latiecoëciënt veronderstelt niet dat het verband lineair is zoals de Pearson
correlatiecoëciënt wel doet. Bij ρs wordt er enkel een monotoon verband
verondersteld tussen beide grootheden. Om een vergelijking mogelijk te
maken werden de datasets van de 3 verschillende tijdstippen (week 10 - FSI,
weken 15/20 - macrofaaginltratie) op eenzelfde rechthoekige grid geprojec-
teerd per bloedvat met behulp van VMTK.
Op het individuele bloedvatniveau werd de surrogaat sample data ana-
lyse (SSDA) herhaaldelijk uitgevoerd voor de individuele bloedvaten van de
individuele muizen. De SSDA is een eenzijdige statistische test om spatiële
correlaties tussen 2 distributies te bestuderen. Deze methode wordt in meer
detail beschreven in Appendix B. Als resultaat van deze test bekomen we
de waarde voor ρs, zijn betrouwbaarheidsgrens (enkelzijdig equivalent van
het betrouwbaarheidsinterval) en de p-waarde. Voor de dataset op week 15
werden geen signicante correlaties gevonden. Een statistisch signicante
positieve correlatie werd gevonden tussen de macrofaaginltratie op week
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20 en de RRT waarde op week 10 voor 4 van de 7 geteste CCA. De TAWSS
was statistisch signicant negatief gecorreleerd met de macrofaag inltratie
in 4 van de 7 CCA. Voor zowel de transWSS en de OSI werden voor 2 van de
7 CCA een signicante positieve correlatie gevonden. Voor zowel de ECA
als de ICA werden geen signicante correlaties gevonden.
Voor het individuele bifurcatieniveau werd dezelfde testmethode toe-
gepast, hoewel hier de drie takken (CCA, ECA en ICA) per bifurcatie nu
in 1 enkele test werden samengevoegd. Dit resulteerde in respectievelijk 4,
2, 4, 2, 1 en 0 signicante correlaties voor de TAWSS, OSI, RRT, transWSS,
HI en de DH. Op het individuele bifurcatieniveau is de correlatie dus meer
uitgesproken aanwezig dan op het individuele bloedvatniveau. Tevens was
de ruimtelijke correlatie met de macrofaaginltratie het hoogst voor de RRT.
Voor de statistische testen, uitgevoerd op het populatieniveau, werd een
verschillende methodologie gevolgd. Voor de verschillende bifurcaties werd
ρs reeds bepaald als resultaat van de testen, op het individuele bifurcatieniveau
(vorige paragraaf). Een Fisher r naar z transformatie werd uitgevoerd op
deze ρs waardes. Vervolgens kon dan een gepaarde t-test uitgevoerd worden
om zowel de populatie gemiddelde ρs, de betrouwbaarheidsgrens en de p-
waarde te berekenen. De populatie gemiddelde ρs waardes waren -0.144,
0.118, 0.148, 0.121, 0.057 en 0.016 voor respectievelijk de TAWSS, OSI, RRT,
transWSS, HI en de DH. Voor de TAWSS, OSI, RRT en transWSS was de
gevonden correlatie statistisch signicant. Op het populatieniveau is de
correlatie dus hoger dan op het individuele bifurcatieniveau. Ter vergelijking
werd ook een SSDAuitgevoerd over de uitgemiddeldewaarde, zoals algemeen
wordt uitgevoerd in de literatuur. Dit resulteerde in een overschatting van de
gevonden correlaties.
Tot slot werd dezelfde methodologie (Fisher r naar z transformatie ge-
volgd door een gepaarde t-test) toegepast om de verschillende WSS parame-
ters met elkaar te vergelijken op het populatieniveau. De DH werd hierbij
niet meegenomen in de vergelijking, omdat deze waarde constant was over
de hele bifurcatie, met uitzondering van een kleine zone ter hoogte van het
stagnatie punt van de bloedstroom. De correlatie tussen de transWSS en de
andere WSS parameters was laag, wat een indicatie is dat de transWSS een
andere fysisch proces beschrij dan de overige WSS parameters. Voor de
andere WSS parameters werd een uiterst signicante, negatieve correlatie
gevonden met de TAWSS. De overblijvende WSS parameters waren uiterst
signicant, positief met elkaar gecorreleerd. We kunnen dus besluiten dat de
verschillende WSS parameters niet onafhankelijk zijn van elkaar.
Deel V: Conclusies
De 3 intermediaire doelen van dit onderzoek werden gerealiseerd. Ten eerste
werd een in vivo beeldvormingstechniek ontwikkeld om macrofaaginltratie
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te kwanticeren in atherosclerotische plaques in muizen. Deze techniek
is gebaseerd op goud-nanopartikel contrast µCT. Ten tweede stelden we
een op vloeistof-structuur interactie gebaseerde methodologie voor om de
hemodynamica in de halsslagaders van muizen zo realistisch mogelijk te
simuleren. Ten derde kwanticeerden we de ruimtelijke correlatie tussen
verschillende wandschuifspanningsparameters enerzijds en de aanwezigheid
van plaque in de bifurcatie van de halsslagader in de muis anderzijds. De
sterkste correlaties met de macrofaag inltratie werden gevonden voor een
(lage) TAWSS en een (hoge) RRT.
Het is echter belangrijk om niet uit het oog te verliezen dat de hemodyna-
mica slechts 1 aspect is van het complexe proces van atherosclerosevorming.
Bovendien vertalen deze resultaten zich niet rechtstreeks naar de mens. De
hemodynamische omgeving in de muis zijn behoorlijk verschillend van de
menselijke hemodynamische omgeving, met veel lagere Reynolds (∼25 keer
lager†) en Womersley (∼9 keer lager†) getallen die aanleiding geven tot lami-
naire en gestructureerde stroompatronen, met minder secundaire stroom en
recirculatie in de zone van de bifurcatie. Een volgende stap richting humane
applicaties kan dan ook zijn om een gelijkaardige methodologie toe te passen
op een proefdier waarvan de hemodynamische omgeving deze van de mens
beter benadert zoals het varken.
Plaqueruptuur, een belangrijk biomechanisch onderzoeksdomein, werd
niet nader onderzocht in dit werk. De FSI-methodologie bevatte reeds een
simpel mechanisch model van de bloedvatwand, maar een complexer model
van zowel de bloedvatwand als de atherosclerotische plaque zijn nodig om
ook plaque ruptuur te bestuderen. Hiervoor is echter hoge resolutie data
nodig van zowel de morfologie als de samenstelling van de bloedvatwand en
de plaque. Recente vooruitgang in hoge resolutie en hoog contrast ex vivo
beeldvorming maken het mogelijk om onderzoek te doen in dit domein.
Dit werk integreert verschillende onderzoeksdomeinen. Signicante
verbeteringen / vooruitgang in één of meerdere van deze domeinen zullen
nieuwe mogelijkheden creëren in de toekomst. Meer speciek, vooruitgang
met betrekking tot beeldsegmentatie enmeshingtechnieken zullen de hoeveel-
heid manueel en dus tijdsintensief werk dat noodzakelijk is om kwalitatieve
modellen te bekomen, beperken. Dit zal het mogelijk maken om de op-
gestelde methodologie uit te voeren op een grotere groep proefdieren om
statistisch robuustere resultaten te bekomen.
†J. Suo, D. E. Ferrara, D. Sorescu, R. E. Guldberg, W. R. Taylor en D. P. Giddens,
„Hemodynamic shear stresses in mouse aortas: implications for atherogenesis.”
Arteriosclerosis, thrombosis, and vascular biology, deel 27, nr. 2, p. 346–51, 2007
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Introduction
Cardiovascular diseases are the main cause of death world-wide. Atheroscle-
rosis is a cardiovascular disease characterised by the formation of plaque in
large- to middle-sized arteries. Atherosclerosis is a slowly progressing dis-
ease, a complicated biological process that includes many dierent signalling
pathways.e two main processes that occur are the accumulation of lipids
in the arterial wall and the inammation of the arterial wall.
Most of the known risk factors are systemic phenomena such as smoking,
high blood pressure, age and high lipid levels. In contrast, atherosclerotic
plaque develops preferentially at the inner bend of arteries and at bifurcations.
It is generally accepted that local haemodynamics is a factor that can (par-
tially) explain this focal character of atherosclerosis.e haemodynamics
trigger the onset of atherosclerosis through the shear force (wall shear stress
(WSS)) that the ow exerts on the endothelial cells lining the arterial wall. A
low and/or oscillatory behaviour of this shear force results in the activation
of atheroprone signalling pathways.
One of the factors complicating fundamental research on the role of
haemodynamics is the fact that baseline shear stress patterns, prior to any
disease development, need to be linked with the occurrence of atherosclerosis
at a later stage.erefore, most of the available studies compareWSS patterns,
measured in a rst group of subjects, with lesion maps measured in a second
group of subjects (cross-sectional analysis rather than longitudinal). To do
this, averaged datasets (=aggregating) are calculated for both groups.e
risk of aggregating datasets is that the nal correlation between the WSS and
atherosclerosis development can be overestimated. In this PhD thesis, it is
our goal to study the a link between WSS and atherosclerosis development
on a within-subject basis in a longitudinal study design, eliminating the need
for the aggregation step.is leads to the central research question of this
thesis:
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Is there an individual and quantitative link between baseline wall shear
stress and subsequent plaque development in mouse models of
atherosclerosis?
In the current work make use of mouse models of atherosclerosis, be-
cause these allow for a longitudinal follow up. More specically, we target
the carotid bifurcation of these mice as this is one of the locations prone to
atherosclerosis development. To be able to answer the research question sev-
eral intermediate goals need to be reached. An in vivo technique to measure
the plaque locations in the murine vasculature has to be developed. Next,
(existing) numerical methods need to be combined to simulate the murine
vasculature. Finally, appropriate statistical testing is needed to quantify the
link between WSS and atherosclerosis.
Part I: Studying atherosclerosis in mice
Chapter 1: Atherosclerosis
is rst chapter provides a background on the anatomy and physiology of
the human cardiovascular system that consists of the heart and the vascu-
lature. A broad overview of the main arteries in the human body is given. A
more in depth anatomical description of the arteries supplying the head and
the brain is provided.e common carotid artery (CCA), external carotid
artery (ECA) and internal carotid artery (ICA) are the region of interest in the
current dissertation.e second section of this chapter explains the patho-
logy of atherosclerosis, which is a disease characterised by the formation
of plaques in the arterial wall. e two main processes are the inltration
of lipids in the arterial wall and inammation. Aer the description of its
pathogenesis, severe clinical complications of atherosclerosis are illustrated.
Rupture of plaques can lead to thrombus formation resulting in myocardial
infarction or stroke, the main causes of death worldwide. Aerwards two
classication systems of atherosclerotic plaques are given. Several risk factors
for cardiovascular diseases are generally known. For atherosclerosis these
risk factors are: gender, age, genetic factors, hypertension, obesity, smoking
and alcohol consumption. ese risk factors are systemic risk factors, yet
plaques tend to develop at specic locations. Haemodynamics are one mech-
anism explaining the focal atherogenicity.e last section of this rst chapter,
describes how the blood ow is responsible for activation of atherogenic
pathways through the WSS sensed by the endothelial cells (ECs).
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Chapter 2: Mouse models of atherosclerosis
e slow time course of atherosclerosis development in humans is a major
drawback for studies on atherosclerosis. erefore several animal models
mimicking human atherosclerosis have been developed.is second chapter
starts with an overview of rabbits, pigs and non-human primates as animal
models for atherosclerosis. Aerwards, the mouse model is described in
more detail because it has some very specic advantages: cheap, short gen-
eration time, easy genetic manipulation and complex lesions are present in
specic strains. Next to this, the use of larger numbers of animals is feas-
ible, allowing for statistically robust results. In addition, rodent models are
ethically more accepted for pre-clinical research. One strategy to study the
impact of haemodynamics on atherosclerosis development is to make use of
surgical techniques to manipulate the blood ow.e main disadvantage of
mousemodels, however, is that the normal wild typemouse is rather resistant
to atherosclerosis development. Some of the inbred strains, however, are
susceptible to diet-induced atherosclerosis showing complex lesions with
the C57BL/6J strain the most commonly used. To elevate the plasma levels
of lipoproteins even further, the low density lipoprotein receptor knockout
(LDLR−/−) and apolipoprotein E knockout (ApoE−/−) mice were introduced.
e ApoE−/− mouse is commonly used because complex plaques are found
in this mouse model. Recently, the apolipoprotein E decient and fbn1
heterogeneous (ApoE−/− Fbn1C1039G+/−) mouse model was developed at the
University of Antwerp.is mouse model shows signs of spontaneous plaque
rupture, which is rare in the other mouse models. In the current work, both
ApoE−/− and ApoE−/− Fbn1C1039G+/− mice were studied, enabling in-depth
investigation of complex atherosclerotic lesions.
Chapter 3: Imaging atherosclerosis in mice
Ultrasound (US) and micro-computed tomography (µCT), the two main in
vivo imaging techniques that were used in this thesis, are introduced. US uses
ultrasonic acoustic waves beyond the audible range. Several dierent images
can be obtained depending on the processing technique. B-mode images
provide a 2D view of the anatomical structures. M-mode show the variation
of a single scan line over time and can be applied to assess the pulsatility of
an artery. Pulsed Doppler imaging can be used to measure the velocity of
the blood.e small animal US measurements are challenging due to the
higher heart and smaller size of mice compared to humans. For this purpose
a special scanner, the Vevo2100, was used for this dissertation.
Computed tomography (CT) is based on ionising radiation. A CT scan-
ner consists of three parts: the X-ray tube (source), the object and the detector.
e X-ray tube generates a cone beam of X-rays.ese X-rays penetrate the
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object, in the current work a mouse, before they are registered on a detector.
When the X-rays travel through tissue, they get partially attenuated depend-
ing on the attenuation coecients of the tissues it travels through. During
a CT measurement, several projections for dierent angles are measured.
In small animal µCT, both the X-ray tube and the detector rotate around
the mouse to measure projections at dierent angles. Aer a reconstruction
process, a 3D dataset with attenuation coecients is obtained, describing the
anatomy of the mouse.e main challenge for vascular small animal µCT,
is obtaining enough contrast. Several contrast agents have been developed
for this purpose. In the current research, a gold-nanoparticle contrastagent
(Aurovist 15nm) has been used.
Part II: Computational techniques to study arterial
haemodynamics
Chapter 4: Numerical simulations of arterial haemodynamics
To know the ow eld at a great level of detail, it is generally calculated using
computational uid dynamics (CFD) simulations. In chapter 4, some back-
ground is given on the numerical techniques that are applied in chapters 8
and 9. First, the equations governing the ow of an incompressible uid are
described.ese equations can be solved using computational uid dynam-
ics.e motion of the of the carotid arteries induced by the blood pressure
and blood ow is included in the simulation methodology to incorporate
their buering capacity in the model.e second part of chapter 4 describes
the equations governing the solid mechanics (arterial wall) and the solu-
tion method of these dierential equations (computational solid mechanics
(CSM)). Finally, the uid mechanics and the solid mechanics models need to
be coupled to solve the uid-structure interaction (FSI) problem. A general
overview of the partitioned, strongly coupling technique Tango is given in
the last part of chapter 4.
Chapter 5: Haemodynamic wall parameters
In this PhD thesis, we are more interested in the biomechanical inuence
that the blood ow has on the ECs, rather than in the blood velocity eld
itself.e ECs form the barrier between the blood ow and the arterial wall
and are thus a crucial component in the mechanosensing, that sets o the
atheroprone pathways. More specically, the ECs sense the shear force (WSS)
that the blood ow exerts on the arterial wall. Over the years a vast amount
of metrics (haemodynamic wall parameters (HWPs)) have been developed
all aiming to quantify that component of WSS that optimally quanties its
atheroprone eect. Chapter 5 lists the most commonly calculated HWPs and
illustrates them on the basis of an example.e rst section lists the HWPs
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that are based on the magnitude of the WSS: time averaged wall shear stress
(TAWSS), oscillatory shear index (OSI), relative residence time (RRT) and
transverse wall shear stress (transWSS).ese parameters give a description
of (a combination of) the magnitude, the oscillatory behaviour and the multi-
directionallity of the WSS. A second group of HWPs are the harmonic based
HWPs. ese describe the atheroprone eect of WSS in function of the
harmonic content in the frequency domain of the WSS. Both the harmonic
index (HI) and the dominant harmonic (DH) metrics belong to this group
and are described in this chapter.
Part III: Pathophysiology of atherosclerosis in mouse models:
imaging results
Chapter 6: Assessment of carotid anatomy and (patho)physiology using
US
is chapter gives an overview of the ultrasound measurement results. In
both strains of mice that were followed up, the ApoE−/− and ApoE−/−
Fbn1C1039G+/− strains, the US imaging protocol was performed 5-weekly,
during the time when they were on a western-type diet. We investigated
the common (CCA), external (ECA) and the internal (ICA) carotid artery,
and this on both the le and the right side. First, the blood velocity was
assessed using pulsed wave Doppler ultrasound (PWDoppler US).e main
trends that were present are: (i) an increase in velocity for the ECA and the
ICA with time, (ii) a small decrease in peak velocity for the CCA, (iii) no
statistical dierence between le and right side and (iv) most velocity based
metrics were dierent for both strains of mice. From the measured velocities,
the resistivity index (RI) and pulsatility index (PI) were calculated. With
exception of the RI of the ECA, there was no signicant inuence of mouse
strain for those parameters. Using M-mode imaging the luminal diameter of
the arteries was measured 5-weekly at the same three locations.is showed
no statistically signicant trends except time was a signicant grouping
factor for the ECA diameter. For the distensibility the most important trend
was that the distensibility of the CCA is higher compared to the other 2
branches.
Chapter 7: Gold particle–enhanced µCT: vulnerable plaque detection
Macrophage inltration in atherosclerotic plaques is one of the determinants
of the vulnerability to clinical complications of the plaque.erefore, it is a
main target for studies targeting molecular small animal imaging strategies.
is chapter describes a novel methodology to measure macrophage inlt-
ration into the murine atherosclerotic plaques using gold-nanoparticle-en-
hanced µCT. In this manner functional information is added to the otherwise
purely anatomical µCT imaging technique.
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In this study ApoE−/− and ApoE−/− Fbn1C1039G+/− mice were followed
up during the time they were put on a western-type diet. At weeks 10, 15
and 20 aer the start of the diet, a pre- and post-contrast injection µCT scan
was taken. At the pre-contrast scan of weeks 15 and 20, contrast present
in the arterial wall from the previous injections was still visible. Histology
conrmed that this contrast was co-localised with macrophages.
Aer construction of an angiographic image, the carotid arteries were
segmented using the Vascular Modeling Toolkit (VMTK). Using a dedicated
methodology, the presence of contrast agent around the lumen (inside the
arterial wall), was mapped on the luminal surface. As a result the presence
of macrophage inltration could be graphically represented on the luminal
surface.
For the three branches of the carotid bifurcation (CCA, ECA and ICA),
the area subject to macrophage inltration could be calculated (contrast-
enhanced area fraction (CAF)).is metric showed a clear increase from
week 15 to week 20. Moreover, the ApoE−/− Fbn1C1039G+/−mice showedmore
macrophage inltration than the ApoE−/− mice. Macrophage inltrations
was most extend in the ECA, and the least in the CCA.
Once the global presence of plaque was calculated using the CAF value,
the precise locations of macrophage inltration along the length of the sep-
arate branches were plotted. is showed that macrophage inltration in
the CCA was very well localised in the region immediately proximal to the
carotid bifurcation. For the ECA and the ICA, the macrophage inltration
showed more spread out patterns.
In an extra section of this chapter, the angiographic imaging of the brain
vasculature is explored, as this part of the mouse was also present in the
measured µCT volume. For this goal, the pre-contrast injection µCT scan
(with the skull visible) needs to be subtracted from the post-contrast injection
scan (with both skull and vasculature visible). As such a 3D volume in which
only the vasculature is highlighted is obtained.
Part IV: Role of wall shear stress in the pathophysiology of
atherosclerosis in mouse models
Chapter 8: Assessment of WSS metrics using mouse-specic FSI
simulations
is chapter presents a methodological framework to calculate the WSS and
the HWPs in the murine carotid bifurcation. It is based on FSI simulations
of the carotid bifurcation and is applied to 8 carotid bifurcations (4 le and 4
right) for 4 ApoE−/− mice.e measurements on which the simulations are
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based, were performed at week 10 aer the start of the diet. At that time point,
no narrowing of the carotid arteries could be detected, and we consider these
data as representative for the baseline, pre-disease state of the animal.
e model is based on in vivo measurements to as close as possible
represent the physiological reality.e velocity measurements at the CCA,
ECA and ICA were rescaled to mass ows. Due to measurement limitations,
the cycle-averaged outow was not equal to the cycle-averaged inow, and
thus a rescaling of the ECA and ICA ow was applied to assure a time-
averaged balance of mass. Aerwards, the mass ow of the CCA and ECA
were imposed as boundary conditions (BCs). For the ICA, the diameter
waveform was used as a surrogate for the pressure waveform, and linearly
scaled using literature values for the diastolic and systolic pressure. Together
with the ICA mass ow this enabled us to t a 3-element windkessel model
that mimics the behaviour of the vasculature downstream of the ICA.is
3-element windkessel model was applied at the ICA boundary to link the
pressure with the ow.
e µCTmeasurements were used to segment the geometry of the carotid
bifurcation lumen. is geometry was geometrically shrunk to diastolic
dimensions based on the diastolic diameters measured with ultrasound.
e in vivo stress state under an axial prestress and diastolic pressure was
calculated using two sequential backwards incremental method (BI) steps.
e BI method is an iterative approach to calculate the internal stresses when
the load and the deformed geometry are given.ese internal stresses were
applied as an initial condition to the numeric simulations. Furthermore, the
external tissue surrounding the arteries was modelled using spring elements.
e prestress and the external tissue were added to optimally simulate the
movement and buering of the arterial wall and to stabilise the calculations.
Using Tango the solid and uid models could be coupled and the FSI
problem was solved. Finally,the WSS and the HWPs were calculated.
e results of the FSI simulations of those 8 carotid bifurcations identied
the outer sinus of the ECA as the most atheroprone region based on the low
and oscillatory WSS hypothesis.is zone had the most critical values for all
three HWPs (TAWSS, OSI and RRT). Next to this, we demonstrated that the
incorporation of the buering capacity of the carotid arteries is indispensable
for a correct application of the BCs.
Chapter 9: Comparison of numerical methodologies to assess WSS
e FSI model described in chapter 8, is one of the more sophisticated meth-
odologies to calculate the WSS related parameters. Simpler methods have
been applied abundantly. e most simple ones are based on steady state
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CFDmodels, that ignore the pulsatility of the blood ow. In these models the
blood ow is modelled as a steady ow with either the time-averaged or the
maximum value of the measurements. As a BC either the average measured
mass ow (or velocity) or the peak mass ow (or velocity) can be applied.
Transient CFD simulations are another possibility.ese models are similar
to the FSI simulations for the uid domain, but they do not take into account
the buering of the arteries.
e dierent simulation techniques led to a dierent (time averaged)
wall shear stress value of 3.25, 7.54, 3.42 and 2.85Pa for respectively the average
steady CFD, the peak steady CFD, transient CFD and transient FSI simula-
tions. When, however, the values were normalised (by dividing them by the
average value), the patterns were very similar.e oscillatory behaviour of
the WSS could not be assessed with the steady CFD simulations. e FSI
simulation showed a much higher value of OSI compared to the transient
CFD simulation.
A second part of chapter 9 investigated the inuence of the physical state
of the mouse on the results. When a mouse is under anaesthesia several
physiological parameters change: the animal has a lower heart rate (HR),
lower blood ow and a lower blood pressure. It has been hypothesised in
literature that this can have a considerable inuence on the calculated WSS
and ow patterns‡. When the mouse is highly active, these parameters dri
even further away from the values under anaesthesia.erefore, the inuence
of anaesthesia and activity level of the animal on the numerical results has
been studied.
From Anaesthesia, Rest towards Active, the TAWSS increased.e nor-
malised TAWSS patterns, however, (by dividing through the average value)
showed very similar results. For the OSI, all regimens identied the same
focal location (outer sinus of the ECA), as atheroprone. For the cases with
a higher activity level, this zone was spread out further. Finally, at higher
activity levels, the WSS vector reversed direction in the early deceleration
phase. is phenomenon occurred at the outer sinus of the ECA, which
explains the more spread out zone with high OSI.
Chapter 10: Correlation between atherosclerosis and shear stress
metrics
In chapter 7 the macrophage inltration maps were calculated at weeks 15
and 20 aer the start of the diet when atherosclerosis was present. On the
‡Z. Mohri, E. M. Rowland, L. A. Clarke, A. De Luca, V. Peier, R. Krams, S. J.
Sherwin and P. D.Weinberg, ‘ElevatedUptake of PlasmaMacromolecules by Regions
of Arterial Wall Predisposed to Plaque Instability in a Mouse Model’, PLoS ONE,
vol. 9, no. 12, e115728, 2014
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other hand, in chapter 8, the WSS distribution was calculated for 8 carotid
bifurcations of 4 ApoE−/− mice at 10 weeks aer the start of the diet (before
any stenosis was present). is provides us with the unique opportunity
to link both datasets on a within-subject level. In contrast to most studies
described in literature, we have the HWP map and the lesion map (=macro-
phage inltration) in the same subjects, allowing us to performed a paired
statistical testing approach.
e spatial WSS patterns and the macrophage inltration patters were
compared at three dierent levels: (i) the individual branch level, (ii) the indi-
vidual bifurcation level and (iii) the population level. All these comparisons
were made for the week 15 and week 20 macrophage inltration datasets.e
maps were compared by calculating the Spearman’s correlation coecient ρs .
is correlation coecient does not assume linearity such as the Pearson’s
correlation coecient, but only assumes a monotonic correlation between
both parameters. Before the comparisons were made, the datasets of the
three dierent time points (week10-FSI, weeks15/20-macrophage inltration)
were mapped per branch to the same rectangular grid using VMTK.
At the individual branch level, the surrogate sample data analysis (SSDA)
was repeatedly applied to individual branches for individual mice.e SSDA
is a 1-tailed statistical method to study spatial correlations between two maps
and is described in more detail in Appendix B. As a result ρs, its condence
bound (CB) (1-tailed equivalent of the condence interval) and the p-value
are obtained. At week 15 no signicant correlations were found. At week
20, for 4 out of 7 bifurcations a signicant, positive correlation was found
between the RRT and the macrophage inltration in the CCA.e TAWSS
was signicantly, negatively correlated with macrophage inltration for 4
CCA branches. For both the transWSS and the OSI, a signicant positive
correlation was found for 2 out of 7 CCA branches. For the ECA and ICA no
signicant correlations were present on the individual branch level.
e testing method applied to the individual bifurcation level was similar,
although the three branches (= the whole bifurcation) were now included
into the same test.is resulted in respectively 4, 2, 4, 2 ,1 and 0 bifurcations
with a signicant correlation for the TAWSS, OSI, RRT, transWSS, HI and
DH.erefore, we can conclude that the link between the HWP and the mac-
rophage inltration is more clearly present when assessed at the bifurcation
level.e TAWSS and the RRT provided the highest spatial correlations with
macrophage inltration.
For the statistical testing at the population level, a dierent approach was
followed. For the dierent bifurcations the ρs was already calculated in the
previous section. A Fisher r to z transformation was performed on these ρs
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values. Aerwards, a paired t-test provided the average ρs, its CB and the
p-value.e population average correlations were -0.144, 0.118, 0.148, 0.121,
0.057 and 0.016 for respectively the TAWSS, OSI, RRT, transWSS, HI and
DH.e correlations between the macrophage inltration and TAWSS, OSI,
RRT and transWSS were statistically signicant. We can thus conclude that
the association between WSS and macrophage inltration is higher at the
population level compared to the individual bifurcation level. As a compar-
ison, an statistical test (SSDA) on the aggregated datasets was performed, as
aggregating is commonly performed in literature. is overestimated the
correlation between the HWPs and the macrophage inltration for all the
HWP.
Finally, a similar statistical testing approach (Fisher r to z transform
followed by a paired t-test) was applied to correlate the dierent HWPs at
the population level.e DH was not included in this analysis because it was
constant in almost the complete bifurcation (for all bifurcations) except for a
very small zone at the stagnation point.e statistical analysis showed that
the ρs between the transWSS and the other HWPs is low, indicating that the
transWSS describes a dierent process compared to the other HWPs. For
the other HWPs highly signicant, negative correlations were found with the
TAWSS. Between all the remaining HWP-pairs a highly signicant, positive
correlation was found. We can thus conclude that the dierent HWPs are no
independent measures.
Part V: Conclusions
ree major intermediate research goals have been achieved. First, an in vivo
imaging technique of the macrophage inltration in atherosclerotic plaques
provided a quantitative marker for plaque development in mice.is tech-
nique is based on a novel application of gold-nanoparticle-enhanced µCT.
Secondly, we provided a uid-structure interaction based methodology to
simulate the haemodynamics in the murine carotid bifurcation as realistic
as possible. irdly, we quantied the association and spatial correlation
between several shear stress metrics and presence of plaque in the mouse ca-
rotid bifurcation, with (low) TAWSS and (high) RRT providing the strongest
correlation
It is, however, important to keep in mind that haemodynamics are only
one aspect involved in this complex process, and that caution is warranted
when extrapolating our ndings to the human setting. Mouse haemodynam-
ics are quite dierent from human haemodynamics, with the much lower
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Reynolds (∼25 times lower§) and Womersley (∼9 times lower§) numbers
giving rise to muchmore laminar and highly organised ow, with less second-
ary ow and recirculation in the bifurcation region. A next step to human
applications could be the application of a similar framework to a laboratory
animal better mimicking the human vasculature such as for example the pig.
An important biomechanical problem in atherosclerosis research, plaque
rupture, was le untouched in the current work. e FSI methodology
already incorporates a basic model of the arterial wall, but more rened nite
element models of both the arterial wall and the atherosclerotic plaques are
needed to expand the topic to plaque rupture. Furthermore, this will require
high resolution data on the exact morphology and composition of the arterial
wall and plaque. Recent advances in high resolution and high contrast ex
vivo imaging, however, opened the doors for this eld of research.
Because the current work integrates several dierent several research
elds, advances in all these dierent elds will provide opportunities for
future work. In particular, advances in image segmentation and meshing
techniques may limit the manual and time consuming work needed to obtain
high quality models.is would allow to apply the developed methodologies
on larger animal groups to get more statistically robust results.
§J. Suo, D. E. Ferrara, D. Sorescu, R. E. Guldberg, W. R. Taylor and D. P. Gid-
dens, ‘Hemodynamic shear stresses in mouse aortas: implications for atherogenesis.’
Arteriosclerosis, thrombosis, and vascular biology, vol. 27, no. 2, pp. 346–51, 2007
xxxiii

Table of contents
Preface ix
Samenvatting xi
Summary xxiii
Table of contents xxxv
Abbreviations and Symbols xliii
Introduction xlix
List of publications liii
I Studying atherosclerosis in mice 1
1 Atherosclerosis 3
1.1 e human cardiovascular system . . . . . . . . . . . . . . . . 3
1.1.1 General overview . . . . . . . . . . . . . . . . . . . . . 3
1.1.2 e systemic circulation . . . . . . . . . . . . . . . . . 5
1.1.3 Main arteries in the head and neck . . . . . . . . . . 5
1.1.4 Structure of the arterial wall . . . . . . . . . . . . . . 7
1.1.5 Dierent types of arteries . . . . . . . . . . . . . . . . 9
1.1.6 Arterial blood pressure . . . . . . . . . . . . . . . . . 11
1.2 Pathology: atherosclerosis . . . . . . . . . . . . . . . . . . . . 12
1.2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . 12
1.2.2 Pathogenesis . . . . . . . . . . . . . . . . . . . . . . . 13
1.2.2.1 Initial steps of atherosclerosis formation . 13
1.2.2.2 Progression of atherosclerosis . . . . . . . 14
1.2.2.3 rombosis and advanced lesions . . . . . 16
1.2.3 Paths to clinical complications . . . . . . . . . . . . . 17
1.2.3.1 (Occlusive) thrombi . . . . . . . . . . . . . 17
xxxv
Table of contents
1.2.3.2 Plaque rupture . . . . . . . . . . . . . . . . 17
1.2.4 Vulnerable plaque . . . . . . . . . . . . . . . . . . . . 18
1.2.5 American Heart Association classication . . . . . . 19
1.2.6 Risk factors . . . . . . . . . . . . . . . . . . . . . . . . 22
1.2.6.1 Non modiable . . . . . . . . . . . . . . . . 22
1.2.6.2 Modiable . . . . . . . . . . . . . . . . . . . 22
1.2.7 Role of haemodynamics in atherosclerosis . . . . . . 23
Bibliography Chapter 1 . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2 Mouse models of atherosclerosis 35
2.1 Animal models of atherosclerosis . . . . . . . . . . . . . . . . 35
2.1.1 e rabbit . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.1.2 e pig . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.1.3 Non-human primates . . . . . . . . . . . . . . . . . . 36
2.2 Mouse models of atherosclerosis . . . . . . . . . . . . . . . . . 37
2.2.1 Surgically manipulated models . . . . . . . . . . . . 38
2.2.2 Dierent mouse strains . . . . . . . . . . . . . . . . . 39
2.2.2.1 C57BL/6J . . . . . . . . . . . . . . . . . . . 40
2.2.2.2 LDLR−/− . . . . . . . . . . . . . . . . . . . 40
2.2.2.3 ApoE−/− . . . . . . . . . . . . . . . . . . . . 40
2.2.2.4 ApoE−/− Fbn1C1039G+/− . . . . . . . . . . . 43
2.3 e murine cardiovascular system . . . . . . . . . . . . . . . . 43
Bibliography Chapter 2 . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3 Imaging atherosclerosis in mice 55
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.2 Ultrasound imaging in mice . . . . . . . . . . . . . . . . . . . 55
3.2.1 General US principle . . . . . . . . . . . . . . . . . . . 55
3.2.2 Interaction between ultrasonic waves and tissue . . . 57
3.2.3 Dierent US imaging modalities . . . . . . . . . . . . 58
3.2.4 e main challenge for small animal ultrasound:
high frequency . . . . . . . . . . . . . . . . . . . . . . 60
3.2.5 e ultrasound measurements in practice . . . . . . 60
3.3 µCT imaging in mice . . . . . . . . . . . . . . . . . . . . . . . 61
3.3.1 General µCT principle . . . . . . . . . . . . . . . . . . 61
3.3.2 Interaction between X-rays and tissue . . . . . . . . . 63
3.3.3 e main challenge for cardiovascular µCT: contrast 64
3.3.4 e µCT measurements in practice . . . . . . . . . . 65
Bibliography Chapter 3 . . . . . . . . . . . . . . . . . . . . . . . . . . 67
xxxvi
Table of contents
II Computational techniques to study arterial haemody-
namics 69
4 Numerical simulations of arterial haemodynamics 71
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
4.2 Computational Fluid Dynamics . . . . . . . . . . . . . . . . . 72
4.2.1 Navier-Stokes equations . . . . . . . . . . . . . . . . . 72
4.2.1.1 Conservation of mass . . . . . . . . . . . . 72
4.2.1.2 Conservation of momentum . . . . . . . . 73
4.2.2 Constitutive law . . . . . . . . . . . . . . . . . . . . . 74
4.2.3 Solution of the uid mechanics equations . . . . . . . 75
4.3 Computational Solid Mechanics . . . . . . . . . . . . . . . . . 76
4.3.1 Conservation of momentum . . . . . . . . . . . . . . 76
4.3.2 Constitutive law . . . . . . . . . . . . . . . . . . . . . 76
4.3.3 Solution of the solid mechanics equations . . . . . . 78
4.4 Fluid Structure Interaction . . . . . . . . . . . . . . . . . . . . 79
4.4.1 Equilibrium conditions . . . . . . . . . . . . . . . . . 79
4.4.2 Monolithic or partitioned FSI approach . . . . . . . . 79
4.4.3 Explicit or Implicit coupling . . . . . . . . . . . . . . 80
4.4.4 Arbitrary Lagrangian-Eulerian formulation . . . . . 80
Bibliography Chapter 4 . . . . . . . . . . . . . . . . . . . . . . . . . 82
5 Haemodynamic wall parameters 85
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.2 Wall shear stress . . . . . . . . . . . . . . . . . . . . . . . . . . 86
5.3 Magnitude-based HWP . . . . . . . . . . . . . . . . . . . . . . 87
5.3.1 Time averaged wall shear stress (TAWSS) . . . . . . . 87
5.3.2 Oscillatory shear index (OSI) . . . . . . . . . . . . . . 87
5.3.3 Relative residence time (RRT) . . . . . . . . . . . . . 88
5.3.4 Transverse wall shear stress (transWSS) . . . . . . . . 88
5.3.5 Other magnitude-based metrics . . . . . . . . . . . . 89
5.3.6 Comparison of the magnitude-based HWP . . . . . 89
5.4 Harmonic-based HWP . . . . . . . . . . . . . . . . . . . . . . 91
5.4.1 Dominant harmonic (DH) . . . . . . . . . . . . . . . 91
5.4.2 Harmonic index (HI) . . . . . . . . . . . . . . . . . . 92
5.4.3 Axial harmonic-based HWP . . . . . . . . . . . . . . 92
5.5 Gradient based HWP . . . . . . . . . . . . . . . . . . . . . . . 93
Bibliography Chapter 5 . . . . . . . . . . . . . . . . . . . . . . . . . . 95
xxxvii
Table of contents
III Pathophysiologyof atherosclerosis inmousemodels: ima-
ging results 99
6 Assessment of carotid anatomy and (patho)physiology using US 101
6.1 Mice included in this study . . . . . . . . . . . . . . . . . . . . 101
6.2 Carotid ow velocities . . . . . . . . . . . . . . . . . . . . . . . 102
6.3 Resistivity and Pulsatility indices . . . . . . . . . . . . . . . . 107
6.4 Carotid diameters . . . . . . . . . . . . . . . . . . . . . . . . . 108
6.5 Carotid distensibility . . . . . . . . . . . . . . . . . . . . . . . 112
6.6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
Bibliography Chapter 6 . . . . . . . . . . . . . . . . . . . . . . . . . 115
7 Gold particle–enhanced µCT: vulnerable plaque detection 117
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
7.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . 119
7.2.1 Mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
7.2.2 In vivo imaging at week 10, 15 and 20 . . . . . . . . . 119
7.2.3 Histologic examination . . . . . . . . . . . . . . . . . 119
7.2.4 Segmentation and image processing . . . . . . . . . 120
7.2.5 Quantifying macrophage presence within the lumen
area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
7.2.6 Quantifying macrophage presence along the centreline 122
7.2.7 Statistical analysis . . . . . . . . . . . . . . . . . . . . 124
7.2.8 Testing for operator independence . . . . . . . . . . . 124
7.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
7.3.1 Available datasets for analysis . . . . . . . . . . . . . . 124
7.3.2 Histology . . . . . . . . . . . . . . . . . . . . . . . . . 125
7.3.3 Validation test for false positive results at week 10 . . 125
7.3.4 Quantication of contrast-enhancement in the arte-
rial branches: CAF and CLF . . . . . . . . . . . . . . 126
7.3.5 Testing for operator independence . . . . . . . . . . . 128
7.3.6 Qualitative visualisation of the contrast-enhanced
regions . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
7.3.7 Precise locations of contrast-enhanced regions in
both groups of mice . . . . . . . . . . . . . . . . . . . 129
7.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
7.4.1 Contrast agent accumulation and distribution . . . . 130
7.4.2 Advantages: imaging technique . . . . . . . . . . . . 133
7.4.3 Advantages: post-processing . . . . . . . . . . . . . . 133
7.4.4 Limitations . . . . . . . . . . . . . . . . . . . . . . . . 134
7.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
7.6 µCT imaging beyond the carotid arteries: the brain vasculature 135
xxxviii
Table of contents
7.6.1 Constructing an angiographic image of the brain . . 136
7.6.2 Segmenting the brain vasculature . . . . . . . . . . . 136
7.6.3 Contrast accumulation in the brain vessels . . . . . . 139
Bibliography Chapter 7 . . . . . . . . . . . . . . . . . . . . . . . . . . 141
IV Role of wall shear stress in the pathophysiology of athero-
sclerosis in mouse models 147
8 Assessment ofWSSmetrics usingmouse-specic FSI simulations 149
8.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
8.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
8.2.1 Mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
8.2.2 Measurements . . . . . . . . . . . . . . . . . . . . . . 150
8.2.2.1 Ultrasound measurements . . . . . . . . . 150
8.2.2.2 µCT measurements . . . . . . . . . . . . . 151
8.2.3 Processing of the measurements . . . . . . . . . . . . 151
8.2.3.1 Ultrasound processing . . . . . . . . . . . . 151
8.2.3.2 µCT processing . . . . . . . . . . . . . . . . 151
8.2.4 Creating a volume mesh using the XTMmethod . . 152
8.2.5 e Wall Mechanics problem . . . . . . . . . . . . . . 153
8.2.5.1 Material Model Parameter Fitting . . . . . 153
8.2.5.2 External tissue support . . . . . . . . . . . 155
8.2.5.3 Initial stresses . . . . . . . . . . . . . . . . . 156
8.2.6 e Flow Mechanics Problem . . . . . . . . . . . . . 157
8.2.6.1 Boundary conditions . . . . . . . . . . . . 157
8.2.7 FSI coupling . . . . . . . . . . . . . . . . . . . . . . . 159
8.2.8 HWP . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
8.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
8.3.1 Fitting the Windkessel model . . . . . . . . . . . . . . 160
8.3.2 e simulated ow eld . . . . . . . . . . . . . . . . . 160
8.3.3 Results for the HWP . . . . . . . . . . . . . . . . . . . 160
8.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
8.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
Bibliography Chapter 8 . . . . . . . . . . . . . . . . . . . . . . . . . 169
9 Comparison of numerical methodologies to assess WSS 175
9.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
9.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
9.2.1 Experimental protocol . . . . . . . . . . . . . . . . . . 177
9.2.2 Post-processing of the measurements . . . . . . . . . 177
9.2.3 Dierent numerical modelling techniques . . . . . . 178
xxxix
Table of contents
9.2.3.1 Steady state CFD simulations . . . . . . . . 178
9.2.3.2 Transient CFD simulations . . . . . . . . . 178
9.2.3.3 Transient FSI simulations . . . . . . . . . . 178
9.2.3.4 Comparing results . . . . . . . . . . . . . . 179
9.2.4 Inuence of anaesthesia and activity . . . . . . . . . . 179
9.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
9.3.1 Dierent simulation types . . . . . . . . . . . . . . . . 181
9.3.2 Inuence of anaesthesia and activity . . . . . . . . . . 181
9.3.2.1 TAWSS . . . . . . . . . . . . . . . . . . . . 181
9.3.2.2 OSI . . . . . . . . . . . . . . . . . . . . . . . 184
9.3.2.3 FSI Recirculations . . . . . . . . . . . . . . 184
9.3.3 Zones with WSS reversal . . . . . . . . . . . . . . . . 186
9.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
9.4.1 Steady CFD vs. Transient CFD vs. Transient FSI . . . 187
9.4.2 Inuence of anaesthesia and activity . . . . . . . . . . 188
9.4.3 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . 192
Bibliography Chapter 9 . . . . . . . . . . . . . . . . . . . . . . . . . 194
10 Correlation between atherosclerosis and shear stress metrics 199
10.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 199
10.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . 201
10.2.1 Mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
10.2.2 In vivo measurements and FSI simulations . . . . . . 202
10.2.3 Derived haemodynamic wall parameters . . . . . . . 202
10.2.4 Mapping the carotid bifurcation . . . . . . . . . . . . 203
10.2.5 Statistical modelling . . . . . . . . . . . . . . . . . . . 203
10.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
10.3.1 Contrast (plaque) accumulation . . . . . . . . . . . . 206
10.3.2 Haemodynamics vs. atherosclerosis in individual
branches . . . . . . . . . . . . . . . . . . . . . . . . . . 206
10.3.3 Haemodynamics vs. atherosclerosis in the complete
bifurcation . . . . . . . . . . . . . . . . . . . . . . . . . 208
10.3.4 Haemodynamics vs. atherosclerosis on a population
level . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
10.3.5 Comparison of the HWPs . . . . . . . . . . . . . . . . 209
10.3.5.1 Visual comparison for a single bifurcation 209
10.3.5.2 Comparison of theHWPs on a population
level . . . . . . . . . . . . . . . . . . . . . . 212
10.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
10.4.1 Week 15 . . . . . . . . . . . . . . . . . . . . . . . . . . 213
10.4.2 Week 20: individual branch level . . . . . . . . . . . . 213
10.4.3 Week 20: individual bifurcation level . . . . . . . . . 213
xl
Table of contents
10.4.4 Week20: population level . . . . . . . . . . . . . . . . 215
10.4.5 Comparing comparisons: which haemodynamic
wall parameter (HWP) to choose? . . . . . . . . . . . 215
10.4.6 Statistical methodology . . . . . . . . . . . . . . . . . 217
10.4.7 Limitations . . . . . . . . . . . . . . . . . . . . . . . . 218
10.4.8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . 219
Bibliography Chapter 10 . . . . . . . . . . . . . . . . . . . . . . . . . 220
V Conclusions 223
11 Conclusions and future perspectives 225
11.1 Research Goals . . . . . . . . . . . . . . . . . . . . . . . . . . . 225
11.2 What about rupture? . . . . . . . . . . . . . . . . . . . . . . . 229
11.3 Where to go from here? . . . . . . . . . . . . . . . . . . . . . . 230
11.4 Take home message . . . . . . . . . . . . . . . . . . . . . . . . 231
Bibliography Chapter 11 . . . . . . . . . . . . . . . . . . . . . . . . . 232
VI Appendices 233
A Linear mixed models 235
A.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
A.2 Description of the numerical data . . . . . . . . . . . . . . . . 235
A.3 GLM: repeated measures ANOVA . . . . . . . . . . . . . . . . 236
A.4 Linear Mixed Model (LMM) . . . . . . . . . . . . . . . . . . . 236
A.4.1 Why LMM in the current PhD thesis? . . . . . . . . . 236
A.4.2 LMM: basic principles . . . . . . . . . . . . . . . . . . 237
Bibliography Appendix A . . . . . . . . . . . . . . . . . . . . . . . . 239
B Surrogate sample data analysis 241
B.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
B.2 Surrogate analysis . . . . . . . . . . . . . . . . . . . . . . . . . 242
B.3 Sample analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
B.4 Condence bound adaptation . . . . . . . . . . . . . . . . . . 245
B.5 Other methods to account for spatial autocorrelation . . . . 247
Bibliography Appendix B . . . . . . . . . . . . . . . . . . . . . . . . 249
C Comparison macrophage inltration and dierent HWPs 251
List of Figures 259
List of Tables 263
xli

Abbreviations and Symbols
Abbreviations
µCT micro-computed tomography.
AHA American Heart Association.
ALE arbitrary Lagrangian-Eulerian.
ANOVA analysis of variance.
ApoE−/− apolipoprotein E knockout.
ApoE−/− Fbn1C1039G+/− apolipoprotein E decient and fbn1
heterogeneous.
BC boundary condition.
BI backwards incremental method.
BP blood pressure.
C57BL/6J inbred strain of laboratory mouse.
CA carotid artery.
CAF contrast-enhanced area fraction.
CB condence bound.
CCA common carotid artery.
CFD computational uid dynamics.
CI condence interval.
CLF contrast-enhanced length fraction.
CSM computational solid mechanics.
CT computed tomography.
DH dominant harmonic.
DH-axial axial dominant harmonic.
DOSI directional oscillatory shear index.
EC endothelial cell.
ECA external carotid artery.
ECG electrocardiography.
ECM extracellular matrix.
Fbn1 brillin-1.
FDG uorodeoxyglucose.
FEM nite element method.
FFT fast Fourier transformation.
xliii
FSI uid-structure interaction.
FVM nite volume method.
GLM general linear model.
HDL high density lipoprotein.
HI harmonic index.
HI-axial axial harmonic index.
HR heart rate.
HWP haemodynamic wall parameter.
ICA internal carotid artery.
IMPACT Iterative Maximum-likelihood Poly-
chromatic Algorithm for CT.
IQN-ILS interface- quasi-Newton with inverse
Jacobian from a least-squares model.
LCB lower condence bound.
LDL low density lipoprotein.
LDLR−/− low density lipoprotein receptor
knockout.
LIC line integral convolution.
LMM linear mixed model.
M-mode US motion mode ultrasound.
MAP mean arterial pressure.
MMP matrix metalloproteinases.
MRI magnetic resonance imaging.
NO nitric oxide.
OSI oscillatory shear index.
OSS oscillatory shear stress.
oxLDL oxidized low density lipoprotein.
PAD peripheral artery disease.
PDE partial dierential equation.
PET positron emission tomography.
PI pulsatility index.
PP pulse pressure.
PRF pulse repetition frequency.
PW Doppler US pulsed wave Doppler ultrasound.
RF radio frequency.
RI resistivity index.
RRT relative residence time.
SA stapedial artery.
SSDA surrogate sample data analysis.
TAWSS time averaged wall shear stress.
TIA transient ischemic attack.
transWSS transverse wall shear stress.
xliv
UCB upper condence bound.
US ultrasound.
VCAM-1 vascular cell adhesion molecule-1.
VLDL very low density lipoprotein.
VMTK Vascular Modeling Toolkit.
VOI volume of interest.
VSMC vascular smooth muscle cell.
VTK Visualization Toolkit.
WSS wall shear stress.
WSSAG wall shear stress angle gradient.
WSSG wall shear stress spatial gradient.
WSST wall shear stress temporal gradient.
XTM Extended TreeMesh method.
Symbols
% Percentage.
λm lock stretch (Arruda-Boyce material).
τ⃗ wall shear stress vector.
m˙ mass ow.
S¯s 2nd Piola-Kirchho stress tensor.
σ¯ stress tensor.
τ¯ shear stress tensor.
ε¯ strain tensor.
µ dynamic viscosity.
µ shear modulus.
ρs Spearman’s rank correlation coe-
cient.
ρ density.
σ stress.
f⃗ body forces.
u⃗ displacement.
v⃗ velocity.
A area.
c body-mass exponent.
d diameter.
i iteration number.
ks spring constant.
ldec spatial de-correlation length.
Mb body mass.
n total number of.
nsmp number of samples.
xlv
nsur number of surrogates.
P pressure.
Q ow.
r Spearman’s correlation coecient.
smap size of the map (grid).
ssmp sample size.
T period.
t time.
U velocity.
V velocity.
W strain energy density function.
X geometry.
Units
µA micro Ampère.
µl microlitre.
µm micrometer.○ degrees.○C degrees Celcius.
%area percentage of the branch area.
%length percentage of the centreline length.
bpm beats per minute.
dl decilitre.
g grams.
GPa Gigapascal.
Gy Gray.
h hour.
HU Hounseld units.
kg kilograms.
kHz kilohertz.
kVp peak kiloVolt.
m meter.
mg milligrams.
MHz Megahertz.
min minute.
ml millilitre.
mm millimetre.
mmHg millimeter of mercury.
MPa Megapascal.
Pa Pascal.
pH pH.
s seconds.
xlvi
Subscripts
f fuid.
s solid.
avg average.
ax axial.
b boundary.
cyl cylinder.
dia diastole.
ed end diastole.
load axial axial prestress load.
max maximum.
mean mean.
min minimum.
smp sample.
sur surrogate.
sys systole.
xlvii

Introduction
Clinical Rationale
Cardiovascular diseases are the leading cause of death world-wide. ey
encompass all diseases aecting the cardiovascular system, that consists of the
heart and the vasculature.e area of interest of this thesis is atherosclerosis,
which is characterised by the formation of plaque in the arterial wall. It is a
slowly progressing disease that sets o as soon as the rst decade of life and
is known as a “silent killer”, as the disease can develop without any symptoms
until it has reached an advanced or lethal state.
e typical atherosclerotic plaque consists of a so core (athe¯ra) lled
with lipids and debris from dead cells. Over this core a hard brous cap
(sclerosis) can develop.e formation of the atherosclerotic plaque is a com-
plicated biological process that includes many dierent cascades.e two
hall marks of the pathology are the accumulation of lipids within the arterial
wall and inammation of the arterial wall. Over time, atherosclerosis grows
and develops dierent characteristics. When at a later stage the brous cap
ruptures, the blood inside the artery comes into contact with the thrombo-
genic content of the plaque and a blood cloth (=thrombus) can form. When
this blood cloth gets stuck in the circulation, possibly downstream from the
spot of origination, this can obstruct the blood ow, depriving specic tis-
sues from the blood ow. Atherosclerosis frequently occurs in the coronary
arteries, which supply the heart muscle with nutrients and oxygen. When a
concurrent thrombus clots the blood ow here, this damages the heart muscle
and leads to myocardial infarction (heart attack). Next to this, atherosclerosis
also frequently occurs in the carotid arteries that supply blood to the head
and brain. In this case rupture of a plaque or thrombus formation can lead
to stroke (brain attack).
Atherosclerosis is a broad and multidisciplinary research eld including
among others physicians, biologists and (biomedical) engineers.e biomed-
ical engineering community has particularly focused on two specic research
questions:
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1. Why does atherosclerosis develop at very specic preferential loca-
tions?
2. What are the determinants of plaque rupture and which plaques are at
risk of rupture?
plaque development and haemodynamics
e current PhD thesis focuses on the rst question. Atherosclerotic plaques
tend to develop at very specic locations; preferentially at the inner bends of
curved arteries and at bifurcations, which are both regions where the blood
ow is disturbed. In contrast most of the risk factors are systemic such as
smoking, obesity, age, . . .
Blood ow exerts a shear force (wall shear stress (WSS)) on the arterial
wall, that leads to the activation of atheroprone molecular pathways at very
specic locations where this shear force is low and/or has an oscillatory
behaviour.is association between WSS and atherosclerosis development
has been studied in several experimental and computational models, as well
as in vivo. However, quantitatively and unequivocally link WSS with the
location and progression of plaque in living subjects remains challenging for
several reasons
First, it is important for these studies to start from a non-diseased refer-
ence condition to be able to start from a clean baseline state from which point
on the disease can develop. Second, the WSS is commonly calculated using
computational uid dynamics (CFD) models. Trustworthy CFD models are
based on measurements providing information about both the geometry and
the blood ow. As a result, in vivo measurements of the baseline state are
necessary to determine the pre-diseaseWSS. Next to this, the plaque location
should be measured at a stage when a reasonable and measurable amount of
atherosclerosis is present.is is only possible aer the time it took for the
atherosclerosis to develop.
In humans, the early onset of atherosclerosis (already from the rst dec-
ade in life) and its slow progression make it virtually impossible to acquire
both measurements, the baseline state of the arteries and the post-disease
development plaque locations, within the same person.erefore, most of
the studies investigating the relation between WSS and plaque development
measure both variables in two separate groups of test subjects, a healthy one
and a group with diseased subjects. Aerwards, the group averaged (=aggreg-
ated) datasets can be compared.e risk associated with this methodology
is that it might overestimate the correlation between WSS and the plaque
development. It is not because there is a correlation present on the averaged
data sets, that this is also the case in the individual subjects.
l
Research question
Overall, there is still relatively scarce strong quantitative evidence relating
WSS patterns in a non-diseased baseline condition with plaque development
at a later stage on an individual subject basis.
Mice are widely used in atherosclerosis research, mainly because of the
availability of mouse models with a rapid development and progression of
atherosclerosis and with lesions that share many of the characteristics of
atherosclerosis in humans. In this dissertation, we will make use of such
mouse models of atherosclerosis, to answer the following overall research
question of this work:
Is there an individual and quantitative link between baseline wall shear
stress and subsequent plaque development in mouse models of
atherosclerosis?
As the carotid bifurcation is one of the locations where atherosclerosis
preferentially develops, we will focus on this location. To be able to answer
the main research question several intermediate goals need to be reached:
1. Development of an in vivomeasurement technique to localise athero-
sclerotic plaques in mice
2. Setup of a measurements-based computational model to calculate the
WSS without sacricing the animal
3. Applying a statistical model to quantify the link between the haemo-
dynamic metrics and plaque location
Structure
e dissertation is divided into 3 dierent parts. Part I provides a background
of the (patho-)physiology of atherosclerosis in chapter 1, a background on the
use ofmice in atherosclerosis research in chapter 2 and a background on small
animal imaging in chapter 3.e second part (Part II), gives an overview of
the dierent numerical techniques that were used in this thesis.e models
needed to simulate the haemodynamics of the mouse carotid bifurcation
are explained in chapter 4. From these simulations, we calculated dierent
metrics that describe the inuence of theWSS on the arterial wall as described
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in chapter 5.is is necessary to get to results with physiological relevance.
In part III, the main measurement results of the current work are described.
In chapter 6, the results of the ultrasound (US) are listed. In the consequent
chapter a new application of gold-nanoparticle-enhanced micro-computed
tomography (µCT) to visualise the macrophage inltration in plaques in vivo
is introduced. Part IV lists the numerical results of this thesis. Chapter 8
describes the full uid-structure interaction model and the derivation of the
WSS with the help of computational modelling is explained.e results of
this complex model are compared with simpler models and dierent activity
levels of the mouse in chapter 9. Finally, the correlation between baseline
haemodynamics and atherosclerosis development is discussed in chapter 10.
Some conclusions are drawn in chapter 11.
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Atherosclerosis
1.1 The human cardiovascular system
A basic understanding of the anatomy and physiology of the cardiovascular
system is indispensable for a clear understanding of the current work.is
introductory section will therefore summarise the most relevant parts.is
section is mainly based on the next sources∗ † ‡ §, which give amore complete
overview of the human anatomy and physiology.
1.1.1 General overview
e human body is a complex system. Structurally the body is organised
on dierent levels including: the chemical level (individual molecules), the
cellular level (individual cells), the tissue level (e.g. connective tissue, en-
dothelium, . . . ), the organ level (e.g. stomach, heart, . . . ) and the organ system
level (e.g. muscular system, skeletal system, . . . ). For a correct functioning
∗E. N. Marieb and K. Hoehn, ‘Anatomy & Physiology’, Pearson In. Pearson
Benjamin Cummings, 2008
†F. H. Martini, J. L. Nath and E. F. Bartholomew, ‘Blood Vessels and Circulation’,
in Fundamentals of Anatomy & Physiology, 9th ed., Boston: Benjamin Cummings,
2012, ch. 21, pp. 707–764
‡M. Nair, ‘e circulatory s ystem’, in Fundamentals of Anatomy and Physiology
for Student Nurses, I. Peate and M. Nair, Eds., Chichester: John Wiley & Sons, 2011,
ch. 12, pp. 366–405
§S. Silbernagl and A. Despopoulos, ‘Hart en bloedsomloop’, in SESAM Atlas
van de fysiology, 14th ed., Baarn: SESAM/HBuitgevers, 2007, ch. 8
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of our body all these systems work together and each one of them fulls a
specic function. Together, these organ systems work towards the well-being
of the human body (homeostasis) and they let us full-ll the necessary life
functions such as maintaining boundaries (separate the internal environment
from the external one), movement, responsiveness, digestion, metabolism,
excretion, reproduction and growth [1].
One of the organ systems in the human body is the cardiovascular system.
As the name suggests, the main parts of this system are the heart (cardio)
and the blood vessels (vascular) together with the blood.e cardiovascular
system is a complex distribution system of nutrients, gases, waste products,
hormones and other substances.e blood also transports the specialised
cells of the immune system that defend the body against infection and disease.
e function of the cardiovascular system is vital and a cell that is deprived
from blood ow may die in a matter of minutes.
e cardiovascular system of a male adult contains 5-6 litres of blood and
an adult female 4-5 litres. When centrifuged, the blood can be split in its 3
main components: plasma (∼55%), the buy coat(<1%) and the erythrocytes
(red blood cells) (∼45%). Together, the erythrocytes and the buy coat are
called the formed elements.e main component of blood plasma is water
(∼92%) and the other components are plasma proteins (∼7%) and other solutes
(∼1%).e buy coat consists of leukocytes and platelets [1], [2].
e heart is the central engine that drives the blood through the blood
vessels. It is a 4 chamber organ that, from an engineering point of view,
consists of two pumps placed in series. When the heart contracts, the blood
is forced into the arterial network.e le atrium (LA) and the le ventricle
(LV) (gure 1.1) together form one of the serial pumps, that supplies the
oxygen-rich blood (bright red) to the dierent organs.e right atrium (RA)
and right ventricle (RV) form the other pump, pumping the oxygen-poor
blood towards the lungs.
e blood vessels are the piping of the human body. In an adult they
stretch for about 100.000 km [1].e blood vessels are divided in arteries,
carrying the blood away from the heart, and veins, carrying the blood to-
wards the heart.e blood vessel network is split in a pulmonary loop (the
pulmonary circulation) connecting the right ventricle to the le atrium of
the heart passing through the lungs. In this way, the oxygen poor blood
that leaves the heart is oxygenated in the lungs and transported back to the
heart.ere, it enters the heart at the le atrium, ready to be sent into the
systemic loop (systemic circulation).e systemic circulation connects the
le ventricle to the right atrium of the heart. In the body, both circulations
(systemic and pulmonary) together form a closed loop with the heart in the
middle as a driving force pumping the blood.
4
1.1. e human cardiovascular system
1.1.2 e systemic circulation
e systemic circulation transports the oxygen rich blood towards the dier-
ent organs of the human body. In resting conditions, the brain receives ∼13%,
the heart ∼4%, the kidneys ∼20%, abdominal organs ∼24% and the skeletal
muscles ∼20% of the systemic blood ow [1]. is systemic circulation is
shown in gure 1.1.
e major artery leaving the le ventricle is called the aorta.e aorta
starts upward from the heart (ascending aorta) but then curves (in the aortic
arch) downward towards the descending thoracic and abdominal aorta. From
the aortic arch, the subclavian arteries originate, supplying blood towards the
arms and hands.e carotid arteries also originate from the aortic arch and
they supply blood to the brain and neck. Because they are the main region of
interest in the current thesis, a more detailed schematic is drawn in gure 1.2.
An anatomical drawing of the arteries in the right side of the head is given in
gure 1.3.
1.1.3 Main arteries in the head and neck
Figure 1.2 shows an asymmetry present in the human body directly at the
point where the carotid and subclavian arteries originate. On the one hand,
the brachiocephalic trunk branches o the aorta, which is a very short artery.
is artery branches shortly thereaer into the right subclavian and the right
common carotid artery (CCA). On the other hand, the le CCA and le
subclavian arteries have no part in common and they both branch o the
aortic arch directly (in most people). At the superior border of the larynx
(level of the “Adam’s Apple”) the CCA bifurcates into the external carotid
artery (ECA) and the internal carotid artery (ICA).is bifurcation is called
the carotid bifurcation. e ECA supplies most of the tissues of the head
except the brain and the eye. Examples of tissues supplied by (branches of) the
ECA are: the tongue, the skin and muscles of the face, the chewing muscles,
. . .e ICA on the other hand supplies more than 80% of the cerebrum of
blood and also supplies the orbits. At the base of the skull, the ICA connects
to the circle of Willis (cerebral arterial circle). is is an anastomosis that
encircles the optic chiasma and the pituitary gland. It unites the anterior and
posterior blood cerebrum blood supply, it equalises the blood pressure and
most importantly it provides alternative pathways for the blood to reach the
brain tissue. Anticipating further chapters, the carotid bifurcation is prone
to stenosis which can (partially) occlude the blood ow. In this case the
redundancy brought in the system by the circle of Willis is indispensable.
In gure 1.3 the precise anatomical location of the dierent arteries de-
scribed in the previous paragraph is shown. Both of the common carotid
arteries run parallel to the spine and trachea. At the carotid bifurcation the
5
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Figure 1.1: Schematic of the systemic circulation (adapted from [1]).
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Figure 1.2: Schematic owchart from the arteries in the neck and head (adapted
from [1]).
ECA branches o anterior from the ICA. Downstream it clearly splits in
arteries supplying the face and the scalp.e ICA enters the skull through
the carotid canal and supplies blood to the cerebrum through an arterial
network centred around the circle of Willis.e vertebral arteries root from
the subclavian arteries and they ascend through the foramina in the trans-
verse processes of the vertebrae. Within the skull the le and right vertebral
arteries join again and connect to the circle of Willis through the basilar
artery.
1.1.4 Structure of the arterial wall
e arterial wall consists of dierent constituents fromwhich the most impor-
tant ones are: endothelial cells (ECs), vascular smooth muscle cells (VSMCs),
elastin and collagen.e ECs form an interface between the blood (inside
7
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Figure 1.3: Drawing of the arteries in the head and neck, shown as seen from the
right side (adapted from [2]).
the lumen) and the arterial wall.ey serve as a selective barrier, but also
produce vasoactive substances.e VSMCs are capable of contracting the
vessel wall and they synthesise elastin and collagen bres. Elastin is an elastic
protein in connective tissues that forms elastic bres together with a brillar
component such as brillin. Elastin has no preferential direction with regard
to load bearing. Collagen on the other hand has a preferential direction for
bearing load. Collagen is present in a coiled up state and these bres only
bear a load when they are stretched completely. At high strains they have a
high Young’s modulus (3-9 GPa for a single molecule [5]) in comparison to
elastin (0.4-1.2 MPa for a single bre [5]) [5]–[8].
e structure of a general artery is shown in gure 1.4. Except for the
smallest blood vessels, all blood vessels have three distinctive layers called
tunica.e three layers are dierent on the cellular and protein level, resulting
in a dierent proportion of the dierent constituents and thus in a dierent
biomechanical behaviour. e same three layers are present in veins and
arteries, but their relative size and importance diers.e three layers of a
blood vessel are:
1. Tunica Externa (Adventitia)
e tunica externa is the outer most layer of the blood vessel wall. It
8
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Figure 1.4: Dierent layers in the arterial wall (adapted from [3]).
mainly consists of collagen bres that protect and reinforce the arterial
wall. Nerve bres and lymphatic vessels are present in this layer. In
larger vessels the tunica externa also contains a network of tiny blood
vessels, called the vasa vasorum supplying blood to the more external
parts of the vessel wall.
2. TunicaMedia (Media):
In general, the tunica media is the bulkiest layer in arteries. For elastic
arteries (see section 1.1.5), the high amount of elastin in the media
provides the elasticity, which assures a continuous blood circulation.
In muscular arteries (see section 1.1.5), the media mainly consists of
VSMCs that can decrease the luminal diameter (vasoconstriction) or
that can increase the luminal diameter (vasodilatation).
3. Tunica Interna (Interna):
e most inner layer of the vessel wall contains simple squamous
epithelium, called endothelium.ese at cells t closely together to
form a smooth surface to minimise the friction between the blood
ow and the vessel wall. A subendothelial layer is present in vessels
larger than 1mm diameter (humans) consisting of loose connective
tissue and a basal membrane.
1.1.5 Dierent types of arteries
Although all the arteries aremade of the three layers described in the previous
paragraph (except the smallest arteries), they still dier in anatomy.ese
dierences are illustrated in gure 1.5.
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Figure 1.5: Structure of dierent blood vessels. A diagram of the cross-sectional
views of dierent arteries and capillaries is drawn (adapted from [2]). Next to this, the
relative tissue makeup for the dierent arteries is drawn in histograms (reproduced
from [1]).
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1.1. e human cardiovascular system
1. Elastic arteries
e elastic arteries are the arteries near the heart.ey are also called
conducting arteries and the aorta and its main branches are classied
in this category. Of all types of arteries, they have the largest amount
of elastic tissues.ey react as pressure reservoirs, buering the blood
ow by distending in systole.
2. Muscular arteries
e muscular or distributing arteries deliver blood to specic organs.
Of the dierent arterial types, they have relatively the thickest media.
ey play a more pronounced role in constriction because of the high
number of VSMCs.
3. Arterioles
On average arterioles have lumen diameter ranging from 0.3mm to
10µm [1]. In the larger arterioles all three layers are present in the
vessel wall but in the smaller arterioles this is not the case.e smallest
arterioles only consist of ECs with a small layer of smooth muscle cells.
4. Capillaries
ese are the smallest blood vessels (lumen diameter ranging from 8
to 10 µm [1]).e thin wall of the capillaries consists of only a very
small tunica interna.
Carotid arteries (at least in humans) are of the elastic artery type.ese
conducting arteries have a low-resistance. Similar to the aorta the carotid
arteries have a high buering capacity that will play a crucial role in the
models developed in chapters 8 and 9 on page 149 and on page 175.
1.1.6 Arterial blood pressure
e heart pumps the blood into the arteries by cycling through a contraction
and a relaxation phase. When contracting, the ventriculo-arterial heart valves
open and blood is pumped in the aorta (and pulmonary artery) which causes
a peak in the pressure (systolic pressure).e aorta is an elastic artery, which
reacts as a pressure reservoir.erefore, the pressure decreases gradually and
the aorta recoils during the relaxation of the heart (diastole) when the aortic
valve is closed. e buering of the aorta and other elastic arteries keeps
the blood owing further downstream.e buering eect of the arteries is
called the windkessel eect.is buering converts the rapid, high-pressure
pulsatile blood ow from the heart to slower, low-pressure blood ow in the
capillaries.e pressure in the dierent vessels is plotted in gure 1.6.
For the dierent types of arteries, the individual area gradually decreases
while the number of arteries increases exponentially. As a result, the total
11
1. Atherosclerosis
cross-sectional area increases and reaches a maximum for the capillaries.
is results in a lower pressure for the capillaries.
Figure 1.6: Pressures in the systemic circuit. Both the pulse pressure and the mean
arterial pressure decrease downstream (reproduced from [2]).
1.2 Pathology: atherosclerosis
1.2.1 Introduction
Atherosclerosis has already been observed for centuries.e term “arterio-
sclerosis” was introduced by Jean Lobstein in 1829 [9]. In the 19th century,
two well-known opposing schools of pathology studied atherosclerosis: the
school of Rudolf Virchow in Berlin and the school of Carl von Rokitansky
in Vienna [9]. Linguistically atherosclerosis is a combination of the Greek
words athe¯ra ( ,αθη´ρα), meaningmush or gruel, and sclerosismeaning harden-
ing.e two concepts appear to be contradictory but they describe the two
main components of the atherosclerotic plaque. Atherosclerosis is a slowly
progressing chronic inammatory disease of the medium-sized and large
arteries characterised by thickening of the arterial wall and the development
of atherosclerotic plaques (see gure 1.8c on page 15) [10]–[12]. ese ath-
erosclerotic plaques consist of lipids accumulating in the arterial wall over
time and are inltrated by macrophages and other (pro-) inammatory cells
[13]–[15].ese lipids form an so lipid-lled core in the plaque, described
by the Greek word athe¯ra. Over this plaque forms a hard and possibly thick
brous cap, which is referred to by the sclerosis in the name of the disease
[15], [16].
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Atherosclerosis is a subgroup of the arteriosclerosis diseases. Arterioscler-
osis is characterised by a reduction of the elasticity, hardening and thickening
of the arterial wall. Next to atherosclerosis, marked by plaque formation,
other pathologies of the arteriosclerosis family include: arteriolosclerosis
(aects the small arteries and arterioles) and calcic sclerosis of Mönckeberg
(calcic sclerosis) [15], [17].
Atherosclerosis is a very common disease that is the underlying cause in
ischemic heart disease and stroke. Both of them are on the top of the causes
of death worldwide gure 1.7. Especially in the industrialised countries such
as the USA and (Western) Europe the incidence of atherosclerosis is high
and a leading cause of death.e prevalence of the disease seems inversely
proportional to the degree of wealth. e prevalence in the developing
countries such as African countries is low, but it is also expected to become
the leading cause of death in those countries by 2025 [15], [18]. Despite the
omnipresence of atherosclerosis in the current time, it is already an “ancient”
disease. It is described in medical works of the ancient Egyptians, Greek and
Romans [18]. Moreover, atherosclerotic lesions have been found in Egyptian
mummies [16], [18], [19].
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Figure 1.7: Top 10 leading causes of death in 2012 worldwide (adapted from [20]).
1.2.2 Pathogenesis
1.2.2.1 Initial steps of atherosclerosis formation
Several mechanisms occur at the same time when atherosclerosis develops
and all these processes are cross-linked to each other. Historically, the accu-
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mulation of lipids in the intimal layer has been emphasised [10], [11], [21],
[22]. More recently the role of inammation and the immune system in
atherosclerosis development is gaining more attention from the scientic
community [23]–[27].
e endothelial cell layer forms the barrier between the blood and the
arterial wall.e oset of atherosclerosis starts with these endothelial cells.
In normal conditions the endothelial layer resists the adhesion of leukocytes
in the blood. Risk factors, however, can induce the expression of adhesion
molecules such as vascular cell adhesion molecule-1 (VCAM-1)[28], [29].
is makes it possible for the monocytes to attach to the arterial wall. Aer
the adhesion to the arterial wall, the monocytes enter the intima through
diapedesis between the endothelial cells.is migration is likely partly stimu-
lated by oxidized low density lipoprotein (oxLDL) (see next paragraph) [24],
[28], [30].
Inammatory stimuli such as dyslipidaemia, hypertension and wall shear
stress (WSS), can lead to changes in permeability of the endothelium for
low density lipoprotein (LDL). Structural changes and a reorientation of the
endothelium have been shown for endothelium subject to low and oscillatory
WSS, resulting in a higher permeability [31]. Both the ECs and the macro-
phages produce nitric oxide (NO), which is a potent oxidant. Once the LDL
particles are present in the intimal layer, they can undergo oxidation to form
oxLDL. Upon oxidation, LDL becomes cytotoxic and pro-inammatory [32].
oxLDL can induce the expression of adhesionmolecules and thus attract even
more monocytes (dierentiating to macrophages).is results in a positive
feedback loop originates because the recruited inammatory cells reinforce
the oxidation of even more LDL [33].
Once inside the arterial intimal layer, the monocytes dierentiate to mac-
rophages and they take up the oxLDL molecules. In this way, the initial
recruitment of macrophages can have a protective function because they
remove the cytotoxic and pro-inammatory oxLDL particles [34]. Yet, the
consecutive, progressive accumulation of macrophages leads to atherosclero-
sis.rough accumulation of the LDL the macrophages become foam cells.
ese foam cells contain a massive amount of cholesterol esters.e macro-
phages that accumulate in the arterial wall release several molecules (growth
factors and cytokines) to attract more macrophages and thus amplifying
the inammation.ese foam cells also produce matrix metalloproteinases
(MMP) which can degrade the extracellular matrix (ECM), that consists of
collagen and elastin.
1.2.2.2 Progression of atherosclerosis
e simple fatty streak lesion, described in the previous section, transitions to
a more complex lesion via the recruitment of VSMCs from the tunica media
14
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1. Atherosclerosis
towards the tunica interna (gure 1.8c).e broproliferative response of
the VSMCs is normally responsible for the healing and repair aer injury
[32]. When the artery is damaged, VSMCs can switch from the “contractile”
phenotype to the “synthetic” phenotype [35]. Due to this proliferation the
VSMCs synthesise ECM proteins, including interstitial collagen and elastin.
ese proteins form (together with the VSMCs) the brous cap which is the
second important component of an advanced atherosclerotic lesion next to
the lipid core.e brous cap separates the lumen from the lipid in the lesion.
It is possible that the inammatory process (including LDL and macrophage
inltration) still continues aer the cap formation. When this happens, the
lesion will cycle through lipid accumulations and brous cap tissue formation,
leading to an enlargement of the lesion [36].
In gure 1.8c it is also visible that the foam cells undergo a gradual trans-
ition during atherosclerotic plaque formation. Some of the LDL-rich mac-
rophages die by apoptosis or necrosis. During necrosis their lipid content
is released in the ECM. Together with the debris from the dead cells (also
apoptosis (or cell death) from other cells including VSMCs occurs) this forms
the so called necrotic core of the plaque. Cholesterol crystals can also be
present in this region.e lipid core is the so component in the plaque that
does not provide mechanical stability and therefore destabilises the plaque
[12], [32].
One last characteristic of advanced atherosclerotic plaque is the formation
of new blood vessels or neovascularization.is intra-plaque angiogenesis is
one of the hallmarks vulnerable plaques with a high risk of rupture (item (E)
in section 1.2.4). e microvessels that originate from this neovasculariz-
ation are fragile and leaky. As a consequence they leak plasma proteins,
erythrocytes and inammatory cells.is can result in an increased plaque
progression [32].
1.2.2.3 rombosis and advanced lesions
ere are dierent outcomes of atherosclerosis that lead to sudden fatal and
non-fatal events.ese dierent events are described in more detail in the
next section (section 1.2.3). Classically most attention went to plaque rupture
and this is plotted in gure 1.8d. If the (thin) brous cap ruptures, this can
result in contact between the blood and the lipid core. Blood coagulation and
thrombus formation can then occur. Several triggers can cause the rupture:
blood pressure (BP), pulse pressure (PP), heart contraction (for coronary
plaques), spasm, mechanical stress and haemodynamic shear stresses [37]–
[39].
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1.2.3 Paths to clinical complications
1.2.3.1 (Occlusive) thrombi
(Occlusive) thrombus (blood clot) formation can occur during plaque rupture
section 1.2.3.2. However, thrombus formation can also occur without the
presence of plaque rupture. In most of these cases the thrombus formation
coexists with plaque erosion (limited to the endothelial cells covering the
brous cap) or calcied nodules [40]–[42].
rombus formation in the carotid arteries can lead to ischemic stroke,
cell death in the brain. Part of the brain is deprived fromblood ow, due to the
blocking of an artery by the thrombus . Carotid atherosclerosis contributes
to at least 15-20% of all ischemic strokes [43]. Yearly ∼795 000 US residents
experience a stroke (both rst attacks and recurrent attacks) [44]. Stroke was
on the 4th place of the deaths (by disease) in the US with an average of every
4min someone is dying of stroke in theUS [44]. Worldwide stroke was ranked
second (aer ischemic heart disease: 7.4 million) on the numbers of deaths
in 2012 with 6.7 million deaths (numbers of the World Health Organisation)
[20]. Ischemic heart disease and stroke are accountable for the most deaths
(places 1 and 2) worldwide for the lower-middle to higher income countries.
Only for the low income countries lower respiratory infection, HIV/AIDS
and diarrhoeal diseases were responsible for more deaths [20].
e damage of the stroke can be permanent (persistent, stable neurologic
deciency > 24h) or the ischemic event can only be temporary (transient
ischemic attack (TIA) temporary loss of sensory or motor function <15min
with complete recovery in 24h) [45]. e most common location for the
occlusion to occur, is in the middle cerebral artery [46]. e symptoms
include hemipareses (weakening of an entire side of the body, opposite to
the side of the lesion location in the brain), hemisensory (loss of sensation
on one side of the body) loss and aphasia (language disorder) [47].
1.2.3.2 Plaque rupture
Plaque rupture accounts for ∼70% of the fatal acute myocardial infarctions
(coronary plaques) [40]. As can be seen in gure 1.8d, the plaque rupture
exposes the thrombogenic (high tendency for blood to form thrombi when
in contact with this material) parts (from which the lipid core appears to be
the most thrombogenic) of the plaque to the blood ow [39].is is the rst
step in the activation of the clotting cascade leading to thrombus formation
(see section 1.2.3.1). 70 to 80% of the coronary thrombi originate from plaque
rupture [38].e plaques prone to rupture do not always present a severe
stenosis due to outward remodelling.
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1.2.4 Vulnerable plaque
Historically, the term vulnerable plaque has been used for thin-cap broath-
eroma, which are plaques that are prone to rupture (for more details see next
section). Yet, a new consensus was reached with regard to plaque vulner-
ability (mainly focused on coronary plaques) in 2 consensus articles [40],
[48].ere are three main conclusions of this consensus: (i) not only rupture-
prone plaques are vulnerable plaques, plaques with a high likelihood of rapid
progression or thrombosis are also vulnerable; (ii) not only the vulnerable
plaques but also vulnerable blood and vulnerable myocardium (coronary
plaques) are important factors; (iii) quantitative methods to assess the risk of
vulnerable plaque, blood and myocardium should be developed.
e classication as proposed in the consensus document by Naghavi et
al. is shown in gure 1.9 and listed here [40]:
(A) Rupture-prone
ese plaques are characterised by a large lipid core, a thin brous cap
and macrophage inltration. Both the thin cap and the large lipid core
make this a mechanically unstable plaque. Macrophages (and other
inammatory cells) can secrete enzymes degrading the plaque matrix
such as MMP [37].
(B) Ruptured/healing
A ruptured plaque with a non-occlusive thrombus present
(C) Erosion-prone
Dysfunctional endothelium is one of the markers of plaque vulnerabil-
ity.ese plaques have a higher risk for erosion of the EC layer.
(D) Eroded
rombosis is associated with plaque erosion of the ECs. Eroded
plaques have an increased risk of thrombosis [41].
(E) With intra-plaque haemorrhage
Neovascularization can be present in complex lesions (gure 1.8c).
When they leak red blood cells in the plaque this can indicate plaque
vulnerability.
(F) With calcied nodule
Calcied nodules (near the surface) may form mechanical trigger
points for plaque rupture and are an indicator of plaque vulnerability.
(G) Critically stenotic
Severe stenosis can lead to ischemia due to the reduced blood ow.
Moreover, the high WSS at the cap raises the risk for thrombus forma-
tion [40].
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Figure 1.9: Dierent types of vulnerable plaque as cause of acute events (reproduced
from [40]).
1.2.5 American Heart Association classication
In a series of three reports [10], [11], [21], the American Heart Association
(AHA) Committee on Vascular Lesions has dened a numerical classication
of the dierent types of the human atherosclerotic lesions based on the
composition and structure of the lesions. In the rst report, published in 1992,
the normal arterial intima was dened, including the atherosclerosis-prone
regions [10].e second in the series, published in 1994, denes the initial,
fatty streak and the intermediate lesions[11]. Finally, the third report (1995)
denes the advanced lesions in terms of composition [21]. It is in this third
report that the AHA classication system is introduced.is classication
was generally accepted by the scientic community and used in numerous
publications (3276 citations on Google scholar for the third and nal report).
Nonetheless, over time new datamade it necessary to update the classication,
which was done in 2000 by the AHA with a brief communication [22]. In
this update 2 extra groups were added to the classication which results in 8
groups, shown in gure 1.10 and listed here [10], [11], [18], [21], [22], [49]:
I (Initial) Lesion
In the type I lesion, isolated foamy macrophages are present in the
intima.
II (Fatty Streak) Lesion
e type II lesions are the rst grossly visible lesions.ey are character-
ised bymainly intracellular lipid accumulation.ese lipids are present
in the macrophage foam cells and under the form of lipid droplets in
the VSMCs. Some extracellular lipid droplets can be present. Next to
the macrophages, also lymphocytes can be present. Generally type I
and type II are the only types of lesions found in children (although
they may also occur in adults).
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Figure 1.10: Classication of eight types of arterial wall lesions (reproduced from
[21]).
III (Intermediate) Lesion
Type III atherosclerosis is an intermediate state between type II and
type IV lesions. In this lesion type sets of extracellular lipid droplets are
present.e coherence of some intimal VSMCs can be disrupted. For
the rst three types of lesions (I - III), the lesion is focal and relatively
small.ere are almost no changes present in either the composition
of the matrix or architecture of the intima.e media is not aected
in this stage of the disease.
IV (Atheroma) Lesion
is lesion type is the rst advanced lesion type in this classication, be-
cause structural changes are present in the intima due to the formation
of a lipid core. In the type IV lesions extracellular lipids accumulate in
a well dened region in the intima forming a so called lipid core.ese
lipid cores are visible by the unaided eye on the histological coups. A
thickening of the arterial wall is present due to the lipid cores. In most
cases the lumen is not narrowed in this stage yet, due to the outward
remodelling of the artery. From this stage on the damage in the arterial
wall is irreversible and regression to lesion types I-III is not possible.
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Via dierent pathways the type IV lesion can evolve to dierent more
advanced lesion types (gure 1.10). From lesion type IV on clinical
manifestations may be present. From this type of lesion on, the lumen
of medium sized arteries can also be obstructed.
V (Fibromuscular) Lesion
In the type IV lesion, the lipid core is still mostly covered by intimal
endothelial cells. When an increase in brous tissue together with
VSMCs at the cover of this lipid core replaces this “normal” endothelial
layer, the lesion has evolved to a type V lesion.e type V lesions are
characterised by the striking amount of new brous connective tissue
that is formed. ese lesions can consist of multiple layers of lipid
cores separated by brous tissue layers.
VI (Complicated) Lesion
Lesions of type IV and V can evolve in dierent lesion types. e
complex lesions (VI) are characterised by either a surface defect (VIa),
haematoma (VIb) or thrombosis (VIc). ese are the three main
pathways for type IV and V lesions to result in morbidity or mortality.
• VIa
Both ulcerations and tears can penetrate the surface of the le-
sion, resulting in an surface disruption. Factors that facilitate
these phenomena are: inammatory cells in the lesion, structural
weakness of the lesion and shear stresses.
• VIb
Haemorrhage ismostly caused by tears in the surface of the lesion,
it can also start due to an haemorrhage of the neovascularization
in the lesion.
• VIc
rombosis (the formation of blood clots), can be involved in
these complex lesions.e thrombus can range frommicroscopic
to clearly visible deposits.is thrombus formation can block
the artery (occlusive thrombosis).
VII (Calcified) Lesion
Mineral deposits can replace the contents of the lipid core and cal-
cied nodules. Plaques with predominant presence of calcications
are labelled as calcied (type VII) lesions.e presence of microcal-
cications is one of the markers of plaque vulnerability. Plaques with
macrocalcications are more stable [15], [50].
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VIII (Fibrotic) Lesion
Lesions with only a limited amount of lipids present but with abundant
presence of brous tissue are called brotic lesions.ey oen occur
in the arteries of the legs.
1.2.6 Risk factors
e most important risk factors are here briey summarised. For a more
detailed description the reader is referred to [15], [51]–[53].
1.2.6.1 Non modiable
1. Gender
Men are at higher risk for atherosclerosis compared to women [15],
[52].
2. Age
e atherogenic processes start already in childhood, but due the slowly
progressing nature of this disease, clinical implication normally only
occur from the fourth decade of life on (time from which type IV
lesions are present [21]).
3. Race & Ethnicity
Studies are showing that race is a possible risk factor for atherosclerosis.
Both the prevalence and the locations of atherosclerosis development
could be dierent between dierent populations [51].
4. Genetic Factors
An active research eld is the genetic inuence on atherosclerosis
development. Although genetics seem to have an inuence, no strong
association is found [51]. Yet, genetics play an important role in some
of the modiable risk factors such as: hypertension, diabetes and
hypercholesterolemia.
1.2.6.2 Modiable
1. Hypertension
Hypertension mechanically stresses the arterial wall and may thus
damage and weaken the arterial wall. Furthermore, hypertension and
hyperlipidemia initiate similar responses of the arterial wall [54].
2. Dyslipidemia
Dyslipidemia is an abnormally high amount of lipids and cholesterol
in the blood. Plaque progression starts with the accumulation of lipids
originating from the blood in the intimal layer of the arterial wall
(section 1.2.5 on page 19). Mainly the LDL are responsible for this
accumulation.
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3. Cigarette Smoke
Smoking is one of the strongest risk factors for peripheral artery disease
(PAD) and it aects all phases of atherosclerosis.e precise mechan-
ism is not fully known, but cigarette smoke increases inammation,
thrombosis, and oxidation of LDL cholesterol [53], [55].
4. Alcohol consumption
e eect of alcohol intake is highly non-linear and the curve is J-
shaped. Light drinkers have a lower risk for atherosclerosis compared
to heavy drinkers and abstainers [29], [56], [57].
5. Diabetes Mellitus
Diabetes mellitus increases the risk of developing atherosclerosis sub-
stantially. e metabolic abnormalities caused by diabetes, initiate
mechanisms that contribute to vascular dysfunction [58].
6. Obesity
Obesity is linked with a higher risk for cardiovascular diseases. Both
in obesity and atherosclerosis lipids and inammation are involved
[33]. [59]
1.2.7 Role of haemodynamics in atherosclerosis
e aforementioned risk factors for atherosclerosis development are all sys-
temic, meaning that they play a role over the entire vascular system. Nonethe-
less, atherosclerotic lesions are known to develop preferentially at arterial
branches and curvatures[30], [60], [61]. What these locations have in com-
mon is the prevalence of spatially complex haemodynamics, with zones of
ow recirculation. In some conditions, regions with (transiently) turbulent
ow may be present.
In the 1970s, two dierent theories emerged aiming to explain this phe-
nomenon. e high WSS hypothesis suggested that high WSS causes en-
dothelial injury which forms the onset of atherosclerosis.e second hypo-
thesis, proposed by Caro et al., linked the initiation of atherosclerosis with
low and oscillatory WSS [62], [63].ey linked haemodynamics and ather-
osclerotic plaque development by comparing cadaver human arteries with
experimental ow studies in casts. Over time the low and oscillatory WSS
hypothesis got generally accepted. Numerous studies have been performed
since then to support this hypothesis [64]–[68].
e endothelium forms the interface between the lumen (blood ow)
and the arterial wall.e ow exerts a shear force (called the WSS) on these
endothelial cells, resulting in a shearing deformation of the ECs [28].e
endothelium responds to changes inWSS. Low and oscillatoryWSS, induced
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by the ow disturbances, leads to functional and structural changes of the
endothelium. e shear rate is thus one of the determinants of vascular
remodelling [31], [60], [69]–[72].
In normal physiological ow conditions with laminar uni-directional
ow, the ECs have an elongated shape in the direction of the main ow
direction. In regions with low, oscillatory and multi-directional ow regimes
this alignment of the endothelium is lost. Several atheroprone pathways are
activated in these ECs.
e magnitude of the WSS (∼5 Pa)is only a fraction of the pressure mag-
nitude (∼10 000 Pa) [28].erefore the eect of WSS is amplied in the ECs
by specialised cellular structures. Primary cilia at the luminal surface, are
connected to the cytoskeleton and amplify the eect of WSS. In this manner,
they raise the responsiveness of ECs to shear stress [28].
Aer the initial sensing, several signalling molecules are activated.e
cytoskeleton forms the bond between the luminal surface with the sensing
mechanisms and the locations where the various signalling molecules are
formed. In this manner, the low and oscillatory WSS starts a cascade of
mechanisms resulting in an atheroprone endothelial phenotype. Some of the
major processes started are [66]:
L Enhanced uptake
In the low WSS regions, the LDL permeability of the endothelium
surface for LDL is increased [31], [73].e ECs change shape to a more
polygonal shape, which results in wider junctions between ECs[74]. A
second pathway is the activation of sterol regulatory elements binding
proteins, leading to an increased synthesis of LDL by the ECs [66].
L Enhanced LDL oxidation
e oxidation of LDL to oxLDL (gure 1.8b) gets promoted by an
upregulation of the main oxidative enzymes [66].
L Attenuation of NO release
is is one of the earliest changes anteceding endothelial dysfunction.
Endothelial NO release results in atheroprotective vascular relaxation
and inhibits several atheroprone pathways: platelet activation, apop-
tosis and monocyte adhesion [75].
L Promotion of inammation
e inltration of the arterial wall with leukocytes is one of the rst
steps of atherosclerosis development (section 1.2.2.1).e expression
of VCAM-1 and other adhesion molecules, facilitating this leukocyte
inltration, is shown to be upregulated in lowWSS regions [76], [77].
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L Promotion VSMC migration, dierentiation and proliferation
e formation of a bromuscular plaque (type V), is characterised by
intimal inltration of VSMCs that are dedierentiated to the synthetic
phenotype producing ECM proteins (section 1.2.2.2).is migration
and proliferation is upregulated by lowWSS by platelet-derived growth
factor released by ECs[78].
L Promotion of ECM degradation
MMP degrades the ECM (in the brous cap), which can lead to a
rupture-prone vulnerable plaque (item (A) in section 1.2.4). It has
been shown that lowWSS upregulates the activity of these MMPs [66].
L Increased thrombogenicity
Low WSS downregulates the expression of several anti-thrombotic
molecules. Moreover, stagnation of the blood ow might facilitate the
accumulation of thrombogenic factors at the arterial wall [66], [79].
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atherosclerosis
2.1 Animal models of atherosclerosis
A variety of animal models has been used to study atherosclerosis. Up till
now, no ideal animal model has been found that reects all the stages found
in human atherosclerosis. Next to the similar atherogenic process to humans,
the ideal animal model would also permit an easy manipulation of the ath-
erogenic process.e most extensively used animal models include: mice,
rats, guinea pigs, pigs, hamsters, rabbits and non-human primates. Some of
the main advantages and disadvantages of the most commonly used species
are listed in table table 2.1. To induce the atherogenic process in these animal
models some common methods are: cholesterol feeding [1]–[5] or surgically
altered blood ow [6]–[8].
2.1.1 e rabbit
Rabbits do not develop atherosclerosis spontaneously but they are very sus-
ceptible to cholesterol manipulating diets [9].e lipid metabolism of rabbits
is much closer to humans than that of mice, explaining their extensive use
[10].e main disadvantage is that the lesions that rabbits develop are not
as complex as the human atherosclerotic plaques. In comparison with mice,
genetic manipulation of the rabbit is more dicult. Next to this, rabbits have
a very low plasma level of hepatic lipase, which is an enzyme that modulates
lipoprotein metabolism.erefore, several studies support an anti-athero-
genic role for this enzyme [11].
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Table 2.1: Advantages and disadvantages of dierent animal models of atherosclero-
sis (adapted from [5] and [4]).
Advantages Disadvantages
Mouse
Easy breading
Ease of genetic manipulation
Low cost and maintenance
Short generation time
No plaque instability\
Monotypic HDL
Small size→ diculties
Limited complexity lesions
Rabbit
Good size
Easy to keep and handle
Cholesterol sensitive
Majority of circularing
cholesterol is HDL
Modest genetic modications
Hepatic lipase decient
Pig
Human- like lipoprotein
prole
Humanoid lesions
Experimental study of carotid
stenting
Size simplies non-invasive
measurements
Vulnerable carotid plaques
Expensive
Diculties in care
Longer time for diet
induction
No genetic modications
Non-
human
Primates
Closest to human species
Develop coronary lesions
Spontaneous early stage
lesions in some strains
Expensive
No genetic modications
Ethical concerns
Dicult to house and handle
\ Except the recently developed ApoE−/− Fbn1C1039G+/− mouse model.
2.1.2 e pig
Pigs develop atherosclerosis spontaneously and this is further accelerated
by feeding them an atherogenic diet.eir size makes it possible to harvest
enough arterial material for analysis.e lipoprotein prole of pigs is similar
to the human prole. 60% of the circulating lipoproteins are being trans-
ported as LDL in pigs which is close to the 63% in humans [4]. Next to this,
both the cardiovascular system and the electro-physiological parameters
of pigs closely resemble the human condition (more closely than the other
laboratory animals except non-human primates).is makes it technically
possible to perform surgical procedures including vascular stenting [12], [13],
making it an ideal surgical model.eir main disadvantages are the relative
long time for diet-induction and the high cost for their upkeep maintenance
cost[4], [5].
2.1.3 Non-human primates
e non-human primates are attractive models for atherosclerosis because of
their higher similarity to humans. Several dierent strains have been studied
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with each of them their own advantages/specic results including: regression
of atherosclerosis when put on a low-fat diet, more rapid atherosclerosis
development, atherosclerosis development dependent on social status, spon-
taneous atherosclerosis development, fatal myocardial infarction, ... [14]–[16]
However, there are some major disadvantages specic to this species. For
example, ethical concerns with regard to their extinction hamper their us-
ability. Next to this, the maintenance cost is very high, the experiments and
atherosclerosis development take a long time.ese are the main reasons
why there is only a limited utility of non-human primates in the current
research on atherosclerosis[4], [5].
2.2 Mouse models of atherosclerosis
e mouse has become the predominately used animal model for atheroscle-
rosis research [17]. Compared to the large animal models mice are much
cheaper to purchase, feed and house in appropriate conditions.is enables
the use of a larger number of animals when this is advantageous or needed to
get statistically robust data. Normally the atherosclerosis develops in a much
shorter time frame for mice compared to bigger animals. More recently, this
has been even further facilitated by the ability to genetically modify mice.
Similar like humans, mice have approximately 30.000 genes of which
approximately 95% are shared with humans [18]. Since 2006, scientists have
been working together in the Knockout Mouse Project, with the goal to de-
velop a knockout mouse model for every gene. In a knockout mouse model,
a specic gene is disabled. e goal of the Knockout Mouse Project is to
produce a phenotype of 5000 knockout mice by 2016 [19]–[21]. Together with
the high amount of dierent inbred strains that are available this provides a
second major advantage. All these mice have dierent genetic backgrounds
and thus present a unique means to link the dierent genes and their expres-
sion to their role in the atherogenic process.us the extensive knowledge
about the mouse genome and the relatively easy genetic modication of mice
play a crucial role in linking genetics with atherosclerosis.
Although these are all arguments in favour of the mouse as a model for
atherosclerosis there are also some important dierences between murine
and human atherosclerosis (see table 2.2). First, a dierent haemodynamic
environment is present with for example a much higher heart rate (HR) and
much smaller dimensions for mice. Secondly, the lipid prole of mice is very
dierent from the lipid prole of humans. Humans carry most of the plasma
cholesterol on LDL while for mice this is mainly on HDL. For humans this
HDL even has an atheroprotective eect. Furthermore, themurine lesions are
showing less complex phenotypes and inmostmousemodels no spontaneous
plaque rupture is present [9].
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Table 2.2: Dierences between mice and humans relevant for atherosclerosis
(adapted from [5]).
Mice Humans
HR > 300 bpm 70-100 bpm
Total plasma cholesterol 50-100 mg/dl (wild
type)
150-300 mg/dl
Major lipoprotein HDL LDL
Development time Months (genetically
modied)
Years
Spontaneous rupture no\ yes
\ Except the recently developed ApoE−/− Fbn1C1039G+/− mouse model.
2.2.1 Surgically manipulated models
e current thesis studies the link between the WSS related to ow patterns
and atherosclerosis development inmice. Specically for this purpose a dier-
ent approach for atherosclerosis research with mice as laboratory animals has
been applied regularly in literature: the surgically manipulated ow models.
e goal of these manipulations can be twofold: directly manipulating the
WSS patterns and/or accelerating the atherosclerosis process.
In the arteriovenous stula model, the CCA is connected directly, end-
to-side, to the neighbouring vein resulting in an increased blood ow [22].
is model is used to study the inuence of high levels of WSS. Next to this,
ligation models of the CCA are commonly used in mice with complete CCA
or partial ligation. Several partial ligation models have been described that
(partially) ligate one or some arteries: CCA [7], [23], ECA [24]–[27], ICA[25]–
[27] and occipital artery [27]. Depending on the ligation site, dierent zones
with low and/or oscillatory shear stress and optionally vulnerable plaques
occur.ese models were used to study molecular mechanisms involving
atherosclerotic plaque development.
Another approach is the insertion of a cast around the CCA. Several cast
models with a dierent design were developed.üsen et al. developed the
rst constrictive cast which induced a 30% luminal stenosis in the common
carotid artery (gure 2.1a). As a result, the WSS decreased upstream of the
cast resulting in the rapid development of atherosclerosis. However, the
induced plaques showed a relatively stable phenotype with low lipid, high
smooth muscle cell and high collagen content [8], [28].
In the tapered cast model, developed by Cheng et al., three dierent
regimes of WSS are obtained: (i) a low WSS region upstream of the cast, (ii)
an elevated WSS region inside the cast and (iii) a low and oscillatory WSS
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Figure 2.1: Dierent CCA casting methods used in mouse models. a)e constrict-
ive cast with two low shear stress zones (LSS) (* level ofWSS dependent on the degree
of constriction). b)e tapered cast model with low shear stress (LSS) proximal and
low and oscillatory shear stress (OSS) distal to the cast. c)e reversed tapering cast
with low shear stress proximal and distal to the cast. (** only steady state simulations
were performed so no information on oscillatory behaviour). Overview adapted
from [8].
region downstream of the cast due to ow separation [29], [30] (gure 2.1b).
Remarkably, the plaques in the proximal region were larger, showed more
outward remodelling and contained more lipids and fewer smooth muscle
cells. In this region intraplaque haemorrhage was observed.erefore Cheng
et al. concluded that a vulnerable plaque phenotype was present in the
proximal region [8], [29], [30].
Another variation on the tapered cast was suggested by Mohri et al.ey
compared WSS patterns and uptake of macromolecules in the arterial wall
for the previously described tapering cast in the conventional direction and
a reversed implantation (gure 2.1c). e pattern of the macromolecule
uptake was not reversed between both cases, suggesting that the underlying
mechanism is not entirely explained by mechanic stresses in the arterial wall.
On the other hand, for the reversed implantation case an elevated uptake
was found in a wide downstream region without remarkable ow patterns
in the computational uid dynamics (CFD) simulations.is suggests that
haemodynamic WSS cannot entirely explain the found patterns [31].
2.2.2 Dierent mouse strains used in atherosclerosis research
Similar to rats, mice are highly resistant to atherosclerosis and are thus, in
principle, not the best animal model to model atherosclerosis. However,
several inbred strains were developed with dierent degrees of susceptibility
to atherosclerosis.
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2.2.2.1 C57BL/6J
e C57BL/6J model is at the same time one of the strains most susceptible
to diet-induced atherosclerosis and one of the most commonly used strains
in laboratory animal research. One of the advantages is that a high quality
sequence and analysis of the genome of this strain is available and published
thanks to the Mouse Genomes Project [32], [33]. When they are fed a very
high cholesterol diet, they develop atherosclerotic lesions that histologically
dier from the human lesion [9]. Only the early stages of the atherosclerotic
lesions such as fatty streaks can be induced [4]. Next to this, the location of
the lesions is restricted to the aortic root, even aer a prolonged feeding of
the cholesterol high diet [17].is limits the usability of this mouse model
together with the fact that the plaques remain small in these mice.
2.2.2.2 LDLR−/−
e low density lipoprotein receptor knockout (LDLR−/−) mouse model is
a model where the LDL receptor is knocked out. In humans, this mutation
leads to a pronounced hypercholesterolemia with a dramatic phenotype
usually resulting in a myocardial infarction in the second decade of life [17],
[34]. In mice, this mutation blocks the clearance of the LDL through the
LDL receptor, resulting to moderate LDL accumulations when on a normal
chow diet and in severe LDL accumulations when on a western type diet.
Compared to the apolipoprotein E knockout (ApoE−/−) mouse (next section),
this strain has a less severe phenotype [35].e phenotype of the lesions in
this mouse model is limited to AHA types I-IV [36].
2.2.2.3 ApoE−/−
Apolipoprotein E (ApoE) is a glycoprotein that is synthesised in the liver,
brain, and other tissues in both humans and mice [9]. is glycoprotein
is present on the surface of several lipoproteins including very low density
lipoprotein (VLDL) and HDL but not on the surface of LDL.e ApoE
molecule is important for the lipoprotein metabolism and allows uptake in
the liver.
In 1992, the ApoE−/− mouse model was generated by several groups,
which was a breakthrough for the use of mice as a laboratory animal for
atherogenesis [37]–[39].e ApoE−/− mice have ve times higher amount of
plasma cholesterol levels compared to their littermates. Evenmore important,
in C57BL/6J mice the highest amount of plasma cholesterol is present as HDL
while for the ApoE−/− strain this has shied to VLDL.
is mouse model is the most used mouse model in the present. An
important factor is that this genetic manipulation has no eect on the fertility
or birth weight compared to normal mice [40].e progression of lesions
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has been described when feeding either a normal chow diet or a western-type
diet (gure 2.3). However, despite the genetic homogeneity and controlled
condition, a considerable variation is present in atherosclerotic lesion size
[35].
Similar to human plaques, the lesions in ApoE−/− mice tend to develop
at vascular branching points. Complex lesions have been found in the aortic
sinus, several regions of the aorta including the ascending region, the arch,
and the renal area, and the innominate and coronary vessels [9], [17].e
precise locations have been mapped by Nakashima et al. for the ApoE−/−
mouse model and by VanderLaan et al. for the LDLR−/− mouse model
[41], [42].e plaque locations for the ApoE−/− mouse model are shown in
gure 2.2.
Figure 2.2: Atheroprone regions in the ApoE−/−mousemodel vasculature: (1) aortic
root, (2) lesser curvature of the aortic arch, (3) branches of the thoracic aorta, (4)
carotid arteries, (5) principal branches of the abdominal aorta, (6) aortic bifurcation
and (7) iliac arteries (reproduced from [41])
Still, caution has to be taken when translating results frommurine plaque
localisation studies to the human setting. In gure 2.2 it is clearly visible that
plaques occur at the aortic root in ApoE−/− (and also in LDLR−/−) mice. In
humans this is not a common location for atherosclerosis [43], except perhaps
for patients with familial hypercholesterolaemia [44]. When assessing the
position of lesions relative to the branching point as a function of age in more
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detail, Weinberg [45] described how human lesions (located at the intercostal
branches of the aorta) progress from a downstream location (infancy) via a
lateral location towards an upstream location (adult) based on experiments
done by Sloop et al. [46]. At an old age, the lesions are all located all around
the sidebranch (giving it the appearance of a volcano pattern) [45]. ApoE−/−
mice predominantly show the volcano pattern, with plaque being present
both up- and downstream from the sidebranch [43]. Unlike in humans, no
change in pattern was observed with ageing in ApoE−/− mice [43], [45]. Both
the presence of plaque in the aortic root in mice and the absence of changing
lesion patterns with age show that there are important dierences between
plaque locations in mice and humans.
A diagram showing the evolution of the atherosclerotic plaques in
ApoE−/− mice when on either a normal Chow diet or a western-type diet is
shown in gure 2.3.e western-type diet accelerates the development of
atherosclerotic plaques. And in contrast to C57BL/6J mice, that only develop
early stage foam cell lesions, the ApoE−/− mouse model also develops
more advanced brous plaques and plaques showing necrotic cores [36],
corresponding to type V plaques (AHA classication) [36]. Spontaneous
rupture and thrombus formation of complex plaques, which are commonly
seen in humans, have not been demonstrated for ApoE−/− mice or at very
low incidence rates (and neither for the C57BL/6J or LDLR−/− mice). Only
in the brachiocephalic artery spontaneous plaque rupture has been reported
(ApoE−/− when on a high fat diet) [40].
Figure 2.3: Diagram showing plaque development in ApoE−/− mice (reproduced
from [41])
Next to the development of atherosclerosis, the knockout of the ApoE
gene also results in: elevated cardiac output, elevated pulse wave velocity,
reduced vascular elasticity, reduced vascular compliance and cardiac hyper-
trophy [47]
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2.2.2.4 ApoE−/− Fbn1C1039G+/−
e most severe limitation of the previously described mouse models is
that spontaneous plaque rupture does not occur (regularly).erefore, re-
searchers had to resort to mechanical injury of the arterial wall or surgical
methods to achieve plaque rupture [48]–[50] (for the surgical methods see
section 2.2.1).
is led to the development of a new atherosclerotic mouse model at the
University of Antwerp. For this purpose, ApoE−/− mice were crossbred with
C1039G+/- mice to obtain mice showing both mutations (apolipoprotein E
decient and fbn1 heterogeneous (ApoE−/− Fbn1C1039G+/−)).e C1039G+/-
mutation in the brillin-1 (Fbn1) gene leads to Marfan syndrome, a genetic
disorder of the connective tissue that results in fragmentation of the elastic
bres [51]. In humans, this leads to decreased arterial compliance, an in-
creased risk for tear and rupture, aortic dilatation, bone overgrowth, joint
laxity and scoliosis [52].
Both ageing and atherosclerosis lead to structural and functional changes
in the elastic bres. Similarly, C1039G+/-mutation leads to a fragmentation of
the elastic Fbn1 bres and thus an increased stiness.is increased arterial
stiness is an important predictor of cardiovascular events. Combining the
atheroprone ApoE−/− mice with this model of increased arterial stiness
resulted in a mouse model with a more severe atherosclerotic phenotype
compared to the ApoE−/− mouse model [51].
e ApoE−/− Fbn1C1039G+/− mouse model develops highly unstable
plaques with plaque rupture.is mouse model also shows many features of
the human end-stage atherosclerosis (listed in section 1.2.4 on page 18): thin
brous cap with loss of collagen bres, presence of intraplaque microvessels
and haemorrhage, outward remodelling, enlarged necrotic core resulting in
plaque rupture, myocardial infarction, stroke and sudden death. Plaque
rupture was observed in this study [53] in 50 % of the brachiocephalic
arteries and 70 % of the proximal ascending aortas. Moreover, presence of
brin deposits and thrombi, suggesting plaque rupture, were found in the
coronary and carotid arteries[53].erefore, this mouse model is well suited
for further research on the mechanisms of plaque rupture and potential
therapeutic targets [51], [53]–[56].
2.3 The murine cardiovascular system
emouse heart is about the same size as a pencil eraser andweighs ∼100-200
mg [57].e restingHR formice is between 500 and 600 bpm (above 750 bpm
is considered non-physiological)[58].e challenges for measurements in
the murine cardiovascular system become clear when comparing an average
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mouse (of ∼25g) with a dog of 25 kg.e body weight decreases 1000 fold,
the surface area decreases 100 fold and the linear dimensions decrease 10
times [58].
Scaling laws have been proposed to link the dierent values of certain
haemodynamic parameters between dierent animals.ese allometric laws
relate the body mass (Mb) with specic haemodynamic parameters such
as for example the HR (see equation (2.1)). Body-mass exponents (c) for
dierent haemodynamic parameters are listed in table 2.3.
HR ∝ Mbc (2.1)
For the current thesis, these body-mass exponents, described by Wein-
berg et al. [59] (for the aorta), can be used to indicate the main dierences in
the haemodynamic environment between mice and humans before any nu-
merical modelling has been performed.e Reynolds number describes the
relative importance of the inertial forces compared to the viscous forces [60].
e body-mass exponent indicates that the murine Reynolds numbers are
lower compared to the human blood ow.erefore, the viscous forces are
more important in the murine blood ow.is will lead to a more stabilised
ow with less perturbations and recirculations (see chapters 8 and 9).
e Womersley number describes the unsteady nature of ow [61].e
lower Womersley number in mice indicates that the transient inertial forces
are smaller (in comparison to the viscous forces) than in the human haemo-
dynamics.
Langille approximated theWSS body-mass exponent to be -0.2 (based on
body-mass exponents of 0.8 and 1/3 for resting blood ow and arterial radius
Table 2.3: Body-mass exponents for dierent haemodynamic parameters (adapted
from [59]).e body-exponent is dened in equation (2.1).
Haemodynamic parameter Body-mass exponent, c
Cardiac outputD 0.75
Heart rateD -025
Aortic diameterD 0.375
Mean aortic blood velocity5 0
TAWSS5 -0.375
Aortic Reynolds number5 0.375
Aortic Womersley parameter5 0.25
D Literature values (see [59])
5 Derived from the rst three entries
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respectively) [62]. Westerhof et al. on the other hand, approximated the WSS
body-mass exponent to be -0.25 (based on c of 3/4 and 1/3 for blood ow
and radius respectively) [63]. Based on the c values for cardiac output and
aortic diameter in table 2.3, Weinberg et al. found the c for time averaged wall
shear stress (TAWSS) to be -0.375 [59].e TAWSS is the average WSS over
a complete heart cycle. As described by Weinberg et al., this means that the
expected TAWSS in mice is about 20 times bigger compared to the TAWSS
found in humans. Finally, Greve et al. experimentally found a value for the
WSS c of -0.38 [64], which gives an 18 fold dierence in WSS between mice
and humans. Although the exact c-value diers between those publications,
a substantially higher WSS value compared to humanWSS values can thus
be expected.
e aortic arch with the main arteries going to the head is shown in
gure 2.4. First the brachiocephalic trunk branches o the arch of the aorta.
Downstream, this artery splits in the right subclavian and the right common
carotid arteries. On the le side, the le CCA and the le subclavian artery
both branch o the aorta directly.
Both common carotid arteries split further downstream in the internal
and the external carotid artery (see gure 2.5).is bifurcation is the main
interest in the current research.e external carotid arteries mainly supply
blood to the face and the neck.e internal carotid arteries mainly supply
blood to the brain through the circle of Willis. In mice the blood ow to the
brain only accounts for ∼3.5% of the cardiac output (for humans this is ∼14%).
e lower amount of blood owing to the brain is likely due to the smaller
brain size per body weight[57].
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(a) Schematic (b) Photo of a cast
1. Aortic Arch 2. Brachiocephalic Trunk
3. Right Subclavian Artery 4. Right Common Carotid Artery
5. Le Common Carotid Artery 6. Le Subclavian Artery
7. Esophagus 8. Trachea
9. Internal Jugular Vein 10. Heart
Figure 2.4: Ventral view of the arteries at the aortic arch. (a) Schematic representa-
tion of the main arteries (adapted from [65]). (b) Photo of a corrosion cast of the
arterial network.
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Figure 2.5: Schematic overview of the murine carotid arteries supplying the brain
with blood (adapted from [66]).
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Imaging atherosclerosis in mice
3.1 Introduction
In the current chapter, the preclinical imaging techniques that were applied
during the current work are introduced: ultrasound (US) and micro-com-
puted tomography (µCT) imaging. For both imaging techniques the basic
imaging principles are explained.
3.2 Ultrasound imaging in mice
e current section gives an overview of the physical principles and the
dierent imaging modalities in ultrasound (US) imaging.is part is mainly
based on these sources ∗ † ‡ §.
3.2.1 General US principle
US imaging is a non-ionising imaging technique that uses acoustic waves
beyond the audible range. Medical US is similar to radar systems, where
∗A. Swillens, ‘A multiphysics model for improving the ultrasonic assessment of
large arteries’, PhD thesis, Ghent University, 2010
†J. E. Aldrich, ‘Basic physics of ultrasound imaging’, Critical Care Medicine, vol.
35, no. Suppl, S131–S137, 2007
‡R. W. Cootney, ‘Ultrasound Imaging: Principles and Applications in Rodent
Research’, ILAR Journal, vol. 42, no. 3, pp. 233–247, 2001
§V. Chan and A. Perlas, ‘Basics of Ultrasound Imaging’, in Atlas of Ultrasound-
Guided Procedures in Interventional Pain Management, S. N. Narouze, Ed., New York,
NY: Springer New York, 2011, ch. 2, pp. 13–20
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information is gathered from wave propagation [5]. Most echo imaging is
performed based on the pulse-echo imaging principle, with the working
principle schematically shown in gure 3.1 [1], [5], [6].
Figure 3.1:e general principle of pulse-echo ultrasound imaging.e transducer
emits an ultrasonic wave.ese waves travel through the tissues and get (partially)
reected back to the transducer (reproduced from [6]).
e imaging starts with the transducer, an array of piezoelectric crystals
that convert electrical energy in mechanical energy (the reversed piezoelec-
tric eect). is result in the emitting of longitudinal pressure pulses at
ultrasonic frequency (typical US frequencies for applications in human ima-
ging range from 2MHz to 10MHz [2]), but frequencies go up to 50 MHz for
imaging in small animals.e speed of these waves (c) is determined by the
compressibility (κ) and the density (ρ) of the tissue it travels through via
equation:
c = √ 1
ρκ
(3.1)
For most so tissues this wave speed is around 1540m/s. When the ultrasonic
waves travel through the tissue and encounter a change in acoustic impedance
Z (Z=ρc with c the wave velocity), a part of the wave is reected back towards
the probe because of reection and scattering. In gure 3.1, schematically two
tissues with a dierent acoustic impedance (dierent gray values) are plotted.
At the boundary between both tissues, the wave is (partially) reected.
e reected wave arrives back at the transducer under the form of
a radio-frequent signal (in the frequency range normally used for radio
communication). e transducer then acts as a receiver and converts the
radio-frequent signal to an electric signal. e time delay (t) between the
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emitted and received wave is related to the depth (d) of the reection/scatter
site using (with c the wave speed):
d = c t
2
(3.2)
Finally adequate processing is used to convert the radio-frequent signal in
an US image.
During the transmit phase the transducer generates a signal that con-
sists of two or three sound cycles with the same frequency. Aer this pulse,
the transducer has to wait for the pulse to travel through the tissue, to be
reected back and to be received before the next pulse is sent. e pulse
repetition frequency (PRF), are the number of pulses sent per unit of time
and for normal medical applications the PRF ranges from 1 to 10 kHz [4]. In
comparison to humans, mice have a heart rate that is about 10 times higher
and the cardiovascular structures are about 10 times smaller (chapter 2). As
a result the required temporal resolution is also higher compared to clinical
imaging. e frame rate is mainly limited by the time that the ultrasonic
waves need to travel through the tissue.eoretically, the smaller imaging
depth can make up for the higher frame rate needed [7].
3.2.2 Interaction between ultrasonic waves and tissue
Figure 3.2 summarises dierent interactions between tissue and ultrasonic
waves:
Figure 3.2: Dierent interactions between US waves and tissue (adapted from [8])
●Attenuation is the energy loss occurring when an ultrasonic beam
propagates through a heterogeneous medium. Absorption, reection,
scattering and refraction are four mechanisms that divert energy of the
incident beam and thus all four of them attribute to the attenuation
of the beam. Overall, the attenuation of the beam is exponentially
related to the frequency of the ultrasonic wave and the image depth.
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●Absorption is the conversion of wave motion into heat and is probably
the most important mechanism for attenuation.
●Reflection occurs when the wave reaches an interface between two ob-
jects that have a dierent acoustic impedance. For (specular) reection
to occur, these objects need to be bigger than the wave length of the
pulse and need to have a relatively smooth surface. When the dier-
ence in acoustic impedance is small, only a small part of the energy
will be reected and most of the wave will propagate further into the
tissue. If the dierence in acoustic impedance is high, most of the US
waves will be reected as is the case for example when a wave travels
from so tissue to bone. Because almost the entire wave is reected,
no transmission occurs and a shadow is present in the image behind
the bone. Specular reection has a preferential direction. For beams
with a normal angle of incidence, the wave is reected back. If the
incidence angle is dierent from 90○, the reected beam leaves at an
angle equal to the angle of incidence (similar to the reection of light
in a mirror). In this case, the reected beam can be directed away from
be transducer.
●Scattering occurs when the objects with a dierent acoustic impedance
are smaller than the wave length of the pulse. Scattering is a more
multi-directional phenomenon compared to reection. Due to this
scattering the intensity of the beam is reduced.
●Refraction is the change of direction of the beam aer hitting an in
interface between to tissues with a dierent wave speed. In medical
applications refractions are most prominent at fat/so tissue interfaces
(cfat∼1450m/s and cso tissue∼1540m/s) [4].
3.2.3 Dierent US imaging modalities
ere are dierent imaging modes that can be obtained, depending on the
processing of the signal measured with the transducer.
●B-mode imaging (Brightness Mode) (gure 3.3a): a view of the anatom-
ical structures in the imaging plane.
●ColourDoppler imaging (gure 3.3b): the (blood ow) velocity eld
is plotted in a 2D colour frame.e velocity magnitude in the direction
of the acoustic pulse (meaning the velocity in the direction from/to the
transducer) is coloured according to the magnitude. By convention
blue is ow away from the probe and red ow towards the probe.
58
3.2. Ultrasound imaging in mice
●M-mode imaging (Motion Mode) (gure 3.3c): the variation over time
of a single scan line.is mode can for example be used to quantify
the distension of an artery.
●PulsedDoppler imaging (gure 3.3d): the velocity of the scatterers
(mainly red blood cells) in the direction dened by the pulse wave in
a small control volume.e velocity in another direction (within the
image plane) can be calculated with a goniometric correction factor
(limited by a range of 30-40○).
(a) B-mode (b) Colour Doppler
(c)M-mode (d) Pulsed Doppler
Figure 3.3: Dierent US applications measured in vivo in mice. (a) B-mode longitu-
dinal view of the aortic arch with the aorta and the brachiocephalic trunk (BRT)
visible. (b) A Colour Doppler image showing the 1D velocity eld of the carotid
bifurcation. Blue indicates ow away from the probe. (c) A M-mode image showing
the distension of a CCA over time.e location of the M-mode image is indicated
with a dotted line in the top B-mode image in the same pane. (d)e Pulsed Doppler
(PD) image showing the velocity of the blood ow in the control volume.e control
volume (CCA) is plotted in the Colour Doppler image in the top of the same pane.
An angle correction was performed to calculate the velocity in the direction of the
dotted line (instead of the measured velocity in the direction of the beam).
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A more thorough theoretical description of the several imaging tech-
niques falls outside the scope of the current text. More information can
be found in literature: general US [1], [2] or small animal ultrasound [3].
Examples of the 4 listed imaging modes are shown in gure 3.3.
3.2.4 e main challenge for small animal ultrasound: high frequency
In comparison to humans, the murine cardiovascular structures are about 10
times smaller (chapter 2). Because of the smaller size, a higher resolution is
necessary.e axial resolution (resolution along the axis of the ultrasonic
beam) depends on both the pulse length and the frequency (wavelength). If
two objects are (axially) located closer than the pulse length, they are not
discernible and are measured as one reection.e lateral resolution (ability
to discern two objects next to each other) is dependent on the frequency
(wavelength) and the beam width [3].
Recently, dedicated scanners designed for small animal imaging were
developed (Vevo 770, 2100 and 3100, VisualSonics, Toronto, Canada).ese
scanners enable the use of high-frequency probes (up to 70MHz). In the
current work, measurements were performed using the Vevo 2100 system
(maximal resolution axial-30µm and lateral-75µm) equipped with a linear
array probe (MS550D, 22-55MHz).is system system has a better resolution
and a higher detection rate of small structures (assessed through the detection
of follicles within marmoset ovaries [9]) compared to clinical scanners.
On the other hand, the attenuation of the ultrasonic beam is also depend-
ent on the frequency.e increase of attenuation limits the penetration depth
of the ultrasonic wave at higher frequencies.is results in a frequency range
between 20 and 56 MHz for dedicated small animal imaging systems.
3.2.5 e ultrasound measurements in practice
For the duration of the US measurements the mice were under anaesthesia
with 1-1.5% isourane (for induction a dose of 5 % isourane was given).
e mice were then xated to the mouse handling table which is kept at a
temperature of 40○C, to prevent a lowering of the body temperature. e
body temperature was monitored with a rectal probe. e handling table
has 4 electrocardiography (ECG) electrodes for the four paws to allow for
monitoring of the HR and respiratory rate during the experiments. e
mouse is xated on the table and the probe is xed on a clamp mounted on
an integrated rail system. Both the position of the table (and thus the mouse)
and the rail system can be changed. Micro-manipulator turning wheels
allow the operator to ne tune the measurement position. e xation of
both the mouse (on the table) and the probe (on the rail system) keep the
measurement plane position xed during themeasurement, which is essential
for the visualisation/measurement in the small mice.
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(a) Scanner (b)Handling table
Figure 3.4: e setup of the US measurement setup for mice. (a)e Vevo2100
scanner (b)e mouse xated on the handling table with the US probe in a clamp.
e four paws are connected to electrodes to measure the ECG and the respiratory
rate.
3.3 µCT imaging in mice
e current section focuses on working principle and the advantages / lim-
itations of micro-computed tomography (µCT) with regard to the in vivo
imaging of the murine vasculature. is section is mainly based on these
sources ¶ ∥ ∗∗ †† ‡‡.
3.3.1 General µCT principle
In contrast to US, µCT is a medical imaging technique based on ionising
radiation. A µCT scanner mainly consists of three parts (gure 3.5A):
●The X-ray tube is the source where the X-rays are generated. For most
scanners, the electron beam is produced at the tip of a tungsten lament.
¶D. Clark and C. Badea, ‘Micro-CT of rodents: State-of-the-art and future
perspectives’, Physica Medica, vol. 30, no. 6, pp. 619–634, 2014∥S. J. Schambach, S. Bag, L. Schilling, C. Groden and M. a. Brockmann, ‘Ap-
plication of micro-CT in small animal imaging’,Methods, vol. 50, no. 1, pp. 2–13,
2010∗∗H. Li, H. Zhang, Z. Tang and G. Hu, ‘Micro-computed tomography for small
animal imaging: Technological details’, Progress in Natural Science, vol. 18, no. 5,
pp. 513–521, 2008
††L. Nebuloni, G. A. Kuhn and R. Müller, ‘A comparative analysis of water-
soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT.’,
Academic radiology, vol. 20, no. 10, pp. 1247–55, 2013
‡‡B. Vandeghinste, ‘Iterative Reconstruction in Micro-SPECT / CT : Regularized
Sparse-View CT and Absolute In Vivo Multi-Isotope Micro-SPECT Quantication’,
thesis, Ghent University, 2014
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A cone beam is generated (gure 3.5A) which speeds the measurement
process up tremendously compared to a plane by plane measurement.
●The object (in the current thesis a mouse) that is scanned is placed in
the middle of the scanner.
●Detector measures the X-rays that have penetrated through the object.
When the X-rays travel through the object, they get partially attenuated
resulting in a lower amount of photon quanta measured by the detector.e
total attenuation of a beam depends on the attenuation coecients from all
tissues it travelled through.erefore, a single projection measurement has
limited information.
To overcome this limitation, the scanner takes several projections for
over at least 180○ (see gure 3.5B). With respect to the rotation two dierent
scanner geometries are present. For ex vivo imaging most of the systems
use a stationary X-ray tube and detector. Instead the specimen is rotated to
measure projections at dierent angles. For most in vivo scanners, rotating
the object is challenging because the object is a breathing mouse, and needs
to be mechanically xated.us, for most in vivo scanners both the X-ray
tube and the detector are placed on a gantry and rotated around the object
while the object does not move (see gure 3.5A).
e image reconstruction process then converts the projection data into
a discrete tomographic representation of the object.e ltered back projec-
tion is the discretized version of the analytic solution of the reconstruction
process. Feldkamp extended this algorithm to be able to deal with cone
beams instead of planar beams [15]. A second family of algorithms applied
for the image reconstruction are the iterative reconstruction methods. Such
algorithms reconstruct the data by iteratively comparing the original pro-
jections with simulated re-projections of the reconstructed dataset.ese
iterative reconstructionmethods can provide a better image quality compared
to the ltered back projection because they are more robust for noise and
other artefacts. A more in depth description of the dierent reconstruction
methods is outside the scope of this text but this can be found in [16], [17].
In the current thesis the Iterative Maximum-likelihood Polychromatic
Algorithm for CT (IMPACT) algorithmwas used to reconstruct the µCT [18].
is iterative algorithm allowed to take the beam hardening due to the dense
skull and spine bones into account.e X-rays are polychromatic and lower
energy X-rays attenuate more rapidly when passing through (dense) tissue.
Due to this beam hardening eect, the IMPACT algorithm is necessary
to prevent dark(er) streaks originating from these dense structures from
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occurring. To speed up the reconstructions, all data were rst reconstructed
at a lower resolution (0.2 mm isotropic voxel size), aer which only the
volume of interest (VOI) was reconstructed at a higher resolution (50 µm
isotropic voxel size)[19]. In a µCT scan of the murine brain, this reduced the
noise to 5.5% instead of 14.1% with the ltered back projection [20].
Figure 3.5: Schematic overview of the µCT imaging process. (A)e X-ray tube
generates the X-rays that penetrate through the animal and get partially attenuated
in the tissues.e detector measures the X-rays that travelled through the animal.
(B)Both the X-ray tube and the detector rotate around the animal and measure
a projection at dierent angles (ranging over at least 180○). (C)e projection
information is processed by the reconstruction algorithm to generate the nal images.
(D)e reconstructed images can be visualised using cross-sectional images or 3D
visualisations.e image was adapted from [10], [12].
Aer the reconstruction, a discrete 3D dataset of the attenuation is ob-
tained. In most applications this attenuation is expressed in HU (Hounseld
units).eHU is calibrated so that the attenuation of air equals -1000HUand
the attenuation of water equals 0 HU (equation (3.3) with µ the attenuation
coecient).
CT [HU] = µ − µwater
µwater
⋅ 1000HU (3.3)
3.3.2 Interaction between X-rays and tissue
Figure 3.6 summarised the twomain interactionmechanisms between X-rays
and tissue with regard to µCT imaging.
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(a) photoelectric eect (b) Compton scattering
Figure 3.6:e two dominant interaction mechanisms between X-rays and tissue
with regard to µCT are the photoelectric eect (a) and Compton scattering (b)[14]
●Photoelectric Absorption (gure 3.6a) occurs when an inner shell
electron absorbs an incident photon.e electron is ejected from the
atom if the energy of the incident photon is high enough. Aerwards,
the vacant place is lled by an outer shell electron [14].
●Compton Scattering (gure 3.6b) occurs when the energy of the in-
cident photon is substantially higher than the binding energy of the
electron. e photon does not get absorbed completely, but keeps
existing with a lower energy and is deected (scattered) from its initial
trajectory [14].
3.3.3 e main challenge for cardiovascular µCT: contrast
µCT does not provide sucient so tissue contrast to image the cardiovascu-
lar structures.erefore, a specialised contrast agent with a high attenuation
factor is needed. In the current clinical setting water-soluble (low molecular
weight) agents are used to provide additional contrast for imaging of the
vasculature.ese contrast agents consist of organically bound iodine, which
has a high atomic number and thus a high attenuation/contrast. ey are
excreted through renal ltration. In mice the rapid renal ltration accounts
for a clearance of the contrast agent within seconds [10], [21]. erefore
in small animal µCT, especially when scanning at high resolution, most of
the current systems are not able to visualise the vasculature using human
tracers [13]. Some custom build systems are able to perform measurements
in this short time frame [22], but the µCT scanner that was available for the
research presented in this thesis (Triumph-II imaging system, TriFoil Ima-
ging, Chatsworth, California, US) and most commercially available scanners
have longer measurement times, which prevents this option. To overcome
this limitation, a second family of contrast agents for cardiovascular µCT
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imaging, has been developed: the blood-pool agent contrast agents. In 1998
Fenestra VC (ARTAdvanced Research Technologies Inc., Montreal, Canada),
an iodinated contrast medium embedded in a lipidic formulation [23], was
the rst contrast agent in the blood-pool agent family [13].e development
of this and other blood-pool contrast agents facilitated the translation of
clinical imaging to the preclinical setting.
More recently, larger nanoparticle metal-based agents became popular
because of their higher attenuation than iodine. For example gold has a ∼2.7
times higher contrast value compared to iodine per unit of weight[24]. As
a result, smaller volumes need to be injected in the mice. Aurovist 15nm
(Nanoprobes, Yaphank, New York, US) is gold particle based and ExiTron
nano 12000 (Miltenyi Biotec, Berlin, Germany) is barium based.
Nebuloni et al. compared in an extensive study one water-soluble agent
(Iomeron 400, Bracco, Italy) and 3 blood-pool agents: eXIA160XL Binitio
Biomedical,Ottawa, Ontario, Canada), Aurovist 15nm and ExiTron nano
12000. eir conclusion was that Aurovist provided the best contrast but
that a dark staining of the skin could limit follow up studies. ExiTron nano
12000 did not have this limitation and could therefore be an alternative for
longitudinal monitoring [13].
Our lab has extensive experience with repeated measurements with
Aurovist as a contrast agent[25].e dark staining of the tail makes it more
challenging, but not impossible, to inject the Aurovist at later time points.
erefore, for the µCTmeasurements done during the current work, Aurovist
15nm is used as a contrast agent.
3.3.4 e µCTmeasurements in practice
During the µCT measurements the mice were under 1-1.5% isourane anaes-
thesia and they were xed at the animal holder of the µCTscanner. All µCT
measurements were performed using a Triumph-II imaging system (TriFoil
Imaging, Chatsworth, CA). First, a pre-contrast injection scan was taken
at 50 µm resolution. en, 100 µl/25g body weight Aurovist was injected,
followed by the post-contrast injection scan. For both scans the scan time
was around 20 min resulting in a scan time around 1 h (including animal
preparation).
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Figure 3.7:e setup of the µCT scanner (reproduced from [7]).
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Numerical simulations of
arterial haemodynamics:
Surpassing measurement limitations
4.1 Introduction
e WSS exerted at the EC is the main biomechanical interaction that the
blood ow has with the ECs (see chapter 1). However, to be able to assess
the WSS and related metrics (see chapter 5), the ow velocity eld needs to
be known in great detail.e small size and the high HR of mice make this
impossible to measure and thus numerical methods such as computational
uid dynamics (CFD) are applied to calculate the WSS with a high accuracy.
For simple cases, the equations describing the physical laws of uid ow
and deformation of solids can be solved analytically. For real in vivo appli-
cations this is generally not the case because of several reasons: (i) complex
geometry, (ii) complex boundary conditions and (iii) complex properties of
the uid (blood) and solid (arterial wall). For these more complex cases CFD
or computational solid mechanics (CSM) provide a solution. ese simu-
lations approximate the solution by discretization of the governing partial
dierential equations (PDEs).
Both the temporal and the spatial domain are discretized. For the spatial
discretization, the domain is split in dierent cells (elements) and nodes called
the computational mesh. Aer this spatial discretization the physics laws can
be described using a Lagrangian, Eulerian or arbitrary Lagrangian-Eulerian
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(ALE) approach. ese three techniques are schematically represented in
gure 4.1.
Lagrangian (gure 4.1a)is method is mostly used for CSM.e nodes
of the mesh follow the material during the deformation over time.e
main advantage is that free surfaces and interfaces can be tracked easily
over time[1].
Eulerian (gure 4.1b)is method is widely used for CFD calculations.
As illustrated in gure 4.1b, the material moves over time but this
motion is not followed by the computational mesh: mesh points do not
move over time. Large displacements of the particles can be simulated
particularly well with this method [1].
ALE (gure 4.1c) With this technique, the nodes of the computational
mesh are allowed to move at an arbitrary speed, dierent from the
particle speed. For uid-structure interaction (FSI) simulations, this
technique is one of the possibilities to be able to deal with the presence
of both uids and solids.is technique is applied to the uid domain
of the FSI simulations in this thesis and more detail will be presented
in section 4.4.4.
e remainder of this chapter is mainly based on ∗ †.
4.2 Computational Fluid Dynamics
4.2.1 Navier-Stokes equations
Isothermal uid ow is described by two principles: conservation of mass
and conservation of momentum. Together they are called the Navier-Stokes
equations.
4.2.1.1 Conservation of mass
e conservation of mass formulates that no mass is generated or lost during
uid ow. Mathematically this principle can be expressed by the following
equation:
∂ρ f
∂t
+∇ ⋅ (ρ f v⃗ f ) = 0 (4.1)
∗J. Degroote, ‘Partitioned Simulation of Fluid-Structure Interaction’, Archives of
Computational Methods in Engineering, vol. 20, no. 3, pp. 185–238, 2013
†A. Quarteroni and L. Formaggia, ‘Mathematical Modelling and Numerical Sim-
ulation of the Cardiovascular System’, in Handbook of Numerical Analysis, October,
P. G. Ciarlet and J. L. Lions, Eds., vol. 12, Amsterdam: Elsevier, 2004, pp. 3–127
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t=0
t=1
(a) Lagrangian
t=0
t=1
(b) Eulerian
t=0
t=1
Particle Motion
Mesh Motion
Material Point
Mesh Point
(c) ALE
Figure 4.1: Dierent formulations of the partial dierential equation based on mesh
motion. (a) In the Lagrangian description, themesh (◯) motion follows thematerial
(x) motion. (b) In the Eulerian description, the mesh does not move. Due tomaterial
motion, material points can move from one mesh cell to another. (c) In the ALE
description, the mesh moves with an arbitrary speed, not necessary equal to the
material speed. Similar to the Eulerian description, material can move between
mesh cells (adapted from [1]).
In these equations ρ f expresses the density of the uid and v⃗ f the uid
velocity. In the case of incompressible uid ow, ρ f is constant and thus
equation (4.1) simplies to:
∇ ⋅ v⃗ f = 0 (4.2)
4.2.1.2 Conservation of momentum
Newton’s second law of motion is generally known in the formM ⋅ a⃗ = F⃗ with
F⃗ force, M mass and a⃗ acceleration. For the uid ow this law is expressed
as the second Navier-Stokes equation:
ρ f
∂v⃗ f
∂t
+ ρ f v⃗ f ⋅ ∇v⃗ f = ∇ ⋅ σ¯ f + f⃗ f (4.3)
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In this equation the forces are grouped as:
surface forces stresses experienced by the uid and expressed by the Cauchy
stress tensor σ¯ f
body forces ( f⃗ f ) external forces applied to the uid for example gravity
For the simulation of the blood ow in the carotid artery of a mouse,
this equation can be simplied further.e body forces are omitted because
the gravity is negligible compared to the surface forces. Next to this, the
conservation ofmass for incompressible uids further simplies this equation
resulting in:
ρ f
∂v⃗ f
∂t
+ ρ f∇ ⋅ (v⃗ f v⃗ f ) = ∇ ⋅ σ¯ f (4.4)
4.2.2 Constitutive law
Equations (4.2) and (4.4) are the equations used to describe the uid ow.
But these equations are not closed yet. In the current form, the velocity
components (v⃗ f ) and the components of the Cauchy stress tensor (σ¯ f ) are the
unknowns. Yet only 4 equations are available: the conservation of mass and
the 3 components (x, y and z) for the conservation of momentum.erefore
the components of the Cauchy stress tensor need to be linked to kinematic
quantities, in particular the velocity eld, for us to be able to solve this system
[3].
e Cauchy stress tensor can be split in the (internal) pressure P f and the
shear stresses.ese shear stresses (τ¯ f ) arise from the viscous forces. In reality
blood is a non-Newtonian uid (the viscosity is dependent on the shear rate)
[4]. However, in the current work blood will be modelled as a Newtonian
uid for simplicity, thus assuming a constant viscosity independent of the
shear rate. Under the assumption of Newtonian uid, the Cauchy stress
tensor (σ¯ f ) is given by the following constitutive law:
σ¯ f = −P f I¯ + τ¯ f = −P f I¯ + 2µε¯ f (4.5)
In this equation I¯ is the identity tensor and the strain rate tensor (ε¯ f ) is
calculated by (with v⃗ f the uid velocity):
ε¯ f = 12 [∇v⃗ f + (∇v⃗ f )T] (4.6)
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is constitutive law (equations (4.5) and (4.6)) can be used for sub-
stitution of the Cauchy stress tensor components in the conservation of
momentum equation (4.4) leading to:
ρ f
∂v⃗ f
∂t
+ ρ f∇ ⋅ (v⃗ f v⃗ f ) = ∇ ⋅ (−P f I¯ + µ∇v⃗ f + µ (∇v⃗ f )T) (4.7)
is results in 4 equations (the conservation of mass equation (4.2) and
3 components of the conservation of momentum equation (4.7)) with only 4
unknowns (P and 3 components of v⃗ f ).is set of equations is closed and
can then be solved numerically.
4.2.3 Solution of the uid mechanics equations
e current section describes the methodology followed in this thesis to solve
the uid mechanics problem.e reader should take into account that this is
only one of several possibilities.
In the current work, the spatial domain is discretized using the Eulerian
formulation (section 4.1) for the CFD simulations (for FSI simulations see
section 4.4.4). Aer the domain is split in dierent cells, the nite volume
method (FVM) was applied using Fluent 14.5 (Ansys, Canonsburg, USA).
e FVM is a possible method to solve the PDEs. In the FVM method,
the mesh is considered as a set of small control volumes. In Fluent all the
quantities (including pressures and velocities) are then stored in the centre
of this control volume (cell). For the solution the face centred values (needed
to solve the set of equations) are constructed using interpolation [5]–[7].
e time is discretised using an implicit second order backward discret-
isation scheme. As an example, the discretization of a general rst order PDE
(equation (4.8a)) is given in equation (4.8b).
∂ϕ
∂t
= F(ϕ) (4.8a)
3ϕn+1 − 4ϕn + ϕn−1
2∆t
= F(ϕn+1) (4.8b)
In this equation, ϕ is a general scalar quantity, ϕn the value at the current
time step, ϕn−1 the value at the previous time step and ϕn+1 the value at
the next time step. e value ϕn+1 is still unknown at this stage. F is a
generic function that includes any space discretization.is method is called
implicit because the value ϕn+1 is only present implicitly and dependent on
the unknown values of ϕn+1 in the neighbouring cells through F(ϕn+1).is
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scheme therefore results in a set of equations that needs to be solved iteratively
at every time point until convergence is reached.
A more detailed description of the solution method is beyond the scope
of this work. For a more detailed explanation the reader is referred to the
manual or the theory guide of Fluent [7].
4.3 Computational SolidMechanics
One of the dierences with CFD simulations is that in CSM simulations
normally the Lagrangian approach is followed (gure 4.1a). erefore, in
this paragraph the equations are presented in the Lagrangian form. e
material derivative (also called Lagrangian derivative) is the time derivative
in a Lagrangian frame.is derivative of a general function f can be calculated
using (with v⃗s the velocity of the solid):
D f
Dt
= ∂ f
∂t
+ v⃗s ⋅ ∇ f (4.9)
4.3.1 Conservation of momentum
In CSM the displacement or the deformation (u⃗) is determined by the Cauchy
momentum equation:
ρs
D2u⃗s
Dt2
= f⃗ s +∇ ⋅ σ¯ s (4.10)
In this formula ρs is the density of the solid, f⃗ s the body forces and σ¯ s the
Cauchy stress tensor of the solid. Similar to the uid ow problem, we will
ignore the body forces because the gravity (= f⃗ s) is low compared to the
other forces involved. Next to this, equation (4.10) diers from the uid
momentum equation (equation (4.3)) by the Lagrangian formulation visible
in the use of the material derivative.
4.3.2 Constitutive law
Similar as to the uid case, constitutive laws are needed to close the equations.
For uid ow, these constitutive laws express σ¯ f in function of the gradient of
the velocity. In solidmechanics the constitutive law links the stress tensorwith
the gradient of the deformation (∇u⃗s).e mass and momentum equations
for solid and uid mechanics are the same, but the dierent constitutive laws
result in major dierences [3].
To derive the constitutive laws, we need the deformation gradient tensor
(F¯) which is dened in function of the reference coordinates (X⃗) and the
coordinates during deformation (x⃗). Suppose a material point p of a solid
76
4.3. Computational Solid Mechanics
body B has coordinates X⃗ in the reference conguration. When the body
deforms, the coordinates change to x⃗. e deformation gradient is then
dened in equation (4.11). In other words, the deformation gradient projects
the vector dX⃗, pointing from p to a neighbouring point q in the reference
conguration, onto the vector dx⃗, pointing from p to q in the deformed
conguration: dx⃗ = F¯.dX⃗
F¯ = ∂x⃗
∂X⃗
(4.11)
Furthermore we note the determinant of F¯ as J. J expresses the relative
change of an innitesimal volume around a material point p and is a measure
for local material compression.
In large deformation theory, the constitutive laws are expressed in func-
tion of the second Piola-Kirchho stress tensor (S¯s) instead of the Cauchy
stress tensor (σ¯ s). When they are dened using S¯s , the Green-Lagrange strain
tensor (ε¯s) is applied to dene the strain.e second Piola-Kirchho stress
tensor and the Green-Lagrange strain are dened in function of the Cauchy
stress (σ¯ s), the displacement (u⃗), the deformation gradient tensor (F¯) and its
determinant (J) as:
S¯s = JF¯−1σ¯ s F¯T (4.12a)
ε¯s = [∇u⃗s + (∇u⃗s)T + (∇u⃗s)T ∇u⃗s] (4.12b)
For hyperelastic materials (such as the models used in this thesis), the
constitutive law is regularly dened in its integral form using the strain energy
density function (W). During deformation this functionW denes the elastic
strain potential energy per unit of initial (undeformed) volume. Dierent
material models are then dened by describing their dierent W.e link
between S¯s and ε¯s can then be expressed as [8], [9]:
S¯s = ∂W∂ε¯s (4.13)
For example for the Arruda-Boyce model the strain energy density func-
tion is dened as [10]–[12]:
W = NkBθ√n ⎡⎢⎢⎢⎣βλchain −√nln(sinhββ )
⎤⎥⎥⎥⎦ (4.14)
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is model was originally developed to describe the mechanics of rubber-
like materials that consist of a network of linked polymeric chains. In the
previous equation several physical and material dependent constants are
included to mimic reality: the number of chain segments (n), the Boltzmann
constant (kB), the temperature in Kelvin (θ) and the number of polymeric /
rubber chains (N). λchain and β are given by:
λchain = √ I13 (4.15a)
β = L−1 ⎛⎝ λchain√n ⎞⎠ (4.15b)
In these equations I1, is the rst invariant (trace) of the le Cauchy –
Green deformation tensor (= F¯ F¯T) and L−1 is the inverse Langevin function.
Together with the conservation of momentum, the constitutive law closes
the governing equations.e CSMmodel can then be solved to calculate the
deformation of the solid material.
4.3.3 Solution of the solid mechanics equations
Both the standalone CSM simulations and the CSM simulations that are part
of the FSI protocol made use of the Lagrangian formulation. A nite element
method (FEM) approach in Abaqus Standard (Simulia, Johnston, USA) was
used to solve the equations.e solution domain is discretized based on a
piecewise representation of the basis functions. e computational mesh
splits the domain into a set of elements and in every element the solution is
formulated in function of the basic functions.is is conceptually dierent
from the FVMmethod used for the CFD in section 4.2.3 on page 75, where
in every cell the solution is only represented by the central value. In the FEM
method the basic function approximation is known, which includes more
information compared to the FVM applied in the CFD simulations[6], [13],
[14].
e time domain is discretised using a rst order implicit backward
discretisation scheme. In this scheme, the time derivative of equation (4.10)
can be expressed using[15]:
˙⃗us ∣t+∆t = u⃗s ∣t+∆t − u⃗s ∣t∆t (4.16a)
¨⃗us ∣t+∆t = ˙⃗us ∣t+∆t − ˙⃗us ∣t∆t (4.16b)
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As for the uid mechanics problem, this is an implicit scheme that needs
to be solved iteratively at every time point.
Amore detailed description of the solution procedure followed byAbaqus
Standard is outside the scope of this text and can be found in the Abaqus
eory Guide [15].
4.4 Fluid Structure Interaction
is section describes the coupling of the CFD and CSM solver using the
coupling code Tango developed by prof. Joris Degroote at Ghent University.
An in depth analysis is beyond the scope of the current work, only a summary
of the work of prof. Degroote is presented. For a more detailed overview the
reader is referred to the original articles describing the coupling code and
comparing dierent FSI methodologies [2], [16]–[18].
4.4.1 Equilibrium conditions
Aer solving the Navier-Stokes equations for the uid domain (section 4.2.1)
and the solid domain equations (section 4.3.1), we still need to describe what
is happening at the interface of both domains. In CFD simulations, the no-
slip boundary condition at physical borders (walls) is commonly applied,
which translates to a zero velocity at the boundary. In FSI simulations the
no-slip boundary condition means that the velocity of the uid is equal to
the velocity of the solid at the interface.
v⃗ f = du⃗sdt (4.17)
At the interface the traction forces also have to be in equilibrium (with n⃗ the
normal of the element on the interface pointing outward of the respective
domain).
σ¯ f ⋅ n⃗ f = −σ¯ s ⋅ n⃗s (4.18)
4.4.2 Monolithic or partitioned FSI approach
FSI simulations combine the uid and solid mechanics simulations. When
they are combined in a monolithic approach, the uid and solid mechanics
equations are solved simultaneously.is approach takes the mutual inu-
ence directly into account which has a benecial inuence on the stability.
Furthermore, no coupling iterations are needed.
On the other hand it is also possible to solve the uid and solid mech-
anics equations separately, which is called a partitioned approach. Over the
years highly specialised and well known codes have been developed to solve
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either the uid or the solid mechanics equations eciently. When using the
partitioned approach, these highly optimised codes can be applied, possibly
resulting in a higher eciency. e partitioned approach also adds more
exibility because it can more easily be adapted to other codes.
At the interface between the uid and the solid, Dirichlet-Neumann
boundary conditions are used to describe the problem. For the ow solver,
the displacement (or velocity) at the interface is applied (Dirichlet boundary
condition) according the the CSM results. For the solid solver, the traction
exerted by the uid at the solid elements at the interface is applied for the
CSM (Neumann boundary condition).
For the current work a strongly coupled partitioned approachwas applied:
Tango [2]. For an in depth comparison between the partitioned approach of
Tango and a monolithic approach, the reader is referred to [16].
4.4.3 Explicit or Implicit coupling
Most partitioned FSI simulation approaches can be grouped in either expli-
citly (=weakly) coupled or implicitly coupled formulations (although other
formulations exist). In explicit coupled codes, only one coupling iteration
is performed (uid⇒ solid⇒ next time step) and thus the solid and uid
equations are only solved once for each time step. As a result the equilibrium
conditions (section 4.4.1) are not exactly imposed [2].
In Tango the uid and solid equations are implicitly coupled. For each
time step the equilibrium conditions are imposed at both the uid and the
solid solver. An iterative process (the coupling iterations) between both solv-
ers (uid and solid) based on the interface- quasi-Newton with inverse Jac-
obian from a least-squares model (IQN-ILS) iteration scheme [16] is applied
to ensure convergence.is ensures the equilibrium of the displacements
and forces at the interface for every time step.
For every time step several solid and uid simulations are performed.
In the previous section, it was mentioned that displacement and traction
are exchanged at the surface between the CFD and CSM simulations. Us-
ing an interface- quasi-Newton with inverse Jacobian from a least-squares
model (IQN-ILS) iteration scheme, the coupling code Tango determines the
equilibrium state for this exchange at the interface at every time step [2], [16].
4.4.4 Arbitrary Lagrangian-Eulerian formulation
In gure 4.2, the mesh deformation is schematically drawn for FSI simula-
tions using the ALE description for the uid domain and the Lagrangian
description for the solid domain.e Lagrangian description makes sure that
the solid mesh is attached to the structure (grey) and the mesh thus deforms
along with the movement of solid particles (dots) in gure 4.2.
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For the uid ow a strict Eulerian formulation is no longer sucient,
because the uid domain is deforming.is deformation is due to themotion
of the solid (arterial wall) and the uid domain needs to stay in contact with
the deforming solid (at least in the application of blood ow in arteries).
In this work, the uid equations were expressed using an ALE approach.
As can be seen in gure 4.2, the uid mesh has the same velocity at the
interface as the solid mesh. To avoid excessive distortion of the uid mesh,
the uid mesh velocity at the interface is extended to the whole uid domain
mesh for example by a spring-based model. is models the edges of the
mesh as springs with a stiness inversely proportional to the edge length [2].
As a result the uid mesh deforms with a dierent velocity compared to the
uid motion (gure 4.2b).
Solid Point Fluid Point
(a) t = 0
Solid Point Fluid Point
(b) t = ∆T
Figure 4.2: Schematic drawing of the ALE (uid) and Lagrangian (structure) grid
motion during the FSI simulations.e original meshes (a) and the meshes at a later
time point (b) are plotted.e solid mesh (grey) deforms together with the structure
(Lagrangian formulation). For the uid mesh, the deformation of the mesh happens
with a deformation dierent from the uid deformation (ALE). At the interface the
solid and uid meshes move with the same velocity.
e disadvantages of the ALE formulation only occur at high deforma-
tions of the structure or when the topology changes (for example closing of a
valve). In these cases, the extension of the displacement of the uid grid at the
interface to the rest of the uid grid will lead to a low quality, highly skewed,
distorted mesh. In the research presented in this thesis, the deformations
are low and no topological changes occur so the ALE formulation causes no
problems. Another advantage of the ALE approach is that the time-depend-
ent WSS can be quantied easily. ese time-dependent changes of WSS
inuence the EC at the solid surface (see chapter 5 on page 85). Because the
uid mesh follows the solid motion at the interface, it is possible to link WSS,
which is a property of the uid domain, with specic locations at the arterial
wall, in the solid domain.
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Haemodynamic wall
parameters:
From simulations to physiology
5.1 Introduction
Perhaps the most important step in the CFD (section 4.2 on page 72) or
FSI (section 4.4 on page 79) tool chain is to translate the calculations into
physiologically relevant results and metrics. CFD is a tool used in a lot of
dierent engineering elds. It is generally accepted that haemodynamics play
a crucial role in atherosclerosis development, with especially the blood ow
close to the arterial wall being important.e shear stress is the frictional
force per unit area that the blood ow exerts on the arterial wall, and it is an
essential biomechanical stimulus of the blood ow on the EC. As described
in section 1.2.7 on page 23, low and oscillatory WSS sets o several molecular
pathways leading to atherosclerosis development. roughout the years,
several haemodynamic wall parameters (HWPs) have been dened which
all aimed to quantitatively link the haemodynamics with atherosclerosis
development through an objective quantication of ow/WSS properties. In
the next part of this chapter, the most important HWPs are listed, subdivided
into three main groups: the magnitude-based, the gradient-based and the
harmonic based HWPs.
We will illustrate the dierent HWPs using a dataset that has been gen-
erated as part of this PhD thesis (simulations of a carotid bifurcation in
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an ApoE−/− mouse, mouse 3L). In chapter 8 on page 149, a more complete
overview of the FSI methodology and results is given.
5.2 Wall shear stress
e shear stress (τ) exerted on the arterial wall is proportional to the local
velocity (u) gradient (shear rate) with the dynamic viscosity (µ) being the
proportionality constant - equation (5.1). In this equation y is the direction
perpendicular to the arterial surface.
τ = µ ∂u
∂y
∣
y=0 (5.1)
e WSS is the tangential force exerted by the owing blood on the
arterial surface per unit of area.e main problem, however, is that the shear
rate in equation (5.1) can not be measured directly.
e simplest method of estimating the WSS is assuming Poiseuille ow.
is assumption is justied in case of: circular tube (rigid walls), steady
state ow (no time dependence), Newtonian behaviour of the uid (constant
viscosity) and suciently low Reynolds number (Re≪ 1900 for pipe ow [1])
to ensure laminar ow. In that case, the velocity prole is parabolic (gure 5.1)
and equation (5.1) simplies to the Hagen-Poiseuille formula (equation (5.2))
[2]. It should be stressed that these assumptions are strict, which practically
renders them unusable for complex ow elds in the vicinity of, for example,
bifurcations, stenoses and aneurysms.
τ = 4µQ
piR3
(5.2)
Another possibility to obtain WSS, is to measure the velocity eld (ow
eld) with high accuracy and to calculate the WSS directly from the shear
rate (equation (5.1)). Magnetic resonance imaging (MRI) and US are the
main imaging modalities used for this kind of studies in humans [2], [4],
[5]. However, the usability of these methods is limited in mice. van Bochove
et al. applied an MRI approach to the casted CCA in mice (tapered cast
section 2.2.1).ey only estimated WSS at peak ow [6] and their method is
not applicable to more complex geometries such as bifurcations.
e challengingmeasurements needed to apply equation (5.1) directly are
one of the reasons why CFD or FSI models are used for WSS studies.ese
simulations allow to calculate the time dependent WSS vector in complex
geometries and to derive several HWPs that take the time dependency into
account.
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Figure 5.1: Schematic representation of the wall shear stress (reproduced from [3]).
5.3 Magnitude-basedHWP
5.3.1 Time averaged wall shear stress (TAWSS)
e TAWSS is calculated by averaging the norm of the time dependent wall
shear vector (τ⃗) over time (one heart cycle - T) - equation (5.3).
TAWSS = 1
T ∫ T0 ∥τ⃗∥ dt (5.3)
Figure 5.2a shows the TAWSS for the example murine carotid bifurcation.
It is clearly visible that the ECA for this specic bifurcation has the lowest
TAWSS value from the three branches and the ICA the highest. Within both
the ECA and ICA, the lowest value of the TAWSS occurs at the outer bend of
the bifurcation.
5.3.2 Oscillatory shear index (OSI)
Next to the average value of the WSS, also its uctuating nature has an
important inuence. It is generally accepted that atheroprone regions are
characterised by low and oscillatory shear stress [7].e oscillatory shear
index (OSI) was originally proposed by Ku et al. to describe this oscillatory
character [8], [9].e OSI also has an average value over the whole heart-
cycle and can be calculated using equation (5.4).
OSI = 1
2
⎛⎜⎜⎝1 −
∥∫ T0 τ⃗ dt∥∫ T0 ∥τ⃗∥ dt
⎞⎟⎟⎠ (5.4)
e OSI value is limited to the range [0,1/2]. When almost no oscillations are
present theOSIwill have a value close to 0. In the case a purely oscillatory ow
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is present (for example a sinusoidal-wave), the OSI will reach the maximum
value of 1/2. As can be seen in gure 5.2b, the zone with a high OSI in the
murine carotid bifurcation is found mainly at the outer side of the ECA sinus.
is overlaps with the low TAWSS region.
5.3.3 Relative residence time (RRT)
Himburg et al. showed that the residence time of particles near the wall is
inversely correlated with both the TAWSS and OSI.e relative residence
time (RRT) can be calculated using equation (5.5). When the oscillatory ow
component is low, the OSI is small (close to 0). In that case, OSI only has a
small inuence on equation (5.5) and RRT. However, when OSI approaches
its limit of 0.5, its inuence increases signicantly.
RRT ∼ 1(1 − 2 ⋅OSI) ⋅ TAWSS (5.5)
e RRT is calculated from both TAWSS and OSI. Because both HWPs
show a similar (but inverse) distribution in the example carotid bifurcation,
RRT shows a highly similar spatial distribution as both previous HWPs
(gure 5.2c).
5.3.4 Transverse wall shear stress (transWSS)
e previous HWPs (TAWSS, OSI and RRT) do not take into account the
multi-directionality of the ow and can thus not dierentiate between uni-
axial and multi-directional ow. However, it has been hypothesised that this
multi-directionality has inuence on the endothelial permeability [10]. More
recently, Wang et al. showed in vitro that ow perpendicular to the EC align-
ment activates pro-inammatory pathways [11]. erefore, the previously
introduced metrics may not include all the relevant information about the
WSS.
To include the multi-directionality of the shear stress, the transverse wall
shear stress (transWSS) metric has been proposed by Peier et al. [12].e
transWSS is calculated as the time average of the WSS component perpendic-
ular to the average shear stress vector.e average shear stress vector (τ⃗mean)
is calculated using equation (5.6b) and the transWSS using equation (5.6a).
e value of transWSS ranges between 0 and TAWSS.e transWSS can
dierentiate between multi-directional (high transWSS) and uni-directional
ow (transWSS close to 0), but it can not dierentiate between purely forward
and ow reversions in unidirectional ow, in contrast to the OSI.erefore,
the transWSS can be used to complement the other metrics. Mohamied et al.
showed that the transWSS correlates with the atherosclerotic lesions in the
aortic branch ostia in rabbit aortas [13].
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transWSS = 1
T ∫ T0 RRRRRRRRRRRτ⃗ ● (n⃗ × τ⃗mean∥τ⃗mean∥)
RRRRRRRRRRR dt (5.6a)
with τ⃗mean = ∫ T
0
τ⃗ dt (5.6b)
When comparing transWSS (gure 5.2d) with the othermagnitude-based
HWPs (gures 5.2a to 5.2c) for the example case of the mouse carotid bifur-
cation, the dierent overall pattern of the transWSS map stands out. While
the TAWSS, OSI and RRT mainly suggest the outer side of the ECA sinus to
be the atheroprone region, this zone is not highlighted by the transWSS.e
zones characterised by a high transWSS, are closer to the inner side of the
bifurcation.ese zones spread out to both the lateral and the medial side of
the arteries.
5.3.5 Other magnitude-based metrics
ere are several other metrics that can be dened based on the magnitude
of the WSS vector [14]–[16]. In the current thesis, however, we will focus on
the ones listed above. Morbiducci et al. proposed a topology driven approach
to project the WSS vector on the secondary and main ow directions [14].
e splitting is based on the centreline of the vasculature, which identies
the main ow direction. However, for trivial ows (laminar ows, following
the centreline direction) this approach is equivalent to the approach followed
by Peier et al. for the transWSS [12].
e directional oscillatory shear index (DOSI) was proposed by
Chakraborty et al., as another method to take the multi-directionality into
account of ow.is metric been developed specically for the unique ow
patterns in an orbital shaker.e DOSI is based on a splitting of the OSI in
its two principal directions. It dierentiates between uniaxial oscillations
(DOSI = 1) and oscillations equal in both principal directions (DOSI =0)
[17].
5.3.6 Comparison of the magnitude-based HWP
In gure 5.3 a schematic overview is given over dierent ow conditions that
can occur in an artery.e inuence of the WSS in these conditions on the
calculated magnitude-based HWPs is schematically plotted. e TAWSS
does not include any directionality information.erefore, the TAWSS can
not dierentiate between the dierent ow conditions and is equal in all three
cases.eOSI is able to dierentiate between purely forward ow (gure 5.3a)
and pulsatile ow (gure 5.3b). However, OSI can not dierentiate between
uniaxial (gure 5.3b) and multi-directional pulsations (gure 5.3c). e
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(a) TAWSS [Pa]
(b)OSI
(c) RRT
(d) transWSS [Pa]
Figure 5.2:e magnitude-based HWP in the murine carotid bifurcation
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RRT is related to both the TAWSS and the OSI and can therefore also not
dierentiate multi-directional pulsatile ow. Since the transWSS takes the
WSS component perpendicular to the main ow direction into account, it
highlights regions with WSS in the secondary direction (at an angle of 90○).
As a consequence the transWSS is not able to discriminate ow pulsations in
the main ow direction.
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(c)Multi-directional
Purely forward Pulsatile Multi-directional
TAWSS 2.5 2.5 2.5
OSI 0 0.4 0.4
RRT∼ 0.4 2 2
transWSS 0 0 0.85
Figure 5.3: Comparison of dierent ow environments of endothelial cells with the
same TAWSS.e inuence of the ow environments on the dierent magnitude-
based HWP is listed. (a) Purely forward ow regime. (b) Pulsatile ow regime with
reversal. (c) Multi-directional disturbed ow regime (inspired by [12]).
5.4 Harmonic-basedHWP
5.4.1 Dominant harmonic (DH)
e response of the vascular endothelium to shear stress is frequency-depend-
ent [18].is led to the development of metrics that include this extra piece of
information. Himburg et al. introduced the dominant harmonic (DH), which
identies the zones where the endothelium is subject to higher frequency
shear forces. Aer applying a Fourier analysis (FFT) to the magnitude of the
WSS, the dominant harmonic is used to calculate the DH (equation (5.7)). In
this formula ω0 is the fundamental frequency and n the harmonic index so
91
5. Haemodynamic wall parameters
that n ⋅ ω0 indicates the nth harmonic. Himburg et al. showed that the zones
with a high harmonic content corresponds to regions with a low mean shear
stress [19].
DH = n ∋ max (F (nω0)) , F ≡ FFT (∥τ⃗∥) , ω0 = 2piT (5.7)
Only a very small zone with an elevatedDHwas present (at the stagnation
point of the ow) in the murine carotid bifurcation.
5.4.2 Harmonic index (HI)
Gelfand et al. proposed the harmonic index (HI) as a HWP that includes
the frequency-dependence [20]. is metric is dened as the harmonic
amplitude of the oscillatory components over the total harmonic amplitude
(including the mean, constant component), as shown in equation (5.8).
HI = ∑∞n=1 F (nω0)∑∞n=0 F (nω0) , F ≡ FFT (∥τ⃗∥) , ω0 = 2piT (5.8)
In comparison with DH, this metric has a continuous value rendering
it a more appropriate choice to study the harmonic content of the WSS in
the murine carotid bifurcation. In gure 5.4a, it can be seen that the HI
parameter has a very smooth distribution. Globally, it highlights the same
region (outer bend of the ECA) as the classical magnitude based HWPs for
the simulated case.
5.4.3 Axial harmonic-based HWP
Lee et al. did not nd the correspondence between low TAWSS and high DH
in the human carotid bifurcation [21], in contrast with the results of Himburg
et al. [19] in the iliac artery in pigs. A possible reason is the highly uni-axial
ow in the porcine iliac artery in contrast to the more multi-axial ow of the
human carotid bifurcation.erefore, Lee et al. proposed to use the axial
dominant harmonic (DH-axial) and axial harmonic index (HI-axial) instead
of the DH and HI in this more multi-axial ow case [21]. Both axial metrics
are calculated as their “normal” counterparts, except that the instantaneous
wall shear vector projected on the average wall shear vector is used. is
can be seen in equation (5.9b).e ow in the murine carotid bifurcation is
highly uniaxial and thus the HI-axial and HI show a very similar pattern.
DH = n ∋ max (F (nω0)) , F ≡ FFT (τ⃗ ● τ⃗mean) , ω0 = 2piT (5.9a)
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HI = ∑∞n=1 F (nω0)∑∞n=0 F (nω0) , F ≡ FFT (τ⃗ ● τ⃗mean) , ω0 = 2piT (5.9b)
with τ⃗mean = ∫ T
0
τ⃗ dt (5.9c)
(a)HI
(b)HI-axial
Figure 5.4:e HI in the murine carotid bifurcation
5.5 Gradient basedHWP
e tension exerted on the EC is expressed by the spatial gradient of the WSS
(wall shear stress spatial gradient (WSSG): equation (5.10a)) [22]. Changes
in the directionality can be quantied by the wall shear stress angle gradient
(WSSAG) [16], [23]. In the WSSAG formula (equation (5.10b)), the WSS
values in the surfacemesh element (el) centroid and the surfacemesh element
nodes of the numerical grid are used. Moreover, (peak) temporal gradient of
the WSS (wall shear stress temporal gradient (WSST): equation (5.10c)) has
been proposed as a metric [24].
WSSG =
¿ÁÁÁÀ⎛⎝∣ ∂τ⃗∂x ∣⎞⎠
2 + ⎛⎝∣ ∂τ⃗∂y ∣⎞⎠
2 + ⎛⎝∣∂τ⃗∂z ∣⎞⎠
2
(5.10a)
WSSAG = 1
T ∫ T0 ∣ 1Ai ∬ ∇ϕ j dAi∣ dt (5.10b)
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with ϕ j = cos−1 ⎛⎝ τ⃗i ⋅ τ⃗ j∥τ⃗i∥ ⋅∥τ⃗ j∥⎞⎠ , i ≡ el centroid , j ≡ el node
WSST = max ⎛⎝∣∂∥τ⃗∥∂t ∣⎞⎠ (5.10c)
ese parameters form a dierent approach to quantify the inuence
of WSS on the EC and were not considered in this thesis. First, Lee et al.
showed that they are highly correlated to the other HWPs in the human
carotid bifurcation [21]. Secondly, TAWSS showed to have a higher sensi-
tivity for identifying zones prone to atherosclerosis compared to the (time
averaged) WSSG in the human le coronary artery [25]. Moreover, Knight
et al. noted that there are dierent denitions of the discrete WSSG in use.
is distantiates the gradient values from the biological processes and limits
their usefulness for practical use [26].
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Assessment of carotid anatomy
and (patho)physiology using
ultrasound
6.1 Mice included in this study
In the next sections, an overview is presented of the results of the small animal
US measurements that were performed in the context of this thesis. Female
ApoE−/− (n=9) and their ApoE−/− Fbn1C1039G+/− (n=14) littermates were
studied.eywere fed aWestern-type diet (TD88137, HarlanTeklad,Madison,
WI) for up to 20 weeks, starting at an age of 6 weeks. All experiments were
conducted according to the European Commission guidelines and were
approved by the Animal Ethics Committee of Ghent University.
Table 6.1: Overview of the number of mice included in the measurement protocol.
e columns are grouped in time aer the start of the diet (starting at an age of 6
weeks).
w0 w5 w10 w15 w20
ApoE−/− 9 8 8 8 8
ApoE−/− Fbn1C1039G+/− 14 13 12 11 8
e animals underwent a 5-weekly measurement protocol consisting of
either solely US or US and µCT.e drop-out of animals with time is because
of sudden death or because of euthanasia for ethical reasons (weight loss or
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signs of stress: panting, head tilt, a hunched body posture, and immobility).
e sudden deaths were related to the severe phenotype [1], while some
deaths occurred because of a combination of the severe phenotype and the
anaesthesia.e total amount of mice included at each time points is listed
in table 6.1.
For the statistical analysis a linear mixed model (LMM) approach was
applied. is is a modelling strategy to determine which xed factors, i.e.
grouping variables, have a signicant outcome on the measurements.e
dierent grouping factors were: time aer the start aer the diet (weeks 0, 5,
10, 15 or 20), the strain (ApoE−/− or ApoE−/− Fbn1C1039G+/−) and the side of
the measurement (le or right).
A short introduction to the LMM is added in Appendix A.e analysis
was performed in SPSS Statistics 22 (IBM, Armonk, NY, US). Results were
deemed signicant if p<0.05 and highly signicant for p<0.01. To compare
individual groups, the estimated marginal means of the tted models were
compared using Bonferroni correction (where applicable).
6.2 Carotid flow velocities
e pulsed wave Doppler ultrasound (PWDoppler US) signal (velocity of the
red blood cells in the control volume) was obtained from the CCA, the ECA
and the ICA branches.e maximum envelope of this signal was tracked in
an application written in Matlab (Mathworks, Natick, Massachusetts, USA)
(see gure 6.1a). A 3-cycle (based on tracking of the QRS-complex at the ECG
signal) averaged curve was constructed to further limit noise (gure 6.1b).
From this curve, the systolic velocity (Vsys) was obtained as the maximum
of the curve; the end-diastolic velocity (Ved) was obtained by selecting the
minimum velocity located before the foot of the ow wave. Finally, the cycle
averaged value of the velocity (Vavg) was calculated.
Common carotid artery
For the CCA an overview of the measured velocities is given in gure 6.2.
In panel A) the Vsys (top, △), Vavg (middle,◯) and the Ved (bottom, ▽)
are shown for the ApoE−/− mice (blue). During the heart cycle, the velocity
will range from the Ved to the Vsys velocity and cycle through the light blue
shaded area in gure 6.2 A). For the ApoE−/− Fbn1C1039G+/− mice, the results
are plotted in red in gure 6.2B. On average, over time a small decrease in
Vsys is visible (time is a signicant grouping factor for Vsys: p<0.01), but
neither Vavg nor Ved change over time (p>0.05). To allow for an easy visual
comparison of both strains of mice, the ApoE−/− Fbn1C1039G+/− results are
plotted in a lighter shade on the ApoE−/− panel (A) and vice versa. e
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(a) Tracking of the PW Doppler US signal (yellow-line)
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Figure 6.1: Post-processing of the PW Doppler US signal in Matlab. (a) Tracking of
the maximum envelope of the PW Doppler US signal (yellow-line) for an example
CCA. A sudden increase in intensity is detected by the algorithm. Aerwards,
limited Savitzky-Golay-ltering was applied to lter out the high-frequent scatter
noise. (b)e three cycle average (thick solid line) is taken of the individual curves
(thin dashed lines) to further reduce the noise.e Vsys, Ved and the location of the
ow foot are calculated automatically.
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estimated marginal mean (LMM) values for the Vsys are 0.316 and 0.272
for the ApoE−/− and the ApoE−/− Fbn1C1039G+/− strain respectively and this
dierence is highly signicant (p<0.01).e plots also show that the three
velocity prole parameters are the same for both strains at weeks 0 and 20
but that for the other time points, the blood velocity is lower in the ApoE−/−
Fbn1C1039G+/− strain (for Vsys p<0.05, p=0.11 and p<0.05 for weeks 5, 10
and 15 – t-test on the le / right aggregated data). Strain is a signicant
grouping variable for Vsys (p<0.05) and Ved (p<0.01) but not signicant for
Vavg (p=0.05).
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Figure 6.2: Evolution of the measured velocity in the CCA.e measured veloc-
ities for the ApoE−/− mice are plotted in blue on the le and for the ApoE−/−
Fbn1C1039G+/− in red on the right.e other strain is plotted in a lighter tint for an
easy comparison.e systolic velocity (Vsys-△), the average velocity (Vavg-◯) and
the end diastolic velocity (Ved-▽) are plotted.
External carotid artery
e velocity in the ECA branch (gure 6.3) is lower compared to the CCA
(Vsys of 0.12 vs. 0.30 m/s) and this dierence is highly signicant (p<0.01 –
paired t-test aer aggregating time and side). For the ECA both the ApoE−/−
(panel A) andApoE−/− Fbn1C1039G+/−mice (panel B), show a clear increase in
blood velocity over time (time grouping p<0.01 for Vsys, Vavg and Ved). Next
to this, the dierence between Vsys and Ved also increases. In the gure this is
clearly shown by the widening of the coloured band.e dierence between
the estimated means for the ApoE−/− and the ApoE−/− Fbn1C1039G+/− strain
is small but signicant for the Vsys (0.121 vs. 0.107m/s; p<0.05 – LMM).
Both Vavg (0.042 vs. 0.036 m/s; p=0.01 – LMM) and Ved (0.018 vs. 0.010
m/s; p<0.01 – LMM) are more clearly lower for the ApoE−/− Fbn1C1039G+/−
strain. Strain is a signicant grouping variable for both Vavg - p<0.05 and
Ved - p<0.05.
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Figure 6.3: Evolution of the measured velocity in the ECA.e measured veloc-
ities for the ApoE−/− mice are plotted in blue on the le and for the ApoE−/−
Fbn1C1039G+/− in red on the right.e other strain is plotted a lighter tint for an easy
comparison.e systolic velocity (Vsys-△), the average velocity (Vavg-◯) and the
end diastolic velocity (Ved-▽) are plotted.
Internal carotid artery
e amplitude of the measured ICA velocity (0.27 m/s - Figure 6.4 ) is much
closer to the CCA velocity (0.30 m/s) compared to the ECA velocity (0.12
m/s).e dierence between CCA-ICA is not signicant (p=0.055) while
the dierence between ICA-ECA is highly signicant (p<0.01 – paired t-test
aer aggregating over time and side). At baseline (week 0), the velocity meas-
ured in the ApoE−/− Fbn1C1039G+/− mice (panel B) is clearly lower than the
velocity measured in the ApoE−/− mice (panel A) (p<0.01 for Vsys – t-test
aggregated over side). e increase in velocity over time that was visible
in the ECA, is also present in the ICA (time is a highly signicant (p<0.01)
grouping factor for the three measures).is increase is more outspoken in
the ApoE−/− Fbn1C1039G+/− strain (interaction between time and strain is sig-
nicant p=0.011 in the LMM), resulting in an higher velocity in the ApoE−/−
Fbn1C1039G+/− mice at week 20 compared to the ApoE−/− mice (but not sig-
nicant p=0.09 for Vsys – t-test aer aggregating over side). Nonetheless, it
is important to keep in mind that the variability of the data also increases
over time, resulting in higher error bars at these time points. Especially in
the ApoE−/− Fbn1C1039G+/− strain, the Vsys rises more compared to the Ved.
is results in a broader range of velocities within one heart cycle.
Overview
An overview of the signicance of the dierent grouping factors in the LMM
is given in table 6.2. Side (le or right) did not inuence any of the measured
velocity parameters in any of the branches.
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Figure 6.4: Evolution of the measured velocity in the ICA.e measured veloc-
ities for the ApoE−/− mice are plotted in blue on the le and for the ApoE−/−
Fbn1C1039G+/− in red on the right.e other strain is plotted in a lighter tint for an
easy comparison.e systolic velocity (Vsys-△), the average velocity (Vavg-◯) and
the end diastolic velocity (Ved-▽) are plotted.
Table 6.2: For every velocity parameter a LMM was applied to test if it has a sig-
nicant inuence. For the Vsys, Vavg and Ved the signicance is listed of the three
grouping variables: time, strain and side.
time strain side
Vsys
CCA .003** .039* .276
ECA .000** .203 .169
ICA .000** .000** .143
Vavg
CCA .530 .050 .200
ECA .000** .031* .291
ICA .000** .000** .232
Ved
CCA .207 .004** .917
ECA .003** .034* .132
ICA .000** .001** .981
* Signicant (p<0.05)
** Highly signicant (p<0.01)
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e signicant inuence of time and strain (in most cases in table 6.2), is
likely linked to atherosclerosis development. Both strains of mice develop
atherosclerotic plaques, resulting in a narrowing of the lumen leading to a
locally increased blood velocity. In chapter 7 we will show that atherosclerotic
plaque development and stenosis mainly occurs in the ECA and ICA and
only to a lesser extent in the CCA (close to the carotid bifurcation) in mice.
e decrease in cross sectional area of the lumen of the ICA and ECA is likely
a reason for this increased velocity. Next to this, plaques in the ApoE−/−
Fbn1C1039G+/− mice are more pronounced than in the ApoE−/− mice [1]–[3]
which is a possible reason for the steeper increase in velocity in the ICA for
the ApoE−/− Fbn1C1039G+/− mice.
On the other hand, especially the ApoE−/− Fbn1C1039G+/− mice also show
other haemodynamics-related symptoms, such as: ventricular dysfunction,
myocardial infarction, cardiac hypertrophy, disturbed cerebral ow and brain
hypoxia [1]. It is therefore also possible that the reduced cardiac function
in the ApoE−/− Fbn1C1039G+/− mice partially explains the lower blood ow
and thus lower blood velocity.is is especially the case for measurements
in the CCA, where the occurrence of plaque is lesser compared to the ECA
and ICA. On the other hand, a (partial) occlusion in the brain can increase
the downstream resistance and thus also oer a possible explanation for the
reduced blood velocity.
6.3 Resistivity (RI) and Pulsatility (PI) indices
Denition of the RI and PI
e resistivity index (RI) and pulsatility index (PI) are commonly used in
literature to quantify ow velocity proles and express downstreamproperties
[4]–[8]. Both indices are calculated based on the Vsys, Ved and Vavg.
Resistive Index = V sys − V ed
V sys
(6.1a)
Pulsatility Index = V sys − V ed
V avg
(6.1b)
Resistivity index
e RI results are plotted in gure 6.5.e scatter for every bar is big com-
pared to the dierences that occur.e gure shows that the on average the
RI is lower for the ICA (0.58) compared to the other two branches (CCA-0.78
and ECA-0.89). All three paired comparisons for 2 RI locations were highly
signicant (p<0.01 – paired t-test aer aggregating side and time).e LMM
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did not reveal a statistical signicant eect of the grouping factor strain for
the CCA or the ICA measurements (p>0.05). However, for the ECA meas-
urements strain was a statistically signicant (p<0.05) grouping factor. Over
time, the dierences are small, with only for the ICA a consistent increase
in both strains. Yet, time showed to be a signicant factor for the ECA RI
(p<0.05) and a highly signicant factor for the ICA RI (p<0.01).
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Figure 6.5: Overview of the resistivity index (RI) for both the (A-blue) ApoE−/−
and the (B-red) ApoE−/− Fbn1C1039G+/− mice.e CCA, ECA and ICA are shaded
from dark to light.
Pulsatility index
In comparison with the RI, the same trends are visible for the PI (gure 6.6).
e ECA has the highest value (3.76), the CCA the middle value (2.12) and
ICA the lowest (0.97).e average dierences between all three locations
were signicant (p<0.01 – paired t-test aer aggregating over time and side).
For the ApoE−/− Fbn1C1039G+/− strain, the CCA/ECA values are higher and
the ICA values lower.e dierences are larger compared to the RI, but the
error bars (standard deviation) have increased accordingly. As a result the
grouping according to strain did not have signicant inuence on the PI
for any of the branches. Time was a signicant grouping factor for all three
branches were the PI was calculated.
Overview
For both the RI and the PI, the side of the measurement did not have a
signicant inuence on the result (table 6.3).
6.4 Carotid diameters
e inner diameter was measured in the three branches of the carotid bifurca-
tion with motion mode ultrasound (M-mode US). For this goal, the RF data
108
6.4. Carotid diameters
ApoE-/-fbn1C1039G+/-ApoE-/-
A) CCA ECA ICA
Pu
lsa
til
ity
 in
de
x 
[-]
0
2
4
6
8
Time [weeks]
0 5 10 15 20
B) CCA ECA ICA
PI
 [-
]
0
2
6
8
Time [weeks]
0 5 10 15 20
Figure 6.6: Overview of the pulsatility index (PI) for both the (A-blue) ApoE−/−
and the (B-red) ApoE−/− Fbn1C1039G+/− mice.e CCA, ECA and ICA are shaded
from dark to light.
Table 6.3: For both the PI and the RI the inuence of the three grouping variables is
listed: time, strain and side.
PI RI
time strain side time strain side
CCA .003** .252 .203 .231 .195 .965
ECA .001** .125 .070 .018* .029* .885
ICA .000** .100 .542 .000** .138 .137
* Signicant (p<0.05)
** Highly signicant (p<0.01)
of the M-mode measurements was tracked using the algorithm described
by Rabbe et al. [9].e exact value of the diameter is highly dependent on
the exact location of the measurement. Plaques that show signs of inward
remodelling will result in a signicant narrowing of the lumen. In the meas-
urements the diameter is measured in a region were no or minimal inward
remodelling was visible. Nevertheless, the results should be interpreted with
care.
Common carotid artery
For the CCA, the measured diameters (dmax, davg and dmin) are shown in g-
ure 6.7.e measured diameters of the ApoE−/− and ApoE−/− Fbn1C1039G+/−
mice are very similar (strain is no signicant grouping factor for the CCA
diameter p>0.05). Further, there is almost no change in diameter visible
over time (time is no signicant grouping factor p>0.05). At week 20 of the
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ApoE−/− Fbn1C1039G+/− mice, there is a (small) increase in diameter from
week 15. However, this increase is smaller than the standard deviation of the
measurements and is thus not signicant (dmax p=0.20 – paired t-test aer
aggregating over side).e dierence between dmax and dmin is also similar
for both strains (p=0.49 – t-test aer aggregating over side and time).
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Figure 6.7: Evolution of the measured diameter in the CCA.e measured diameter
for the ApoE−/− mice are plotted in blue (A) and for the ApoE−/− Fbn1C1039G+/−
in red (B).e other strain is plotted a lighter tint for an easy comparison. e
maximum diameter (dmax-△), the average diameter (davg-◯) and the minimum
diameter (dmin-▽) are plotted.
External carotid artery
In gure 6.8, the diameters of the ECA are shown.e average ECA diameter
is smaller (dmax:410 µm) than the CCA (dmax:524 µm) (p<0.05 — paired
t-test aer aggregating time and side). Also for the ECA there is no clear
dierence visible between the ApoE−/− and the ApoE−/− Fbn1C1039G+/− mice
(p>0.05 for strain as grouping factor – LMM). From week 10 on, there is
a small decrease in diameter visible for both strains (time is a signicant
grouping factor for dmax, davg and dmin p<0.05).e dierence between the
maximum and minimum diameter is smaller in the ECA compared to the
CCA (p<0.01 — paired t-test aer aggregating time and side).
Internal carotid artery
Finally, the diameter results for the ICA are plotted in gure 6.9.e dmax of
the ICA (379µm) is a little smaller than the dmax of the ECA (410µm) (p<0.01
– paired t-test aer aggregating time and side). Between species and over time
there is not much change. Although, similar to the CCA case, there is also
an increase in diameter present at week 20.
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Figure 6.8: Evolution of themeasured diameter in the ECA.emaximumdiameter
(dmax-△), the average diameter (davg-◯) and the minimum diameter (dmin-▽) are
plotted.
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Figure 6.9: Evolution of the measured diameter in the ICA.e maximum diameter
(dmax-△), the average diameter (davg-◯) and the minimum diameter (dmin-▽) are
plotted.
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Overview
Remarkably, side was a signicant (p<0.05) grouping factor for the CCA-
dmax (Table 6.4). As described in the previous paragraphs, the dierences
for the measured diameters, with regard to the dierent grouping factors,
were smaller compared to the velocity measurements. is results in less
signicant factors for the measured diameter (table 6.4).e only consistent
signicant grouping factor is the time for the ECAbranch. In a further chapter
(chapter 7) it will be shown that the atherosclerotic plaque development
inuences the ECA the most and that the plaque is much less localised there.
e ECA plaque has a more spread out phenotype. erefore, this might
be an explanation why only in the ECA a clear decrease was visible. As a
reminder, the diameter was measured in a part of the artery where the least
lumen narrowing was visible.
Table 6.4: LMM analysis of the maximum (dmax), average (davg) and minimum
(dmin) measured using M-mode US. For the dierent grouping factors, their statist-
ical signicance is show.
time strain side
dmax
CCA .093 .140 .049*
ECA .009** .405 .159
ICA .951 .174 .656
davg
CCA .308 .241 .130
ECA .017* .261 .111
ICA .953 .242 .607
dmin
CCA .594 .324 .385
ECA .047* .191 .088
ICA .898 .278 .556
* Signicant (p<0.05)
** Highly signicant (p<0.01)
6.5 Carotid distensibility
e distension is calculated according to equation 6.2 [10] and is an indication
of the local functional stiness of the artery (although pressure is required to
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truly assess stiness).
dist = dmax − dmin
dmin
(6.2)
An overview of the resulting distension is plotted in gure 6.10.e global
averages for the CCA, ECA and ICA are: 18.0, 14.0 and 11.4%.e distension
of the CCA is thus on average higher than the distension of the ECA or ICA.
e pairwise comparisons of the three locations are highly signicant (p<0.01
– paired t-test aer aggregating side and time).e estimated means for the
ApoE−/− and ApoE−/− Fbn1C1039G+/− mice are similar: 18 vs. 18.2 (p=0.783 -
CCA), 13.3 vs. 14.2 (p=0.277 - ECA) and 11.4 vs. 11.3% (p=0.838 - ICA). Time
is a signicant grouping factor for the distensibility of the CCA (p<0.01) and
the ECA (p<0.05) but not for the ICA (p=0.097).
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Figure 6.10: Overview of the distention in the three main branches of the carotid
bifurcation. On the le (blue) the ApoE−/− mice are shown and on the right (red)
the ApoE−/− Fbn1C1039G+/− mice. On the x-axis the results are grouped according
to the timing of the measurement.e CCA, ECA and ICA are show coloured from
dark to light.
6.6 Conclusion
is chapter presented an overview of the USmeasurements in both ApoE−/−
and ApoE−/− Fbn1C1039G+/− mice. For the ECA and ICA an increase in velo-
city over time was present. Overall, the velocities measured in the carotid
bifurcations of ApoE−/− Fbn1C1039G+/− mice were a little bit (but signic-
antly) lower than the velocities of ApoE−/− mice. However, in ApoE−/−
Fbn1C1039G+/− mice the velocity increased more over time for the ECA and
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ICA. Both the RI and the PI were similar for both strains. Next to this, the di-
ameter measurements (M-mode US) were also similar for both strains. Only
the small decrease of the ECA diameter was signicant. Finally, no signicant
dierence between ApoE−/− and ApoE−/− Fbn1C1039G+/− mice was found
with regard to the distensibility of the carotid arteries.e distensibility of
the CCA was markedly higher compared to the ECA and ICA.
Overall, we can conclude that the bulk ow (velocity) and distension
parameters assessed by US did not show distinct dierences between both
strains. Amore detailed study of the local haemodynamics is needed to assess
the inuence of haemodynamics on atherosclerotic plaque development.
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Gold particle–enhanced µCT:
vulnerable plaque detection
and quantification ∗
7.1 Introduction
Cardiovascular disease is the leading cause of morbidity and mortality in
the developed countries [1], with atherosclerosis oen being the underlying
cause of myocardial infarction and stroke. Atherosclerosis is a slowly pro-
gressing chronic inammatory disease of themedium-sized and large arteries
and characterised by the development of atherosclerotic plaques. One of
the major emerging clinical challenges is the need to dierentiate between
vulnerable plaques, which are likely to cause embolic stroke upon rupture
and thus need immediate treatment, and stable plaques, which do not cause
an immediate threat. Traditionally, the ApoE−/− decient mouse model is
the most popular mouse model to study atherosclerotic plaque at a pre-clini-
cal stage [2]–[5]. When fed a Western type diet, these mice develop stable
atherosclerotic plaques. Recently, ApoE−/− Fbn1C1039G+/− mice have been
described as a novel mouse model for vulnerable plaques and plaque rupture
∗is chapter is based on the work: D. De Wilde, B. Trachet, C. Van der Donckt,
B. Vandeghinste, B. Descamps, C. Vanhove, G. R. Y. De Meyer and P. Segers, ‘Vul-
nerable plaque detection and quantication with gold particle-enhanced computed
tomography in atherosclerotic mouse models.’ Molecular imaging, vol. 14, pp. 9–19,
2015
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[6], [7]. A heterozygous mutation in the Fbn1 gene leads to fragmentation
of the elastic bres in the artery wall. When fed a Western type diet, vul-
nerable plaque formation occurs, including intraplaque neovascularization,
intraplaque haemorrhage and plaque rupture.
Both stable and unstable plaques consist of lipids accumulating in the
artery wall and are inltrated by macrophages and other inammatory cells.
Since the presence of a high number of macrophages is one of the indications
of a more severe, unstable plaque phenotype [8], macrophage quantication
is a main target for molecular small animal imaging strategies [9]. For ex-
ample, ultra-small superparamagnetic iron oxide particles have been used to
detect the macrophages present in plaques withMRI [10]–[13], and so has the
vascular cell adhesion molecule-1.is molecule has been targeted with su-
perparamagnetic peptide-functionalised nanoparticles for MRI [14], [15] and
with lipid-shelled microbubbles for ultrasound imaging [16]. Furthermore
18uorodeoxyglucose (FDG) positron emission tomography (PET)- com-
puted tomography (CT) imaging has been used to visualise plaque-related
inammation [17], [18].
However, the (through-plane) resolution of the used scanners, mainly
MRI and PET, is limited for capturing the presence of atherosclerotic plaques
in the carotid bifurcation of mice [19]. erefore, plaque imaging is oen
restricted to anatomical images obtained by CT in combination with (io-
dinated) contrast agents, in which narrowing of the lumen indicates the
presence of a plaque [20]. Enhancing anatomical CT with molecular imaging
could help to better understand the processes taking place in vivo during
the formation of atherosclerotic plaques. For this purpose N1177, a suspen-
sion of crystalline iodinated particles dispersed with surfactant, has been
explored in rabbits [21], [22]. High-risk, macrophage-rich atherosclerotic
plaques could be detected with CT resolution, but unfortunately the half-life
of water-soluble iodine contrast agents is too short to be used with a single
bolus injection in mice [23]. Accordingly, there is a need for a high-precision
µCT scan protocol that allows detection of macrophages in murine plaques
as a marker of plaque vulnerability.
In the present study, we show that Aurovist (Nanoprobes, Yaphank, NY),
a recently introduced µCT contrast agent, can be used as a 'tracing marker'
for macrophages. Aurovist consists of 15 nm gold particles with a polyethyl-
ene glycol coating, which increases its circulation time by partial switching
its elimination pathways from the reticuloendothelial system to the mono-
nuclear phagocyte system. Details on the mechanism of action and the
biodistribution of the contrast agent are found in [23]–[26]. ApoE−/− mice,
developing stable plaques, and ApoE−/− Fbn1C1039G+/− mice, developing vul-
nerable plaques, were injected with Aurovist and scanned with µCT at three
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consecutive time points. Animals were sacriced and dissected carotid arter-
ies were investigated with histology, conrming that Aurovist is phagocytized
by macrophages that accumulate within the atherosclerotic plaque. Further-
more, we propose a novel methodology to quantify Aurovist/macrophage
accumulation in vivo, along the carotid bifurcation. A signicant dierence
in macrophage accumulation was found between mice with stable and mice
with vulnerable plaques.
7.2 Materials andMethods
7.2.1 Mice
Female ApoE−/− Fbn1C1039G+/− mice [7] (n=14) and their ApoE−/− litter-
mates (n=9, 6 weeks old) were fed a Western type diet (TD88137, Harlan
Teklad, Madison, Wis, USA) for up to 20 weeks.e mice were kept under
environmentally controlled conditions (12h normal light/dark cycles, 20-
23○C and 50% relative humidity) with food and water ad libitum.ey were
housed in groups of 4-8 animals in well-ventilated cages with appropriate
cage enrichment. All the experiments were conducted according to the ethics
committee guidelines and were approved by the animal ethics committee of
Ghent University.
7.2.2 In vivo imaging at week 10, 15 and 20
e animals underwent contrast-enhanced µCT scans at weeks 10, 15 and 20
aer the start of the diet. Anaesthesia was induced using amixture of medical
oxygen and 5% isourane, reduced to 1-1.5% during the scan. A rst µCT scan
(termed the pre-contrast µCT measurement)(see gure 7.1 A) was acquired
using a Triumph-II imaging system (TriFoil Imaging, Chatsworth, CA, USA).
Aer this measurement, the animal bed was moved out of the scanner and
100 µl/25g body weight Aurovist was injected [27] in the tail vein through a
previously inserted catheter to avoid animal movement. Immediately aer
this injection, the animal was translated back to its initial position in the
scanner and a post-contrast µCT measurement was taken (see gure 7.1 B).
e µCT scan settings were set to a 50 µm focal spot size, 50 µm detector
pixel size, 1024 projections, 3.5 times magnication, 500 µA tube current, 75
kVp tube voltage and a continuous rotation mode.e acquisition region
of interest spanned the entire volume between the root of the aorta and
approximately half of the skull.
7.2.3 Histologic examination
Aer euthanasia or sudden death, mice were dissected and the aorta (in-
cluding the brachiocephalic and carotid arteries) was isolated. Arteries
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Figure 7.1: Overview of the measured and post-processed images. Images represent
the right carotid bifurcation of an ApoE−/− Fbn1C1039G+/− mouse on a Western type
of diet for 20 weeks. (A)e pre-contrast measured µCT dataset where the contrast
agent accumulation in the artery wall is clearly visible around the bifurcation. (B)
Post-contrast injection image showing the vasculature. (C)e angiographic image,
constructed by subtracting the registered pre-contrast image from the post-contrast
image.e vasculature is clearly visible in this image. (D)e vesselness ltered
angiographic image showing higher contrast for the vasculature.is facilitates the
initialisation of the segmentation process. (E) Segmentation of the right carotid
bifurcation depicting the CCA (blue), the ECA (cyan), the rst part of the ICA
(green), part of the stapedial artery (SA) (red) and the second part of the ICA
(orange).
were xed in 4% formaldehyde (pH 7.4) for 24 h, processed and embed-
ded in paran. Histological analysis was performed on serial cross sections
(5µm) of the proximal ascending aorta, brachiocephalic and carotid arter-
ies. Macrophages were determined by immunohistochemistry using anti-
Mac-3 antibody (Pharmingen, San Diego, CA). Secondary antibody was
species-appropriate horseradish peroxidase-conjugates (Vector Laborator-
ies, Burlingame, CA). 3-amino-9-ethyl-carbazole (Vector Laboratories) was
used as a chromogen. Images were acquired with the Universal Grab 6.1
(IDL) soware (Exelis, Boulder, CO, USA) using an Olympus BX40 micro-
scope (Tokyo, Japan). Images were quantied using ImageJ soware (NIH,
http://imagej.nih.gov/ij/).
7.2.4 Segmentation and image processing
e IMPACT algorithm [28] was used to reconstruct the CT data, in order
to reduce the eect of beam hardening due to the dense skull bone. To speed
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up the reconstructions, all data were rst reconstructed at a lower resolution
(0.2 mm isotropic voxel size), aer which only the VOI around the carotid
arteries was reconstructed at a higher resolution (50 µm isotropic voxel size)
[29].is method was applied to both the pre- and post-contrast datasets.
To get rid of misalignment between the pre- and post-contrast image,
an image registration step was applied based on the BRAINSt toolbox [30]
in 3D slicer4 (www.slicer.org)[31].e following parameters were inser-
ted in the rigid registration algorithm: number of samples=300000, spline
grid size= 14, 10, 12, number of iterations=1000, linear interpolations, min-
imum step length= 0.000001, number of histogram bins=200 and number
of matchpoints=40.e pre-contrast injection image was set as the moving
image. Aer automatic registration the 3Dslicer-chequerboard module was
used to visually inspect the registration results and if there was a residual
misalignment the dataset was removed from the database. Subsequently, an
angiographic image was constructed by subtracting the registered pre-con-
trast image from the post-contrast image (gure 7.1 C). A vesselness-enhanced
image (gure 7.1 D) was constructed based on the angiographic image. To that
end a Frangi vesselness lter was applied in the Vascular Modeling Toolkit
(VMTK) (www.vmtk.org) [32] with parameters: α 0.3, β 500 and γ 200. For
the algorithm 10 logarithmically spaced steps between 0.05 and 0.5 mm were
taken.
e le and right carotid arteries were segmented with the levelset seg-
mentation algorithm of VMTK [33]. First an initial levelset was segmented
based on the vesselness-enhanced image. e CCA, ECA and ICA were
initially segmented by repeated executions of the colliding fronts algorithm,
which returns a branch of the vascular network between a source and a target
point. e threshold level was taken to be 40 HU but manually adapted
between 30 HU and 50 HU to get rid of noise or nearby veins if needed.
e ICA was segmented beyond the emerging of the SA and the rst part
of the SA was also segmented (see gure 7.1 E).e ECA was segmented as
far as the bifurcation into the maxillary and supercial temporal arteries.
Aer the initialisation an evolution step based on the angiographic image
was carried out. e parameters for this step were: propagation weight=1,
curvature weight=0.4, advection weight=0.6, edge weight=0 and number of
iterations=200.e resulting surface was consecutively remeshed, smoothed
and remeshed again in VMTK to get an optimal surface representation. For
the rst remeshing the area of the triangles was taken to be between 500 and
300 µm2. Aerwards smoothing was performed with a passband of 0.1 and
30 iterations. For the nal remeshing, the triangle area ranged between 150
and 50 µm2. Based on the calculated centreline the carotid bifurcation was
split in its 3 branches (CCA, ECA and ICA).
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7.2.5 Quantifying macrophage presence within the lumen area
e next step was to quantify the presence of contrast agent in the arte-
rial wall on the pre-contrast images (i.e. with contrast agent originating
from injections at previous time points). In principle, this is only relevant
for data measured at weeks 15 and 20, but pre-contrast scans at week 10
were also processed to serve as controls (since there should be no contrast
detected). To allow a smoother integration, the registered pre-contrast im-
age was resampled to a resolution of 0.025 mm. Subsequently, the volume
inside the segmented carotid arteries was masked on the resampled pre-con-
trast image using the vtkImageStencil tool of Visualization Toolkit (VTK)
(www.vtk.org).e carotid bifurcation was cut out of the segmented sur-
face by cutting the three branches based on the length of the ICA (between
the carotid bifurcation and the SA bifurcation).e ICA was cut at 95% of
its length, the ECA was cut at the point where it reached the length of the
ICA and the CCA was cut at 2 times the length of the ICA. For every triangle
of the surface mesh at the carotid bifurcation, the normal was calculated in
pyFormex (www.nongnu.org/pyformex/) (gure 7.2 A).ese normals
were uniformly sampled at 100 points over a total length of 0.3 mm. e
sample points were classied to have an increased intensity, indicating the
presence of contrast agent, if the image intensity was higher than a cuto
value of 350 HU. Based on the volume mask we veried that every point
was located outside the artery. Finally, for every surface triangle the relative
number of selected high-intensity points on the corresponding normal was
expressed divided by the total amount of points outside the artery (gure 7.2
B).us, we obtained a clear visual representation of the presence of contrast
agent near the boundary of the lumen. Finally, we quantied the results as
follows: every surface element in which more than 25% of the points of its
surface normal had elevated intensity values was categorised to the increased
intensity group, while all other elements were categorised in the normal
intensity group. Subsequently, for every bifurcation branch (CCA, ECA and
ICA) the contrast-enhanced area and the contrast-enhanced area fraction
(CAF) (CAF%area), were calculated.
7.2.6 Quantifying macrophage presence along the centreline
Because the ApoE−/− Fbn1C1039G+/−mice develop a high degree of stenosis in
the carotid arteries over time, only considering the luminal surface holds the
risk of a bias. Stenosis will reduce the internal area of the artery wall, which
leads to an underestimation of the inuence of these regions when using an
area-averaged value. To circumvent this risk, the contrast-enhanced regions
were mapped to the centreline of the lumen, since the centreline length is
not aected by the presence of stenosis. For this operation, the centreline
was calculated, resampled to 0.05 mm and split into branches in VMTK.
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Figure 7.2: Overview of the dierent steps involved in the quantication of the
contrast-enhanced regions. (A)is panel shows 1 out of 10 calculated normals
(black) perpendicular to the lumen surface (grey). (B)e amount of points along
each normal with an intensity higher than 350 HU indicates the regions with contrast
agent present. (C)e luminal area is split in rings with an average width of 0.05
mm to map the contrast-enhanced regions along the length of the arteries. (D)e
surface zones with contrast agent present along more than 25% of the normals, are
indicated in red. Aer the splitting of the lumen area in rings, a ring was selected
to belong to the contrast-enhanced group if more than 10% of the surface showed
contrast.e aected regions of the centrelines are indicated in red, the unaected
regions in grey.
For every segment of the centreline, the corresponding part of the luminal
wall was selected in pyFormex by cutting the entire luminal surface with two
planes, thus splitting the total geometry into rings with an average width
of 0.05 mm (gure 7.2 C). Again, we categorised the data and considered
each segment to belong to the contrast group if the outer contrast-enhanced
lumen area in the corresponding ring segment was more than 10% of the
total lumen ring segment area (gure 7.2 D). Similar to the method proposed
by Brown et al. with regard to calcication of plaques [34], we were thus
able to track the presence of contrast agent along the centreline. Finally, we
calculated for every branch for what distance along the centreline contrast
agent was present: contrast-enhanced length fraction (CLF), (CLF [%length]).
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7.2.7 Statistical analysis†
e same statistical analysis was performed for the CAF [%area] and
CLF[%length]. Genotype was taken as a between-subject factor because the
mice were grouped accordingly (ApoE−/− or ApoE−/− Fbn1C1039G+/−). In
addition, the measured dataset was split by 3 within-subject factors namely:
time (week 15 or week 20), side (le or right carotid bifurcation) and location
(CCA, ECA or ICA).e measurements at week 10 were used to validate
the process and did not receive a contrast injection at a previous time
point; therefore these measurements were not included in this analysis.e
statistical analysis was performed in SPSS Statistics 22 (IBM, Armonk, NY,
USA).e preferred test for this type of dataset is the general linear model
with repeated measures. However, for this test only the subjects (mice) for
whom all measurements are available are taken into account, which reduced
the dataset to 3 ApoE−/− and 6 ApoE−/− Fbn1C1039G+/− mice. Hence, we
decided to use a linear mixed model in which the within-subject variables
are included as repeated measurements. is test can handle missing
values, so no measured data was excluded. We opted for an autoregressive
heterogeneous covariance structure for the residuals aer minimising the
information criteria for dierent covariance structures. A random eect,
with scaled identity as covariance type and including the intercept, was
added for the mice identities to account for the random mice selection out
of the population for this study. Next, a type-III type of sum of squares was
chosen. Finally, a full factorial analysis was performed for the four factors
namely, strain, time, side and location.
7.2.8 Testing for operator independence
To verify the operator independence of the proposed methodology, the op-
erator dependent segmentation step was performed (blinded) by a second
operator. From these second set of segmentations, further operator inde-
pendent processing steps resulted in a new set of CAF and CLF values.e
correlation between the results of both operators for CAF and CLF was cal-
culated, as we tested for equivalence of the average values of both datasets
using a two one-sided paired T-tests approach [35] (Microso Excel).
7.3 Results
7.3.1 Available datasets for analysis
One ApoE−/− and two ApoE−/− Fbn1C1039G+/− mice died or were euthanized
for ethical reasons before they reached week 10 of the diet. Signs of severe
†is research has beneted from a statistical consultation with Ghent University
FIRE (Fostering Innovative Research based on Evidence)
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pain and distress, which led to the euthanasia, included panting, head tilt, a
hunched body posture and immobility.erefore at the rst imaging time
point 8 ApoE−/− and 12 ApoE−/− Fbn1C1039G+/− mice were still included in
the study. Aerwards 4moreApoE−/− Fbn1C1039G+/− died or were euthanized
before the end of the experiment. Two measurements failed because of a
human error. Next to this, in six cases the registration of the pre- and post-
contrast image failed due to motion artefacts. Finally, only a portion of
the right ECA of two ApoE−/− mice at week 20 could be resolved, due to
severe stenosis, and only the le carotid bifurcation was thus included at
this time point. In summary, the analysis includes 14, 8 and 14 ApoE−/−
carotid bifurcations (le and right) at week 10, 15 and 20 respectively. For
the ApoE−/− Fbn1C1039G+/− mice, 20, 16 and 14 bifurcations were available
for analysis at these time points.
7.3.2 Histology
As a rst step we investigated whether the injected Aurovist particles can
be used as a tracing marker for macrophage presence. e Mac-3 stain in
gure 7.3 shows a representative example of macrophage inltration (in red)
in dierent areas of an atherosclerotic plaque (panels A and B). Aurovist
particles (visible on the Mac-3 stain as black dots) are abundantly present
in macrophage-rich regions (panels C, D) as well as in the plaque necrotic
cores (panels E, F). We hypothesise that in the hours and days aer Aurovist
injection, macrophages phagocytize the Aurovist particles and migrate to
inamed zones within the plaque. At the necrotic cores, Aurovist particles
accumulate yet no macrophages can be detected on the Mac-3 stain. We
hypothesise that Aurovist particles at this location have been released by
necrotic macrophages that are no longer visible on the Mac3 stain (loss of
epitope). We conclude that Aurovist can be used in combination with µCT
as an in vivo tracer for macrophage presence.
7.3.3 Validation test for false positive results at week 10
e results at week 10 served to validate the performance of the proposed
framework with regard to false positives (contrast-enhanced locations found),
as these animals did not receive any prior contrast injection.e maximum
value for an individual mouse at week 10 of the CAF was 0.15, 1.17 and 0.22
%area for the CCA, ECA and ICA respectively. For the CLF these values were
respectively 0.00, 3.36 and 0.00 %length. Averaged over the whole group, the
false positives for the CCA and the ICA were smaller than 0.02%area/l ength.
For the ECA the average false positives were 0.077%area and 0.18%lengthmainly
because of the presence of a tracheal cartilage ring in the image eld in one
animal. Both measures are thus reasonably robust but fail in the rare case
that a trachea cartilaginous ring is present in the region of interest.
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Figure 7.3: (A-B) Mac-3 stain showing a representative example of macrophage in-
ltration in dierent areas of an atherosclerotic plaque of an ApoE−/− Fbn1C1039G+/−
mouse. Macrophages are stained in red while Aurovist particles are visible as black
dots. Aurovist particles are abundantly present in macrophage-rich regions such as
the plaque shoulder as well as in the plaque necrotic cores. (C-D) Detailed images
show howmacrophages have engulfed Aurovist particles. (E-F) In the necrotic cores
Aurovist particles accumulate yet no macrophages can be detected on theMac3 stain.
Scale bars of A and B are 200 µm and scale bars of C-F are 50 µm.
7.3.4 Quantication of contrast-enhancement in the arterial branches:
CAF and CLF
Table 7.1 quanties theCAF [%area] for every separate branch of the bifurcation
(CCA, ECA and ICA). In bothApoE−/− andApoE−/− Fbn1C1039G+/−mice, the
highest contrast agent uptake occurred in the ECA, both at week 15 and week
20. In both mouse models there was an increase over time, especially in the
ApoE−/− model where a 4-fold increase in contrast uptake between week 15
and 20 could be observed.e increase in the ApoE−/− Fbn1C1039G+/− model
was less pronounced, with a 200% increase for the CCA and ICA, and a 50%
increase in the CCA.is is, however, mainly due to the already higher extent
of contrast agent uptake at week 15 in the ApoE−/− Fbn1C1039G+/− mice.e
statistical CAF analysis in dierent branches revealed that time (week 15-week
20) and location (CCA, ECA or ICA) are highly signicant factors (p<0.01).
Genotype (ApoE−/− or ApoE−/− Fbn1C1039G+/−) has a higher p-value but is
still a signicant factor (p<0.05). No dierence was found between the le
or right side (p=0.745). Finally, the interaction between the factors time and
location was also highly signicant (p<0.01).is supports the trends shown
in table 7.1.e estimated averages showed that on average, ApoE−/−mice had
14.2%area less contrast-enhanced area compared to ApoE−/− Fbn1C1039G+/−
mice and this eect was signicant (p<0.05). At week 15, the aected area was
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smaller than at week 20 with an average dierence of 19.6%area (p<0.01).e
dierences between the locations in both strains were also highly signicant
(p<0.01): the contrast-enhanced area in the CCA was smaller compared to
the ECA (32.3%area) or to the ICA (13.6%area).
Table 7.1:e CAF [%area] with the standard deviation at the dierent branches.
ApoE−/−
CCA ECA ICA
w15 2.77 ± 3.33 12.56 ± 10.32 4.20 ± 2.97
w20 11.70 ± 18.23 51.74 ± 27.68 27.11 ± 24.56
ApoE−/− Fbn1C1039G+/−
CCA ECA ICA
wk15 8.02 ± 5.94 40.35 ± 26.53 18.98 ± 15.81
wk20 18.05 ± 18.22 64.55 ± 24.16 43.27 ± 20.98
e results depicted in table 7.2 represent the CLF expressed in %length for
the three dierent branches (CCA, ECA and ICA).ese results are similar
to the results shown in table 7.1. However, the absolute values are higher,
since this way of calculating contrast agent accumulation attributes a higher
weight to regions where contrast agent is present only partially around the
circumference.ese results are summarised in gure 7.4. Amarked increase
in Aurovist accumulation can be observed from week 15 (cross hatched bars)
to week 20 (bars without hatching).e statistical analysis of the CLF yields
slightly dierent results compared to the CAF. Time and location are still
highly signicant (p<0.01) but in this case genotype is also highly signicant.
Still there is no statistical indication of a dierence between le and right
(p=0.609). Furthermore the interaction between time and location remains
highly signicant. Finally the interaction between genotype and location,
which was almost signicant in the CAF, became signicant (p<0.05) for
the CLF.e ApoE−/− mice have on average 20.7%length smaller contrast
accumulations (p<0.01) compared to ApoE−/− Fbn1C1039G+/− mice. From
week 15 to week 20 the model estimated average growth of the contrast
deposits is 30.5%length. Moreover the CLF in the CCA is 51.3%length lower
compared to the ECA, and 32.0%length lower compared to the ICA (both
p<0.01). For both the CAF and the CLF, the statistical tests show that there is
a signicant dierence between both groups ofmice. We can conclude that on
average the ApoE−/− Fbn1C1039G+/− mice have more contrast accumulation,
that there is a signicant growth in accumulation over time and that it is very
location dependent.
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Table 7.2:e CLF [%length] with the standard deviation at the dierent branches.
ApoE−/−
CCA ECA ICA
w15 10.23 ± 17.23 40.87 ± 21.75 11.31 ± 10.79
w20 23.51 ± 28.77 82.30 ± 25.61 67.44 ± 33.43
ApoE−/− Fbn1C1039G+/−
CCA ECA ICA
wk15 15.78 ± 10.10 75.65 ± 36.17 48.57 ± 34.64
wk20 39.34 ± 12.93 95.32 ± 12.77 87.88 ± 17.71
CCA ECA ICA
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Figure 7.4:e length of the centreline of each branchwhere contrast agent is present
(CLF) [%length].
7.3.5 Testing for operator independence
e resulting CAF and CLF values were compared for 2 sets of segmentations,
executed by 2 dierent operators.e correlation between both CAF datasets
was 0.993 and for the CLF it was 0.986.e mean dierence between both
CAF datasets was smaller than 1%area (p<0.001). For CLF, themean dierence
is smaller than 5%length (p<0.001).
7.3.6 Qualitative visualisation of the contrast-enhanced regions
e quantitative results described above are further illustrated by graphical
representations of the precise contrast-enhanced locations. Figure 7.5 shows a
representative example of an ApoE−/−mouse at week 15 and week 20. At week
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15 there were only small regions where contrast-enhancement was visible.
e two largest regions were located in the ECA. At week 20 the shape of
the contrast-enhanced area had changed, with contrast-enhanced zones at
regions of the ECA, ICA and CCA close to the bifurcation. In gure 7.6,
similar images are shown for an ApoE−/− Fbn1C1039G+/− mouse at weeks 15
and 20. In this case, the shape of the contrast-enhanced area was similar
for both time points, with Aurovist present along the entire ECA and ICA
and in the part of the CCA closest to the carotid bifurcation. However, the
contrast-enhanced area was signicantly increased at week 20, conrming
the quantitative results indicated in table 7.1.
7.3.7 Precise locations of contrast-enhanced regions in both groups of
mice
On top of the quantitative and qualitative analysis, the proposed framework
also allows for an exact and detailed visualisation of the locations of Aurovist
accumulation.e rst row of gure 7.7 (panels A and B) shows the number
of cases for which Aurovist was present in the CCA as a function of the
distance to the bifurcation. e distance is zero (right side of the x-axis)
at the bifurcation and decreases downstream from there. On the le side
(panel A) the values for the ApoE−/− mice are shown and on the right side
(panel B) the values for the ApoE−/− Fbn1C1039G+/− mice can be found. For
both cases the status is pictured with circles at week 15 and with crosses at
week 20. A rst striking feature is that the contrast preferentially builds up
near the bifurcation and is more or less conned to this region, especially
for the ApoE−/− Fbn1C1039G+/− mice. For the ECA, shown in the second row
in gure 7.7 (panels C and D), the contrast agent is much less restricted to a
specic region. On an average basis the locations are more or less uniform
along the inspected length of the artery. Finally for the ICA, shown in the
third row in gure 7.7 (panels E and F), the contrast agent is mostly located
near the bifurcation at week 15, with a gradual decrease downstream. At
week 20 however it evolved to a state where the Aurovist was more equally
distributed along the whole artery, conrming earlier results.
7.4 Discussion
In this study, we investigated contrast-enhanced, in vivo µCT imaging to
visualise macrophage inltration over time in murine atherosclerotic plaques.
e techniquewas validatedwith histology and applied in a longitudinal study
including both ApoE−/− mice, a model for stable atherosclerotic plaque, and
ApoE−/− Fbn1C1039G+/− mice, a model for vulnerable atherosclerotic plaque.
We used two dierent methods to quantify the contrast accumulated in the
atherosclerotic plaque: the CAF for the contrast-enhanced area fraction
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Figure 7.5: Contrast-enhanced regions around the carotid bifurcation of an ApoE−/−
mouse at weeks 15 and week 20 aer the start of the diet. At week 15 both the medial
side of the carotid bifurcation (A) and the lateral side (B) only show small zones
with little contrast-enhancement. ese zones are preferably located at the ECA.
e contrast-enhanced regions have grown over time and are at week 20 (C-D)
merely located in the ECA and ICA.ey are mainly situated at the medial side (C)
compared to the lateral side (D).
and the CLF for the contrast-enhanced centreline length fraction of the
branches along the carotid bifurcation. We visualised and quantied the
dierent contrast-enhanced locations, and found signicant dierences in
macrophage inltration between time points and between mouse models.
7.4.1 Contrast agent accumulation and distribution
We observed a signicant growth of contrast-enhanced (and thus macro-
phage-inltrated) regions over time in both mouse models and these re-
gions were signicantly larger in ApoE−/− Fbn1C1039G+/− mice compared to
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Figure 7.6: Contrast-enhanced regions around the carotid bifurcation of anApoE−/−
Fbn1C1039G+/− mouse at weeks 15 and 20. (A-B) At week 15 regions with contrast-
enhancement are visible in the last part of the CCA, in the rst part of the ICA
and along the ECA.ese regions span both the medial (A) and the lateral (B) side
of the carotid bifurcation. (C-D) At week 20 the area with contrast-enhancement
has increased. It are still the same zones as at week 15 but they have considerably
grown in size. Especially in the ECA contrast-agent is present along whole the length.
e contrast agent is present around the whole bifurcation and thus spans both the
medial (C) and the lateral (D) side.
ApoE−/− mice. Nevertheless, interesting geometrical dierences could be
observed between dierent branches. In the ApoE−/− Fbn1C1039G+/−mice the
CAF andCLF increased signicantly fromweek 15 to week 20 at both ICA and
CCA, while only a small increase was noticeable at the ECA.is could be
explained by the fact that in about 75% of the ApoE−/− Fbn1C1039G+/−mice the
contrast agent was already present along the entire ECA at week 15.erefore,
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D) ApoE-/-Fbn1C1039G+/-: ECA
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F) ApoE-/-Fbn1C1039G+/-: ICA
Figure 7.7: Localisation of Aurovist at the dierent branches. At the horizontal axis
the distance, sampled at 0.05mm, from the bifurcation is depicted and on the vertical
axis the percentage of cases with Aurovist at that precise location is shown. e
occurrence of Aurovist at every location was determined by projecting the lumen
surface contrast agent plot on the centreline.e rst row (panels A and B) shows
the CCA, the second row (panels C and D) the ECA and the third row (panels E and
F) the ICA. On the le hand side (panels A, C and D), the ApoE−/− mice, and on
the right hand side (panels B, D and F) the ApoE−/− Fbn1C1039G+/− mice are shown.
For every case the comparison was made between the situation at week 15 (circles)
and week 20 (crosses).
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there was only little space for an expansion of the contrast-enhanced region
along the lumen over time, as it occurred in the other two branches. Another
interesting observation in this respect was that in both mouse models, at
both time points, a larger part of the ECA and ICA was contrast-enhanced
compared to the CCA. Moreover, the contrast-enhanced regions in the CCA
were localised near the bifurcation whereas the contrast-enhanced regions in
ECA and ICA were smeared out away from the bifurcation. Likely, the latter
can be linked to ow haemodynamics, since locations of low and oscillatory
ow are known to promote macrophage inltration [36], [37]. Since the
ow distally to the bifurcation is likely to be more disturbed, ow perturb-
ations will induce more spread-out ow patterns in the ECA and ICA. In
the CCA on the other hand, the blood ow reaches a stagnation point at
the bifurcation and little ow perturbations occur upstream. We conclude
that macrophage inltration occurs with similar geometrical patterns but
dierent intensities in both mouse models, and that the ECA is exposed to
macrophage inltration at an earlier time point than the other two branches.
e study does not include control animals not developing atherosclerosis.
Note, however, that the animals included can, to a certain extent, be used as
their own controls. It is known that atherosclerosis develops only in a later
stage in the central section of the common carotid artery.is is consistent
with our observation that no contrast accumulation was visible, in neither
ApoE−/− nor ApoE−/− Fbn1C1039G+/− mice at week 15 (gure 7.7 panels a and
b – dotted lines with circles) at the proximal end of the CCA.
7.4.2 Advantages: imaging technique
e present methodology enabled the use of a high-resolution µCT scanner
for molecular imaging of the location of macrophages in atherosclerotic
plaques in the carotid bifurcation of mice.is enables the measurement of
plaque development very precisely, which was not possible with standard,
purely anatomical µCT imaging. Moreover, it allows longitudinal in vivo
studies of the inammation process in the artery wall in mice. erefore,
this methodology has potential to be used in preclinical studies on plaque
development or plaque stabilising therapeutics. To the best of our knowledge
no such technique currently exists in mice.
7.4.3 Advantages: post-processing
e processing and quantication of the data has advantages as well. We
described a method to Colour-code contrast-enhanced areas on the luminal
surface, which gives a clear overview of all the targeted areas (gure 7.5 and
gure 7.6). is allows the demonstration of small location shis of the
longitudinal data and is an excellent technique to follow-up individual cases.
For example, in gure 7.6 the contrast-enhanced regions for the ApoE−/−
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Fbn1C1039G+/− mouse clearly originate at the outer bends of the bifurcation at
week 15 but at week 20 they also span the inner side. Another asset of this
method is the user-independency. Only for the segmentation of the arterial
geometry interaction of the user was necessary, by selecting points inside
the arterial network.e operator dependency study, however, showed that
operator dependency in this step is likely to have only a very small inuence
on the resulting CAF and the CLF values. For the more critical selection
of contrast-enhanced regions, no interaction was needed. In the future, as
segmentation- and/or imaging-techniques evolve, the segmentation would
probably evolve more towards automatic algorithms where (almost) no user
interaction will be needed.
7.4.4 Limitations
e main limitation of the scanning protocol is that two µCT scans are
needed, a pre- and a post- contrast injection scan, at every time point. First
of all, this doubles the amount of scans which have to be successful for one
measurement dataset. Moreover, rigid image registration is an eective way
of removing translations between both scans but it cannot remove animal
repositioning eects, between the pre- and post-contrast injection scan at
the same time point. In the current study, this accounted for 6 failures out
of 50 measurements. As such, measures to limit animal motion in between
scans are warranted.e duration of every scan was around 20 min, so one
option is to reduce the scan time by using another scan protocol or scanner
to reduce the amount of registration failures. Another option is to use a more
advanced registration method with more degrees of freedom for example a
deformable method, which can take into account movements of the mouse
[38].
e repeated injections of Aurovist do not seem to have an eect on the
animal welfare [23] or plaque development. However, due to the need for pre-
and a post-contrast injection scans, the animals get twice as much radiation.
In this study, the mice were scanned 6 times spread out over 10 weeks, with
an estimated total radiation dose of 6Gy. erefore, we cannot rule out
radiation dose induced morbidity and mortality. Moreover, it has been
shown in literature that (high) radiation doses accelerate the development
of inammatory, macrophage-rich lesions in ApoE−/− mice [39], [40]. It is
therefore important to optimise protocols in terms of radiation dose and
number of intermediate time points as well as required image quality.
A larger sample size would result in a smoother curve for the localisa-
tion of the contrast agent in the dierent branches (gure 7.7).e applied
framework lacks inherent information about the depth of the contrast ac-
cumulations as long as they are closer than the threshold value of 0.3 mm
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to the lumen surface.erefore, it is a useful tool to determine the size and
location of the areas with contrast agent, but is less suited to study outward
or inward remodelling related processes occurring in atherosclerotic plaque
development.
In the present study, there was a time dierence of 5 weeks between
consecutive measurements.e Aurovist stayed inside the lumen for more
than 24 h but aerwards gradually decreased. During this time the Aurovist
was taken up by macrophages and migrated to the atherosclerotic plaque
regions. However, it is possible that these macrophages migrated and mixed
with macrophages that had migrated at a later time point.
Finally, we chose to express the contrast-enhanced regions in terms of
inuenced luminal area and inuenced artery length. As a side eect of this
choice, the inner curve of the bifurcation can be taken into account twice.
If the curve is sharp enough, the surface normals of both the ECA and ICA
will penetrate this region. However, this eect only plays a role for a small
fraction of the surface and does not aect the meaning of the inuenced area,
since this is the transition between both branches.
7.5 Conclusion
We propose Aurovist-enhanced µCT as a promising new tool to visualise
macrophage inltration in vivo in preclinical small animal research. By using
histology, we showed that Aurovist coincides with macrophages using his-
tology, and developed a methodology to quantify Aurovist presence within
atherosclerotic plaques based on in vivo µCT images. We applied this meth-
odology in a longitudinal follow-up study in two dierent mouse models
for atherosclerotic plaque. We observed a signicant growth of contrast-en-
hanced (and thus macrophage-inltrated) regions over time in both mouse
models and these regions were signicantly larger in ApoE−/− Fbn1C1039G+/−
mice (a model for vulnerable plaque) compared to ApoE−/− mice (a model
for stable plaque). Regional dierences in macrophage distribution over
dierent branches suggested that local haemodynamics aect macrophage
inltration.e developedmethodology will be used in the future to perform
more in depth research on the presence of macrophages in cardiovascular
disease in mice.
7.6 µCT imaging beyond the carotid arteries: the brain
vasculature
In this section, a short exploration to the brain vasculature will be taken,
demonstrating the possibility to visualise the cerebral vasculature using the
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µCTmeasurements that were taken. No extrameasurements were performed
for these results, just another VOI was selected in the measurement domain
and further post processing of the measurements was performed. Visualisa-
tion of the brain vasculature may be of interest because it has been shown
that hypoxia and disturbed blood ow occurs in the ApoE−/− Fbn1C1039G+/−
brain (based on MRI and histology) [6].
7.6.1 Constructing an angiographic image of the murine brain
e technical description of how to construct this angiographic image is
equal or very similar to the methodology used in the previous sections (sec-
tion 7.2.4) to construct the angiographic image of the carotid bifurcation.
e measured pre- and post-contrast injection images are cropped to only
contain the skull. ese images are shown in gures 7.8a and 7.8b for an
example animal.
Aer cropping, a rst step is to register both images, as the animal might
have moved in between both scans due to the necessity to translate the mouse
out of the scanner for the contrast injection.e BRAINSt toolbox [30] in
3D slicer4 (www.slicer.org)[31] was used to apply a rigid registration.e
parameters used were: number of samples=300000, spline grid size= 14, 10,
12, number of iterations=1000, linear interpolations, minimum step length=
0.000001, number of histogram bins=200 and number of matchpoints=40.
e pre-contrast injection image was set as the moving image. By subtracting
the pre-contrast injection image from the post-contrast injection image, an
angiographic image (gure 7.8c) could be constructed.ese images can be
used directly to visualise thewhole brain vasculature using volume renderings.
A volume rendering with the vasculature in yellow/red and the bone (skull)
in blue is shown in gure 7.9.
7.6.2 Segmenting the brain vasculature
In a next step, the cerebral arteries can be segmented from the angiographic
image. Probably due to the high density of the surrounding skull, the image
quality is not perfect inside the skull and the arteries are rather noisy (shown
in gure 7.8c).us, a vesselness enhancement lter was applied to facilitate
the segmentation initialisation. In the VMTK(www.vmtk.org), a Frangi
vesselness ltered image was constructed with parameters: α 0.3, β 500, γ
150.e radius of the lter varied between 0.05 and 0.7 mm.
For the initialisation of the vesselness enhanced image, an isosurface
algorithm was applied.is was followed by an evolution step based on the
original angiographic image. For this step, the parameters were: propagation
weight=0, curvature weight=0.4, advection weight=0.6, edge weight=0 and
number of iterations=500.e skull was segmented on a single thresholding
136
7.6. µCT imaging beyond the carotid arteries: the brain vasculature
(a) Pre-contrast (b) Post-contrast
(c) Subtracted (red) (d) Frangi ltered (red)
Figure 7.8: Creating an angiographic image of the murine cerebral vasculature. (a)
the pre-contrast injection imagewith only the skull visible. (b) the post-contrast injec-
tion image with both vasculature and skull visible. (c) the subtracted, angiographic
image (red) in an overlay on the pre-contrast injection image (white, skull). (d)
result aer applying a Frangi lter to the angiographic image.
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(a)Dorsal
(b) Posterior
Figure 7.9:e murine brain vasculature assessed with gold-nanoparticle-enhanced
enhanced µCT. A volume rendering of the dorsal (a) and the posterior (b) view.e
vasculature is shown in red and the skull in blue.
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and propagation step with a lower threshold of 700 HU. An example seg-
mentation result is shown in gure 7.10. In gure 7.10a, the circle of Willis is
clearly visible in the middle of the image.
7.6.3 Contrast accumulation in the brain vessels
As explained in more detail in chapter 7 on page 117, the contrast agent
from the injections of weeks 10 and 15 accumulates in the macrophages in
atherosclerotic plaques and is therefore visible on the µCT image at week 20.
Similarly, contrast agent accumulations from previous injections are visible
in the brain.e blue structures in gure 7.10, are present in virtually all mice.
eir anatomical location suggests that this is possibly the choroid plexus.
e choroid plexus is a structure that is mainly involved in the production
of cerebrospinal uid and that stands into close contact with leaky vessels
[41]. However, it has been shown that xanthomas (accumulation of lipid
rich macrophages) are located near the choroid plexus in both ApoE−/− and
ApoE−/− Fbn1C1039G+/− mice [42].e current results are still preliminary
and further investigation is needed before any conclusion can be made.
In addition to the contrast accumulations described in the previous
paragraph, 3 animals also showed signs of contrast accumulation at another
location (green on gure 7.10). e origin of the contrast is not clear. It
could also indicate the presence of a xanthoma or it could be plaque content
from a plaque rupture that occurred for example at the level of the carotid
bifurcation. Without further histological examination it is not possible to
draw any conclusions, but we do consider it as an interesting observation,
worth reporting
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(a)Dorsal
(b) Lateral
Figure 7.10: e segmented murine brain vasculature assessed with gold-nano-
particle-enhanced enhanced µCT. Contrast remaining from previous injections
is visible in 2 regions presumed to be: the atherosclerotic plaque (green) and the
choroid plexus (blue).e dorsal (a) and the lateral (b) view are shown.
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simulations ∗
8.1 Introduction
Mousemodels are oen used to study the development of atherosclerosis, due
to their rapid development of atherosclerotic plaques. In particular, ApoE−/−
knockout mice have been reported to develop spontaneous diet-induced
plaques, which have morphological resemblance to human plaques [1]–[3].
It is generally accepted that shear stresses, imposed by the blood ow on
the endothelial cells, play a crucial role in the onset of atherosclerosis.is
hypothesis has been extensively studied and validated in humans [4], [5] and
animal models [6], [7], as well as in surgically altered ow conditions in vivo
[8], [9]. However, the smaller dimensions and the higher heart rate in mice
make measurements to calculate the shear stress challenging. Although the
Hagen-Poiseuille formula may provide an estimate of the order of magnitude
of wall shear stress, its accuracy is expected to be low in bifurcation regions
(e.g. carotid bifurcation) where the blood ow is more complex. Alternatively,
the wall shear rate can be calculated from anMRImeasurement of the velocity
∗is chapter is based on the work: D. De Wilde, B. Trachet, N. Debusschere,
F. Iannaccone, A. Swillens, J. Degroote, J. Vierendeels, G. R. De Meyer and P. Segers,
‘Assessment of shear stress related parameters in the carotid bifurcation using mouse-
specic FSI simulations’, Journal of Biomechanics, In press, 2015
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eld in the murine CCA [10]. Nevertheless, spatial resolution is still limited
and the temporal resolution of MRI does not allow capturing complex ow
oscillations in the mouse carotid.
In order to overcome these limitations, computational uid dynamics
(CFD) simulations have been used to calculate WSS. Several derived param-
eters such as the TAWSS, the OSI [11] and RRT [12] have been proposed
to serve as indicators plaque initiation regions [13].ese parameters have
been studied in the murine aortic arch, CCA and/or the abdominal aorta
[14]–[22], in relation to both plaque and aneurysm development. Moreover,
altered shear stress patterns induced via surgical implantation of a tapering
cast around the murine right CCA have been assessed with CFD [23]). CFD
simulations, however, assume rigid walls and do not take the volume buer-
ing in the arteries into account. Fluid-structure interaction (FSI) simulations
add the wall movement through combined computational solid mechanics
(CSM) and CFD simulations. is approach makes the simulations more
complex and time consuming, but leads to more realistic simulations as we
recently demonstrated in an FSI model of the abdominal aorta of the mouse
[24].
In the current study, we show that the rigid wall assumption of CFD
simulations hampers the application of realistic ow boundary conditions at
the carotid bifurcation in mice.erefore, we performed FSI simulations of 8
carotid bifurcations (le and right) in 4 ApoE−/− mice, using mouse specic
geometries and boundary conditions measured in vivo.
8.2 Methods
8.2.1 Mice
Data were acquired in 4 female ApoE−/− mice, fed a Western type diet
(TD88137, Harlan Teklad, Madison, Wis, USA) ad libitum from the age of
6 weeks until 16 weeks. e mice were housed in groups of 4-8 animals
in well-ventilated cages. eir cages were kept under controlled environ-
mental conditions, resulting in a 12h normal light/dark cycle, a temperature
of 20-23○C and a 50% relative humidity. All the experiments were conducted
according to the EC guidelines and were approved by the animal ethics com-
mittee of Ghent University.e data represents a subgroup of a larger study,
with the complete protocol described in [25].
8.2.2 Measurements
8.2.2.1 Ultrasound measurements
Animals underwent an imaging protocol at week 16 consisting of ultrasound
examination and a contrast-enhanced µCT protocol. US imaging was per-
formed using a high-frequencyUS scanner (Vevo 2100, Visualsonics, Toronto,
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Canada) equipped with a linear array probe (MS550D, 22-55MHz). A single
operator (DDW) performed all measurements. e mice were secured in
a supine position while monitoring the ECG, the respiratory rate and the
body temperature under 1-1.5% isourane anaesthesia. Flow velocities were
assessed using PW Doppler US measurements proximal to the bifurcation
in the CCA and distal to the bifurcation (outows) at the ECA and ICA.
radio frequency (RF) M-mode US measurements were performed at CCA,
ECA and ICA.e distance of these ultrasonic measurement locations to the
bifurcation was measured.
8.2.2.2 µCT measurements
Aer the US examination, anaesthesia was maintained, and the mice im-
mediately underwent a contrast-enhanced µCT scan using a Triumph-II
imaging system (TriFoil Imaging, Chatsworth, CA, USA). First, 100 µl/25g
body weight Aurovist (Nanoprobes, Yaphank, NY, USA) was injected in the
tail vein (Wathen et al., 2013).e scanner settings were set to 50 µm focal
spot size, 50 µm detector pixel size, 3.5 times magnication, 500 µA tube
current, 75 kVp tube voltage, 1024 projections and a continuous rotation
mode.
8.2.3 Processing of the measurements
8.2.3.1 Ultrasound processing
e outer envelope of the Doppler spectrumwas tracked using an application
written in Matlab (Mathworks, Natick, Massachusetts, USA).e diameter
distension was obtained using an ultrasonic vessel wall tracking algorithm
as described by Rabben et al. [26]. A owchart of the processing of the
measurements is given in gure 8.1. Signals were cycle-averaged (minimally
3 cycles) based on the R-peak of the ECG.e velocity and diameter signals
were time-aligned (since a non-consistent time-oset was detected between
both signals) by shiing the diameter distension waveforms.is was done
automatically as part of the ln(D)U method for local wave speed assessment
[27], [28].e time shi for which the ln(D)U-loop tted best to the theor-
etical straight line in the early systolic region was selected by minimising
the L2-norm of the dierence between the measured data and the linear t,
divided by the number of sample points in the selected upslope region.
8.2.3.2 µCT processing
e Iterative Maximum-likelihood Polychromatic Algorithm for CT was
applied to reconstruct the µCT data at a 0.05 mm isotropic voxel size [29].
Mimics (Materialise, Leuven, Belgium) was used to semi-automatically seg-
ment the three branches of the carotid bifurcation, CCA, ECA and ICA.
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Figure 8.1: Overview of the processing of the measurement data. e US meas-
urements were used to generate mouse specic boundary conditions for the ow
simulations. From the µCT measurement, the diastolic geometry of the carotid
bifurcation was created.
e workow was based on thresholding and region growing steps, com-
bined with manual editing where needed. Aerwards, ow extensions with
a length equal to the diameter of the arteries were added in the VMTK
(www.vmtk.org). In the end, the segmented geometry was shrunk to the
diastolic radius measured with M-mode US (with a rescale factor of 0.8, 0.84,
0.84 and 0.88 for the four mice).e nal result was inspected visually by
plotting the segmented contours on the µCT images.
8.2.4 Creating a volume mesh using the XTMmethod
From the resulting STL-surface, a volumemesh was constructed in pyFormex
(http://www.nongnu.org/pyformex/) using the Extended TreeMesh
method (XTM) [30]. is meshing method results in a high-quality un-
structured hexahedral mesh, with the cells aligned along the predominant
direction of ow. A mesh sensitivity study was performed to assure that the
90% percentile of the TAWSS, OSI and RRT were converged.e 10% per-
centile of the TAWSS (TAWSS-low) was also included to assure low TAWSS
were correctly calculated. Convergence was obtained with 303k cells as depic-
ted in gure 8.2 a). Meshes of the arterial wall were generated assuming a
wall thickness of 10% of the local luminal diameter and 3 cell layers in the
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radial direction [24].e structural meshes contained around 65k cells and
convergence was assured using the 90% percentile of maximum displacement
gure 8.2 b). Figure 8.3 depicts the uid mesh (white) and the structural
mesh (grey) for a representative geometry.
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Figure 8.2: (A) Results of the mesh convergence study for the uid domain. Conver-
gence of the high values (90% percentile) of the TAWSS, OSI and RRT are plotted.
For the TAWSS also the low values (10% percentile) values are considered. e
dierence with the values of the reference mesh (433k cells) is shown. For 300k cells
convergence is reached. (B)e 90% percentile of the maximum displacement for
the solid domain convergence study with respect to the reference value (87k cells
mesh).
8.2.5 e Wall Mechanics problem
e CSM simulations were performed using the commercial nite element
solver Abaqus Standard via an implicit (backward-Euler) time integration
scheme.
8.2.5.1 Material Model Parameter Fitting
e blood vessel wall was modelled as an incompressible hyperelastic Ar-
ruda-Boyce material [24], with material parameters tted to measurement
data.e material parameter tting procedure is illustrated in gure 8.4: an
idealised cylindrical CCA geometry Xcyl was constructed using the following
dimensions (averaged on 8 carotids): inner diastolic radius of 0.215 mm, wall
thickness of 10% of the diameter, spring constant ks of 1e6 Pa/m (to model
external tissue; see further). e Arruda-Boyce λm parameter was set to
153
8. Assessment ofWSS metrics using mouse-specific FSI simulations
Figure 8.3:e uid mesh (white) and structural mesh (grey) constructed with the
XTM algorithm.e boundary conditions for both the CFD and CSM simulations
are also schematically represented.
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1.01 [24]. For the shear modulus µ an iterative optimisation procedure was
performed based on the initial shear modulus µ0 and the average measured
systolic radius of 0.24716 mm. Applying the axial prestress and diastolic
inate backwards incremental method (BI) (see below) and a static structural
simulation with a systolic pressure load of Psys=119 mmHg [31], the simulated
systolic diameter could be calculated as a function of the material parameter
guess µi and was compared to the peak of the distension waveform. e
material model optimisation resulted in a value of 9516 Pa for µ*.e same
parameter value was used for all 8 simulations.
BI-inflate
BI-axial
CSM
minimize
[dsysi-1(μi-1) - dmeasured]2
Pdia
Xcyl
dsysi
dmeasured μi-1
σax
σax+dia
μ*
σload axial
Xcyl
μi
μ0
ks
Psys
Xcyl
ks
FSI 
calculations
Figure 8.4: Flowchart of the material parameter optimisation. For this parameter
optimisation loop, an average CCA cylindrical geometry (Xcyl) was pre-loaded
with the axial prestress (σ load axial) and the diastolic pressure Pdia. e systolic
distension dsys was calculated by applying the systolic pressure Psys.e material
model parameter was optimised iteratively so that dsys equalled the measurement.
8.2.5.2 External tissue support
e stabilising inuence of external tissue was modelled using spring ele-
ments at the outer wall surface [32], as plotted schematically at the bottom of
gure 8.5 b).is resulted in around 20k springs per model (ranging from 18k
to 23k springs).e results are independent of the exact amount of springs
due to the adaptation of the spring constant to the local cell area. Assuming
that the tissue pressure of mice and humans is similar, the spring constant ks
as given by [32] in humans (1e4 Pa/m) rescales to a value of approximately
1e6 Pa/m in mice (tissue pressure = ks*distension, with the distension of the
aorta artery in humans (2.3 mm) [33] being about 50 times higher than the
murine carotid artery distension).
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8.2.5.3 Initial stresses
To account for the diastolic in vivo stress state, the BI method was applied
[34], [35] (gure 8.5 b). In short, this is an iterative approach that starts
from the deformed geometry, to nd the internal stresses under a load.e
resulting stress state in the original geometry is in equilibrium with the
applied load, leading to no further displacements. We rst applied an axial
prestress of 100 kPa (σ load axial) to the cross section of the CCA while xing
the ECA and ICA outlets (schematic overview: gure 8.5 a - bottom).is
is a stress value in between the low and medium extension found in [36].
e forward calculation steps of the BI method were performed using the
commercial nite element solver Abaqus Standard (Simulia, Johnston, USA).
e axial loadwas smoothly increased to 100 kPa in 10 steps and kept constant
aerwards [34].
Figure 8.5:e two BI steps (BI-axial and BI-inate) to calculate the in vivo stress
state. (A)e maximal principal stress in the carotid bifurcation under an axial
prestress with the original geometry, calculated with the BI-axial step. (B)e in
vivo stress state, under a combined load of an axial prestress and a diastolic pressure,
calculated with the second BI step, BI-inate.e resulting stress eld was used as
an initial condition for the following CSM step and the nal FSI calculations.
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Secondly, a diastolic pressure (Pdia) of 87 mmHg [31] was added by per-
forming a second BI calculation with altered loads and boundary conditions.
At the inner surface of the artery, the pressure was increased in 50 steps from
zero to a value of 87 mmHg.is time, only radial movement was allowed at
the three boundaries: CCA, ECA and ICA.e stress eld resulting from the
axial prestress procedure (σax) was applied as an initial condition to the BI-
inate step. Because no axial displacement was allowed, the axial pre-stress
could not relax and remained present in the solution. e external tissue
was modelled with springs, as explained previously (schematic overview:
gure 8.5 b – bottom). e convergence criteria were: 1e-6m maximum
displacement, 1e-11m L2 norm of the displacement and 1 Pa for the L2 norm
of the dierence in maximal principal stresses between two iterations.is
second BI step resulted in the in vivo stresses (σax+dia) in the geometry under
a combined axial prestress and a diastolic pressure load. How both BI steps
t into the general work ow, is indicated in gure 8.6.
8.2.6 e FlowMechanics Problem
All ow simulations were performed with the nite volume solver Fluent 14.5
(Ansys, Canonsburg, USA).e density of the blood was set to 1060kg/m3
with a constant dynamic viscosity of 3.5mPas [16], [19], [37].e SIMPLE
algorithm with second-order upwind discretization was used for the pres-
sure-velocity coupling and the momentum equations, respectively. For the
time integration, a second order implicit discretization scheme was used.
Convergence was reached when the continuity and momentum relative resid-
uals dropped below 1e-6. For the FSI-simulations, a spring analogy was used
to move the interior grid nodes of the uid domain at an arbitrary velocity
(arbitrary Lagrangian–Eulerian method).
8.2.6.1 Boundary conditions
Mass ow inlets were used at the inlet (CCA) and one outlet (ECA), while
a windkessel model was imposed at the ICA outlet. As blood ow velocity
Ub(t) was measured rather than mass ow, rescaling was mandatory. To
calculate the instantaneous average velocity over the cross-section, the max-
imum velocity was divided by 2, assuming a parabolic ow prole at the
measuring location (which was conrmed a posteriori by the simulations).
As also the cross section varied throughout the cardiac cycle, a structural
simulation was performed inating the prestressed geometries according to
the pressure curve.e cross-sectional area at the location of the ow velocity
measurements was exported.e mean velocity curve was then multiplied
with the cross sectional area curve and the density of 1060 kg/m3 to calculate
the mass ow prole at these locations.
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Figure 8.6: Flowchart depicting the followed methodology for the FSI simulations.
First, the segmented geometry was meshed with the XTM. Using the optimised
parameter µ* (see material optimisation owchart gure 8.4), the in vivo stress state
under an axial stress load (σ load axial) and a diastolic pressure (Pdia) was calculated
with two BI steps (BI-axial and BI-inate).e areas of the lumen boundaries was
approximated by inating the bifurcations according to the pressure prole. Based
on the resulting areas (Ab) and the measured US velocity (Ub), the mass ow (m˙b)
at the boundaries was determined. Finally the ICA windkessel was tted to the
pressure (PICA) and ow prole (m˙b).
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Due to measuring errors and assumptions in the data processing, the
time-averaged mass ow balance in the model (cycle-averaged dierence
between in- and outow) was not completely fullled. As we estimated the
CCA measurement to be the most accurate, a scaling factor c was applied to
the ICA and ECAmass ows such that averaged over a heart cycle m˙CCA-meas
= cte*(m˙ECA-meas+m˙ICA-meas). Note that only the rescaled ECA ow is dir-
ectly imposed as boundary condition.e average correction factor for the
measured ECA and ICA ow was 1.20±0.22 (ranging from 0.9469 to 1.6839).
For the FSI simulations, a three element windkessel model [38] was
applied at the ICA outlet (gure 8.3). Model parameters were tted in Matlab
byminimising the dierence between a target pressure curve and the pressure
curve predicted by the windkessel model, when imposing the rescaled ICA
ow.e target pressure curve was approximated by linearly rescaling the
measured diameter distension waveform to the assumed in vivo diastolic and
systolic pressures PICA(t) (87/ 119 mmHg) [31]. As such, the global pressure in
the model is not a priori prescribed, but will be determined by the imposed
inlet and outlet ow, the 3-element windkessel model parameters and the
properties of the arterial wall.
8.2.7 FSI coupling
e in house developed code Tango was applied to couple the ow and
structural solvers for describing the FSI problem. At the interface a new
prediction of the location was made with an IQN-ILS algorithm based on the
previous positions calculated by the structural solver [39]. At each time step
coupling iterations between both solvers were performed tomeet equilibrium
at the interface.
8.2.8 HWP
Derived haemodynamic wall parameters include the TAWSS, OSI and RRT
[11]–[13].
TAWSS = 1
T ∫ T0 ∥τ⃗∥ dt (8.1a)
OSI = 1
2
⎛⎜⎜⎝1 −
∥∫ T0 τ⃗ dt∥∫ T0 ∥τ⃗∥ dt
⎞⎟⎟⎠ (8.1b)
RRT ∼ 1(1 − 2 ⋅OSI) ⋅ TAWSS (8.1c)
τ⃗ is the instantaneous wall shear stress vector and T the period of the
cardiac cycle. In the case of FSI simulations where the arterial wall was
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moving, a local coordinate system was constructed at every interface node
using pyFormex moving with the arterial wall. e wall shear stress was
expressed in this local frame of reference.
8.3 Results
8.3.1 Fitting the Windkessel model
e tting of the Windkessel model resulted in the following values: Z=
1603.8±755.0 mmHg/mm/s, R= 8147.4±1491.1 mmHg/mm/s and C = 8.22E-
06±2.61E-06 ml/mmHg. e diastolic pressure at the inlet was 91.2±2.4
mmHg (averaged over the 8 simulations), while the systolic pressure was
118.3±4.9 mmHg (table 8.1).e pressure drop over the carotid artery was
1.99+/-0.40mmHg between CCA – ECA and 2.52±0.71 mmHg between CCA
– ICA.
8.3.2 e simulated ow eld
Figure 8.7 displays simulated pressure and ow waveforms for a represent-
ative case (mouse2, right bifurcation), as extracted from the cross-sections
indicated in gure 8.8.e ow prole is highly laminar with no recircula-
tion present around the bifurcation for any of the cases with the boundary
condition (BC) extracted from the measurements (under anaesthesia). In
diastole only a small amount of mass ow is present in the ECA, and the
highest velocities are visible in the ICA at both time points. e displace-
ment (gure 8.8 b) is smooth over the entire bifurcation with the highest
displacement present at the bifurcation itself.
e simulated ow at the ICA agrees very well with the ow directly
derived from the measurements (gure 8.9). In a CFD approach, the ICA-
ow would equal the dierence between inow at CCA and outow via the
ECA, which would result in a much more peaked waveform due to the lack
of buering in systole (gure 8.9).
8.3.3 Results for the HWP
Flow derived indices are displayed in gure 8.10 (TAWSS), gure 8.11 (OSI)
and gure 8.12 (RRT) for all eight simulated cases. Despite dierences in
absolute values of TAWSS, a similar spatial distribution of the lowered (blue)
and elevated TAWSS (red) is present in all cases (gure 8.10). e high
velocity in the ICA results in an elevated TAWSS compared to the CCA. A
region with a lowered TAWSS (in blue) was present at the outer bend of the
ECA.e OSI is highest mainly at the outer bend of the ECA zone but stays
more localised compared to the TAWSS (gure 8.11).is trend continues
in the RRT pattern shown in gure 8.12. In mice 2 and 3, the higher RRT
value at the outer bend of the ECA is most pronounced, but only in mouse
3R (right bifurcation) this spans the whole ECA.
160
8.3. Results
ICA
T1 = 0.008 s
T2 = 0.020 s
T3 = 0.061 s
Pressure
Flow
Pressure [m
m
H
g]
85
90
95
100
105
110
115
120
Fl
ow
 [m
l/s
]
0
0.01
0.03
0.04
time [s]
0 0.025 0.05 0.075 0.1 0.125 0.15
(a) ICA
ECA
Pressure
Flow
Pressure [m
m
H
g]
85
90
95
100
105
110
115
120
Fl
ow
 [m
l/s
]
0
0.01
0.03
0.04
time [s]
0 0.025 0.05 0.075 0.1 0.125 0.15
(b) ECA
CCA
Pressure
Flow
Pressure [m
m
H
g]
85
90
95
100
105
110
115
120
Fl
ow
 [m
l/s
]
0
0.01
0.03
0.04
time [s]
0 0.025 0.05 0.075 0.1 0.125 0.15
(c) CCA
CCA-in
PressureFlow Pressure [m
m
H
g]
85
90
95
100
105
110
115
120
Fl
ow
 [m
l/s
]
0
0.01
0.03
0.04
time [s]
0 0.025 0.05 0.075 0.1 0.125 0.15
(d) CCA-in
Figure 8.7:e calculated pressure and ow proles in an example bifurcation at
four dierent locations: (a) ICA,(b) ECA,(c) CCA, (d) CCA-in. (a-c) are taken close
to the bifurcation and (d) at the inlet.e precise locations are shown in gure 8.8.
e CCA buers the ow, resulting in a less peaked ow prole at the CCA compared
to the CCA-in.e ow in the ECA is small compared to the ow through the ICA.
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Figure 8.8: (A)e velocity elds at end diastole (+ in gure 8.7) and peak velo-
city (x). Laminar ow, without recirculation at the bifurcation is visible. (B)e
displacement at peak pressure is largest at the bifurcation (●).
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Figure 8.9: Comparison of the dierent ow proles at the boundaries. For the
CCA and ECA, the imposed ow proles are plotted.e ICA measured ow, aer
correcting for the ow imbalance, is the target ow prole for the simulations.e
FSI simulation resulted in an ICA ow prole (ICA simulation) that corresponds
well with this prole. CFD simulations would neglect the buering of the bifurcation
and would have resulted in an ICA ow equal to QCCA-QECA
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Figure 8.10:e TAWSS result from the FSI simulations of all the dierent bifurc-
ations, medial (M) and lateral (L) views. Dierences in absolute values between
dierent bifurcations are present. However, the qualitative patterns are similar for
all bifurcations.
8.4 Discussion
In this study, an FSI model of the carotid bifurcation was developed for
the le and right carotid of 4 ApoE−/− mice, providing, to the best of our
knowledge, the rst estimates of wall shear stress distributions along the
mouse carotid artery that take into account the buering capacity of the
walls. e model was animal-specic in terms of carotid geometries and
imposed ow boundary conditions; thematerialmodel was tuned to averaged
diameter distension measurements in the animal cohort.
In order to determine haemodynamic wall parameters, a realistic sim-
ulation of the blood ow is important. We are convinced that accounting
for the uid-structure interaction is of added value as it allows for a volume
buering in systole and a much more natural application of the boundary
conditions.is is best illustrated in gure 8.9, where it is shown that merely
using the dierence between CCA inow and ECA outow to retrieve the
ICA outow (as is the case in CFD) leads to waveforms diering much more
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Figure 8.11:e OSI result from the FSI simulations of all the dierent bifurcations,
medial (M) and lateral (L) views.
Table 8.1: Pressures [mmHg] and distensions [%] at the boundaries of the FSI
simulations.
CCA ECA ICA
Pulse Pressure - FSI 27.2±7.0 27.3±6.8 27.1±6.9
Pdia - FSI 91.2±2.4 90.5±2.3 89.8±2.5
Psys - FSI 118.3±4.9 117.8±4.8 117.0±4.7
Distension - FSI 9.4±1.5 10.1±1.3 8.2±1.3
Distension - Measured 16.2±2.8 11.7±4.1 8.4±3.2
164
8.4. Discussion
Figure 8.12:e RRT result from the FSI simulations of all the dierent bifurcations,
medial (M) and lateral (L) views.
from the measured waveform than the one retrieved in the FSI simulations
(L2-norm dierence of 0.1330±0.0317 ml/s vs. 0.0111±0.0039 ml/s). Both
approaches can also be compared with the pulsatility index (PI), dened
as (Usys-Ued)/Umean with Usys the systolic, Ued the end diastolic and Umean
the average outow velocity.e pulsatility index (PI) at the ICA obtained
by CFD (1.86±0.300) is considerably higher than the measured value of
0.777±0.164 which again was much better replicated by the FSI simulations
(0.555±0.180). A full overview of the measured PI of all mice is given in
section 6.3 on page 107.
In humans, ow separation and recirculation in the carotid bifurcation
have been reported in 99 out of 100 subjects [40]. None of the 8 simulated
murine carotid bifurcations, however, presented ow separation (neither in
the FSI, nor in CFD simulations). It has been reported that the critical Reyn-
olds number, below which no recirculation is present, is geometry dependent
[41].e Reynolds numbers in mice are much lower than in humans, and
are lower in the carotid arteries than in the central aorta. Our simulations re-
sulted in a Reynolds number of 12.7±2.9 (peak systole). Womersley numbers
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were 0.46±0.03 at the CCA inlet. Note, however, that simulations were done
in animals not showing any signs of plaque. As demonstrated in the aorta
[15], the presence of plaque may lead to geometrical discontinuities that can
induce local ow recirculation zones. Another explanation might be that the
(ow) boundary conditions are based on US measurements performed while
the mice were under anaesthesia. Mohri et al. showed that ow recirculations
are present in the casted carotid artery, when simulating highly locomotor
active mice by adapting the boundary conditions [23].e inuence of the
anaesthesia and the locomotor activity is studied in more detail in chapter 9.
e main interest of the current research is the inuence of the ow on
the arterial wall through the WSS.e inuence of these ow recirculations
is minimal because the magnitude of the WSS vector is low at these location
(with or without recirculations).erefore, based on the single case that we
computed, we can presume that the inuence of the anaesthesia onto the
HWPs is minimal when a normalisation is used to take the lower overall
WSS into account.
Overall, the patterns of TAWSS and RRT were quite consistent between
animals. Only for the CCA of mouse1 L/R and mouse3 R, the global TAWSS
is lower compared to the other mice.is is consistent with the calculation of
the TAWSS based on the Poiseuille ow assumption [42], which is lower for
these CCA (between 3.3 and 4.7 Pa) compared to the other CCA (between
6.1 and 9.2 Pa). However, the locations where TAWSS is lowest (blue in
gure 8.10) are similar in all mice: the outer bends of the ECA branch of the
bifurcation. It was also observed that TAWSS in the ECA is lower compared
to the ICA and CCA due to the lower ow.
Setting up and tuning the animal specic model is largely dependent on
the haemodynamic measurements that are much more challenging in mice
than in humans. Direct measurement of the ow in the murine CCA using
MRI is possible but results in limited spatial (50x50x500 µm) and temporal
(27 timeframes/cardiac cycle) resolution [10]. We determined the ow by
multiplying the PWDoppler US velocity with the cross-sectional assuming a
parabolic prole. As can be seen from gure 8.8 on page 162, the parabolic
ow prole is a reasonable assumption for the CCA and for the side branches
when measuring far enough downstream. Probably the largest error source
is the angle correction of the PW Doppler US velocities, especially for the
ICA and ECA measurements. To guarantee a correct mass balance over the
bifurcation, we decided to apply a rescaling factor at the outow velocity
waveforms of the ECA and ICA outlets. On the other hand, the smaller
magnitude of the ECA blood velocity and the higher penetration depth to
reach the ICA are arguments to select either the ECA or the ICA as the least
accurate measurement.erefore we decided to distribute the error equally
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over both branches.e high average ow correction factor (1.20±0.22) is
mainly explained by the large correction for case 1L (1.68). erefore, the
results for bifurcation 1L should be interpreted with caution. When omitting
that case, the average correction factor is 1.13±0.23, which is in the same order
of magnitude as previous performed studies [19], [24].
A major drawback of our study is the absence of pressure measurements,
which are still extremely challenging inmice. In our experience, non-invasive
(tail-cu) pressure data show large variability and we judged them insu-
ciently accurate, while invasive pressure measurements imply sacricing
the animal. We therefore decided to generate a pseudo pressure waveform
based on rescaling the M-mode US diameter distension to a pressure range
that was previously reported [31]. Although the high correlation between
the measured and simulated distension curves justies this choice, a mouse
specic measurement would have further improved the simulations.
As described in the methods section, we applied a shrinking step aer
the initial segmentation based on the µCT images. is was necessary to
account for the arterial pulsation/movement during the µCT measurements,
and the partial volume eect, resulting in a gradual intensity transition from
artery to surrounding tissue. With an extra shrinking step added to the
measured diastolic diameter (M-mode US), we veried that these artefacts
did not articially inate the geometry.e nal segmentation was visually
inspected on the µCT image. In the future, cardiac gated µCT [43] might
circumvent the necessity of this step.
e material model used in these simulations is fairly simple. It does not
include anisotropy, neither does it account for the layering of the arterial
wall. We also assumed a xed ratio between local radius and wall thick-
ness. Given the focus of the study on ow-derived parameters, any material
model providing a realistic degree of wall distension over the physiological
pressure range would suit our purpose. Our choice for the Arruda-Boyce
model is mainly driven by the model simplicity, with hyper-elastic behaviour
achieved by tting only one model parameter. We did, however, include the
supporting eect of surrounding tissue in the simulations. is, together
with the implementation of the axial prestress improved both the realism
and the stability of the simulations compared to previous FSI simulations of
the murine vasculature [24].
In the present study, we focused on advancing our computational bio-
mechanics approach, and we have implemented a methodology that allows
assessing carotid haemodynamics and derived ow-related parameters in
what we think is a fairly realistic way. Overall, the zones of low TAWSS corres-
pondedwith the areas in which plaque development was found (chapter 7). In
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chapter 10 the spatial correlation between these uid mechanical parameters
and plaque development and progression is studied.
8.5 Conclusion
We have presented mouse specic FSI simulations of eight carotid bifurca-
tions of 4ApoE−/−mice. A realistic wallmovementwas obtained by including
the axial prestress, the in vivo stress state and the support of the surrounding
tissue.e calculated haemodynamic wall parameters identied the sinus of
the ECA at the bifurcation as the region that would be exposed most to an
atherosclerosis-promoting haemodynamic environment.
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Comparison of numerical
methodologies to assessWSS
9.1 Introduction
e hypothesis that low and oscillatory WSS has an atheroprone eect on the
endothelial cells lining the inner arterial wall is generally accepted [1]–[5] .
In mouse models of atherosclerosis, it has been shown that atherosclerotic le-
sions preferentially develop at branching points, bifurcations and at the bends
of arteries [6]. However, to the best of our knowledge, no study directly ad-
dressed the quantitative association between development of atherosclerosis
and patterns of WSS on a within-subject bases in this animal model.
To be able to calculate murine WSS, highly accurate measurements of
the blood velocity near the arterial wall are needed, which is extremely chal-
lenging [7]. A commonly used alternative is applying numerical modelling
to calculate the velocity eld and to derive WSS from the spatial velocity
gradient perpendicular to the arterial wall. An important component of
numerical simulations is the application of appropriate BCs. In most publica-
tions measurements of the bulk blood velocity are used at the in- and outlets
of the region of interest, which are then applied as mouse specic BCs to
ensure the validity of the calculations.
e simplest type of numerical simulations to calculate WSS in arteries
are steady state CFD calculations [8]–[10]. In these calculations either the
peak or mean velocity (or ow) is applied at the boundaries. e time de-
pendence is ignored and a steady state ow condition is calculated.e WSS
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pattern is aerwards calculated based on this ow eld. Steady state CFD has
been performed to link the WSS in the casted CCA to the uptake of plasma
macromolecules[8] or the wall thickness [9].
Transient CFD simulations also take into account the time dependency
of the blood ow. Typically the velocities (or ows) are measured during
the heart cycle and these curves are imposed.e calculated WSS is now a
function of time and therefore the TAWSS is calculated in most cases.ese
simulationsmake it possible to study the oscillatory behaviour of the ow and
the WSS, which is also assumed to play an important role in the atheroprone
eect of low WSS on the endothelium. Transient CFD simulations of the
mouse vasculature have already been performed inmany cases.e aorta was
themain region of interest inmost of these publications with themain regions
of interest: the aortic arch [10]–[17] , the abdominal aorta [18]–[20] or the
whole aorta (arch+abdominal) [21]–[23].e most of these publications were
mainly oriented towards the methodology and the feasibility to calculate
WSS in mice [10]–[14], [18], [21]–[23]. In these publications, the found
WSS patterns were not linked (quantitatively or qualitatively) to biological
responses or processes. In the abdominal aorta, studies were focused on
aneurysm progression andWSS has been linked to aneurysm progression
in mice [19], [20]. With regard to atherosclerosis development, Assemat et
al. linked dierent HWPs with plaque development. To achieve this goal,
they virtually removed the plaque from the model to link pre-disease HWPs
with plaque presence. Other studies linked HWPs with plaque progression
markers such as presence of fat in the wall [24] or the expression of VCAM-1
[17]. In these studies, a between animals comparison was made, meaning
that the HWPs were calculated in another group of animals compared to the
group of animals used to determine the progression marker(s).
Feintuch et al. compared the steady state CFD WSS and the transient
CFD TAWSS in the mouse aortic arch. Both metrics show a close agreement
but a small dierence in absolute value was present [10].
A further step to get even closer to reality is the inclusion of the mechan-
ical behaviour of the arterial wall in the model, resulting in FSI simulations.
In these models, the eect of the distension and buering of the arteries is
taken into account. Our group has done this for the mouse carotid arteries
(chapter 8) [25] as part of this PhD thesis and the mouse abdominal aorta
[26].is adds an extra layer of complexity to the modelling methodology,
but also results in more realistic results.
Important to keep in mind when interpreting data from these studies
is the fact that most of these models are based on measurements obtained
while the mice were under anaesthesia. Anaesthesia has an inuence on
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the cardiovascular parameters, resulting in a lowered mean arterial pressure
(MAP), a lower cardiac output and blood ow and a lower HR [27], [28].
When the activity level of the mice increases, these parameters will increase
even further. Mohri et al. showed that the increased blood velocity due to in-
creased activity levels can considerably inuence the ow patterns [8]. When
under anaesthesia, ow recirculation is normally not visible in the murine
vasculature [8]. Taking the eect of anaesthesia into account, considerably
recirculation was observed in the modelled, casted murine carotid artery [8].
In the current chapter the dierent modelling methodologies are com-
pared for a single carotid bifurcation (bifurcation 3L). Steady state CFD
simulations are performed for both peak and mean velocity, as well as transi-
ent CFD simulations.e third investigated option is the FSI model setup
discussed in the previous chapter (chapter 8 on page 149).
As performed by Mohri et al. [8], the inuence of the anaesthesia is
also investigated.e ow and HR (CFD and FSI) are rescaled to both the
conscious-rest condition and the active condition (=high locomotor activity).
For the FSI simulations the BP is also scaled to model the same conditions.
9.2 Methods
9.2.1 Experimental protocol
e study is based on data acquired in a female ApoE−/− mouse (mouse 3L),
fed a Western type diet (TD88137, Harlan Teklad, Madison, Wis, USA) ad
libitum from the age of 6 weeks until 16 weeks.e housing of the animal
and all the experiments were conducted according to the EC guidelines and
were approved by the animal ethics committee of Ghent University [25], [29].
At week 16 the mouse underwent an imaging protocol. Using a high-
frequency US scanner (Vevo 2100, Visualsonics, Toronto, Canada) with a
linear array probe (MS550D, 22-55MHz), the blood ow velocity was assessed
in the CCA, ECA and ICA of the le carotid bifurcation with PWDoppler US.
e distension of the artery was measured using M-mode US measurements.
A contrast-enhanced (100 µl/25g body weight Aurovist, Nanoprobes,
Yaphank, NY, USA) µCT scan using a Triumph-II imaging system (TriFoil
Imaging, Chatsworth, CA, USA) provided the geometrical information of
the carotid bifurcation at a 50 µm resolution.
9.2.2 Post-processing of the measurements
e outer envelope of the Doppler signal and the diameter distension of
the US measurements were tracked to obtain respectively the blood velocity
and the diameter curve. For the three locations (CCA, ECA and ICA) both
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signals were aligned in time.e measured velocity was rescaled to a mass
ow and a ow correction factor of 1.1275 was applied to the ECA and ICA
ow to make the total cycle mass-balance t. More information about the
post processing of the US measurements can be found in section 8.2.3.1 on
page 151.
Mimics (Materialise, Leuven, Belgium) was used to semi-automatically
segment the three branches of the carotid bifurcation, CCA, ECA and ICA
from the µCT datasets. Flow extensions with a length equal to the diameter
of the arteries were added in the VMTK (www.vmtk.org).Finally, the seg-
mented geometry was shrunk to the diastolic radius measured with M-mode
US, resulting in a shrinking factor of 0.84.
From the resulting STL-surface, a volume mesh of both the uid (lumen)
and the solid (arterial wall) domain was constructed using the XTM [30]. A
mesh convergence study resulted in convergence for 300k uid domain cells
and 65k solid domain cells (section 8.2.4 on page 152) [25].e wall thickness
of the artery was assumed to be 10% of the local luminal diameter
9.2.3 Dierent numerical modelling techniques
9.2.3.1 Steady state CFD simulations
For the steady state CFD simulations 2 sets of BCs were applied: (i) the
average velocity/ow of the three branches and (ii) the peak velocity of the
three branches. For both cases, the mass ow of the three branches was
calculated from the measurements, assuming a parabolic ow prole. At the
CCA the calculated mass ow was applied. At the ECA and ICA the mass
ow split was calculated and they were applied using outow BCs with the
constant outow fraction. For the steady state simulations convergence was
reached when the continuity and momentum residuals dropped below 1e−10.
9.2.3.2 Transient CFD simulations
For the transient CFD simulations a mass ow inlet was applied at both the
CCA and the ECA (at the ECA themass ow inlet behaved as an outow).e
ICAwasmodelled as a traction free outlet. For the transient CFD simulations
a convergence criterion of 1e−10 was applied for both the continuity and the
momentum equations.
9.2.3.3 Transient FSI simulations
e methodology for the FSI simulations is described more in depth in
chapter 8 on page 149 [25]. In short, the same mass ow inlets as in the
transient CFD simulations were applied. At the ICA a windkessel was im-
plemented, with the parameters tted to the measurements. e external
tissue was modelled using linear springs [31].e BI method was executed
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sequentially to take axial and diastolic pre-stresses into account.e absolute
coupling iterations convergence criteria for the residuals were set to 10−8m
for the displacement and 0.5Pa for the load at the interface.
9.2.3.4 Comparing results
For theWSS and the TAWSS, the absolute values were compared between the
dierent simulations. To also be able to compare the patterns, the normalised
values were also studied.e values were normalised by dividing the absolute
values by the average value (over the whole bifurcation-surface). Because the
OSI is a dimensionless number, the absolute values where compared and no
normalisation was carried out.
9.2.4 Inuence of anaesthesia and activity
An overview of the dierent parameters for the dierent calculated cases is
given in table 9.1.is table is based on an experimental paper by Janssen
et al. [27].e Anaesthesia case is the physical condition of the mouse that
was calculated in the previous chapter (chapter 8 on page 149). In this case,
the measurements (performed while the mouse was under anaesthesia) were
imposed as BCs directly as described in the previous paragraphs.is means
that we are not calculating the “actual” physical condition of the mouse, but
rather the physical state of the mouse while being under anaesthesia (hence
the name Anaesthesia).
By estimating the eect of the anaesthetic, the physical state of the mouse
under “normal” resting conditions (=awake but resting) can be determined.
is is a better indication of the “real life”, long term WSS that the ECs
are subject to. In the study of Janssen et al., the experiments were done at
doses between 1% and 2 % isourane at two dierent universities. In the
current study a dose of 1.5% was used and thus the values of Janssen et al.
can be seen as the lower and the higher bound estimates of the inuence
of anaesthesia. erefore, in the current chapter the most extreme values
(lowest and highest inuence of isourane found by Janssen et al.) will be
investigated to estimate the inuence of isourane. Rest1 is the lower bound
estimation of amouse under conscious resting conditions (Rest1) [27]. For the
same conscious resting conditions, Rest2 is the higher bound estimation of
the physical condition of the mouse (Rest2), adaptation from the Anaesthesia
case with the 2% isourane rescaling factors. According to Janssen et al., the
changes under anaesthesia are: HR -11/38%, ow -5.4/42% and blood pressure
-24% as lower and higher estimate of the inuence of isourane anaesthesia
(between 1 and 2% isourane). is results in scale factors for the ow of
1.06 and 1.72 for cases Rest1 and Rest2 respectively. e HR of our mouse
specic measurements were also rescaled according to the percentage found
by Janssen et al.ese rescale factors for Q were applied to all simulations
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(steady state CFD, transient CFD and FSI).e change in HR could only be
taken into account for the transient (CFD and FSI) simulations.
Table 9.1: Adaptation of the BC to account for anaesthesia and activity.
Mouse 3L scale factor Q Psys Pdia Ts HR [bpm]
Anaesthesia 1.00 119 87 0.1719 349
Rest1 1.06 119 87 0.1530 392
Rest2 1.72 119 87 0.1066 563
Active1 2.04 156 114 0.1236 485
Active2 3.33 156 114 0.0861 697
e BP was not changed for the conscious resting state (Rest1 and Rest2),
because the measured values of van Herck et al. (used in our simulations:
MAP=102± 2mmHg) [32] are already in the same order of magnitude as the
conscious state measurements of Janssen et al. (MAP=105± 3mmHg) [27].
During a period of high locomotor activity (=active state), these param-
eters increase even further with the conscious resting case as a reference.
Janssen et al. found this increase to be: HR +23.77%, blood ow +93% and
BP +31.3%.is extra increase rescales case Rest1 to case Active1.is means
that Active1 is a lower bound estimate of the active condition, with regard to
the rescale factors to neutralise the inuence of the anaesthesia on our initial
measurements (done in case Anaesthesia). Similarly, Active2 is the adaptation
of case Rest2with regard to the inuence of activity. With respect to the factor
to neutralise the inuence of anaesthesia Active2 is an upper bound estimate.
In the Active cases the HR, blood ow and the BP are increased. Once again,
the change in HR could only be applied to the transient simulations (transient
CFD and FSI) and the BP only for the FSI simulations.
For the CFD simulations, the BCs were simply scaled according to the
factors of table 9.1. For the FSI simulations the rst step was to recalculate
the 3-element windkessel model based on the new, rescaled ICA ow and BP.
It is important to note that the rescaled pressure is not applied explicitly, but
implicitly through this windkessel. For both the CCA and ECA the rescaled
mass ows are applied at the boundaries.is means that for the 4 extra cases
(Rest1/2 and Active1/2), we step into the previous explained FSI workow in
chapter 8 on page 149 at the determine ow BCs block in the diagram on
gure 8.6 on page 158.e prestress calculation is not repeated, because the
previously found stress-state at a pressure of 87 mmHg (= Pdia) is still valid.
e new, higher windkessel pressure will result in an extra distension of the
artery.
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9.3 Results
9.3.1 Dierent simulation types
In gure 9.1, the ow across the dierent boundaries is plotted for the dierent
simulation types. For both steady state simulations (gures 9.1a and 9.1b)
all three boundary ows are applied directly (ECA and ICA through an
outow split). It is clearly visible that the ECA/ICA ow-split for the mean
ow steady state CFD simulation (0.13/0.87) diers from the ow-split of
the peak ow steady state CFD simulation (0.24/0.76).e transient CFD
ICA ow (gure 9.1c) is much more peaked compared to the transient FSI
ICA ow (gure 9.1d). When comparing the resulting ICA ow with the
measured waveform, it is obvious that the FSI simulations approximate the
measurements better compared to the CFD simulations.
Figure 9.2 shows the WSS distribution for the steady state CFD simula-
tions (gures 9.2a and 9.2b) and the TAWSS for the transient simulations
(gures 9.2a and 9.2b). e most striking, is the higher WSS of the peak
velocity steady state CFD simulations. e other 3 simulation techniques
(mean steady state CFD, transient CFD and transient FSI) show a similar
WSS distribution
Figure 9.3 shows the normalised WSS for the steady state simulations
(gures 9.3a and 9.3b) and the normalised TAWSS for the transient simula-
tions (gures 9.3c and 9.3d) for the mouse under anaesthesia.e WSS and
TAWSS values were divided by their mean values of respectively 3.25, 7.54,
3.42 and 2.85Pa to normalise them.e dierent normalised WSS patterns
show very similar distributions.
e steady state CFD simulations do not take into account the time
dependency of the ow and owoscillations are not included in themodelling
strategy. For the transient CFD and FSI simulations the oscillations were
assessed and compared by means of the OSI (equation (8.1b) on page 159).
For the CFD simulations the OSI was negligible with an average value of
1.3*10−3 (gure 9.4a) and a maximum value of 0.166 (at the ow stagnation
point). For the FSI simulations on the other hand, there was a clear increase
in OSI at the outer side of the ECA sinus (gure 9.4b), increasing the average
value to 2.46*10−2 with a maximum value of 0.272.
9.3.2 Inuence of anaesthesia and activity
9.3.2.1 TAWSS
Figure 9.5 shows the TAWSS plotted on the diastolic geometry for the FSI
simulations of the 5 dierent physical conditions of the example mouse. With
the rising activity level, the ow (see rescale factors in table 9.1) and thus
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Figure 9.1: Overview of the ow across the boundaries for the dierent simulation
types. (a) constant ow based on the mean velocity measured. (b) constant ow
based on the peak velocity measured. (c) measured ow at the CCA and ECA and
free outlet at the ICA. (d) measured ow at the CCA and ECA and windkessel at the
ICA. For subgures (c) and (d) the measured ICA ow is plotted as a reference
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(a)Mean (b) Peak (c) Trans (d) FSI
Figure 9.2:e WSS (steady state simulations) or TAWSS (transient CFD and FSI)
pattern for the dierent types of simulation: (a): steady state CFD with mean mass
ow (b): steady state CFD with peak mass ow (c): transient CFD (d):transient FSI.
the TAWSS increases.erefore, an increase in WSS is visible from le to
right in gure 9.5 (with only Rest2 having a slightly higher value compared
to Active1).
In gure 9.6, the normalised TAWSS is plotted on the diastolic geometry
for the FSI simulations of the 5 dierent physical conditions of themouse .e
TAWSS was normalised by dividing it by the average value of the subsequent
case. For Anaesthesia, Rest1, Rest2, Active1 and Active2 the average TAWSS
was respectively: 2.85, 3.08, 5.12, 4.77 and 8.11 Pa. Because the pressure was
increased to simulate the high locomotor activity states (Active1 and Active2),
the diameter has increased for those cases (see gure 9.11).e normalised
TAWSS distribution is, however, very similar for the dierent cases.e most
apparent dierence is the relatively higher TAWSS at the inner bend of the
bifurcation.
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(a)Mean (b) Peak (c) Trans (d) FSI
Figure 9.3:e normalisedWSS (steady state simulations) or TAWSS (transient CFD
and FSI) pattern for the dierent types of simulation.e values were normalised
by dividing them by the respective average values of 3.25, 7.54, 3.42 and 2.85Pa. (a):
steady state CFD with mean mass ow (b): steady state CFD with peak mass ow
(c): transient CFD (d):transient FSI.
9.3.2.2 OSI
e dimensionless FSI OSI was not normalised like the TAWSS. For the cases
describing a dierent condition for mouse 3L the OSI is plotted in gure 9.7.
In both the CCA and ICA branch, no dierences are discernible between the
dierent conditions. For the ECA, globally the same region has an elevated
value in all 5 cases. A similar pattern is visible for the Anaesthesia case and
the rest cases (Rest1 and Rest2), but the maximum is not the same for all those
cases. In case Active2, the maximal value is clearly increased and the zone
with an elevated OSI spreads out further.
9.3.2.3 FSI Recirculations
In the Anaesthesia condition, no ow recirculations were visible in this bifur-
cation (or any of the other bifurcations of chapter 8). When adapting the BCs
for the dierent physical states of the mouse, ow recirculations becamemost
apparent in the early deceleration phase in the cases with high locomotor
activity (Active1 and Active2). To visualise the presence of recirculation struc-
tures, the line integral convolution (LIC) of the normalised FSI WSS was
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(a) CFD (b) FSI
Figure 9.4:e OSI pattern for transient CFD and FSI simulations: (a): virtually no
oscillations present in the ow pattern for a CFD simulation (b): more oscillations
present in the ECA for a FSI simulation.
plotted in the early deceleration phase for the 5 physical condition cases for
mouse 3L in gure 9.8.e LIC is the mathematical equivalent on a surface of
putting drops of ink in ow/vector eld. Figure 9.8e shows that a substantial
zone with reversed WSS is present for case Active2 in the outer bend (frontal
side) of the ECA.is zone overlaps with the zone where the OSI is elevated
in gure 9.7e. for both cases Rest2 and Active1 (gures 9.8c and 9.8d), smaller
zones with reversed WSS are present. Although the reversed WSS is clearly
present, the magnitude of the vectors in this reversed zone is low.
For FSI Active2, the most extreme case with high locomotor activity and
the highest anaesthesia inuence estimate, the velocity is plotted in gure 9.9.
e velocity plots (gures 9.9b to 9.9e), show the LIC for the velocity vector
eld in themid plane of the ECA.is velocity eld is plotted for 4 time points
that are indicated on theCCAboundary ow curve in gure 9.9a.ese results
show a clear ow recirculation zone in the deceleration phase (gures 9.9c
and 9.9d).e velocity in these ow recirculation zones is very low.
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(a) Anaesthesia (b) Rest1 (c) Rest2 (d) Active1 (e) Active2
Figure 9.5:e TAWSS for mouse 3L under dierent circumstances: anaesthesia (a:
Anaesthesia), conscious-rest lower bound (b: Rest1), conscious-rest higher bound (c:
Rest2), high locomotor activity lower bound (d: Active1) and high locomotor activity
higher bound (e: Active2). ese circumstances were simulated by changing the
boundary conditions according to [27].
9.3.3 Zones with WSS reversal
For the dierent simulation types the zoneswith reversedWSSwere identied.
For the transient simulations this was done in the early deceleration phase
(point c in gure 9.9a). Reversed WSS was dened according to the scalar
product with the normal of the CCA boundary. If the scalar product with
the WSS was negative (component in the direction of the CCA according
to the normal), the zone was indicated to have a reversed WSS.e area
[mm2] with reversed wall shear stress is plotted in gure 9.10 for the dierent
simulation types and the dierent BCs. At the stagnation point, the WSS
vector is perpendicular to the CCA-inlet normal and therefore the current
denition of reversed WSS is not applicable in this zone.is zone (coloured
in blue in the close up on gure 9.9a) accounts for the small false positive
values in all cases. Physical ow andWSS reversal at the outer bend of the
ECA sinus are only present for cases Rest2, Active1 and Active2. For the FSI
simulations the largest area is exposed to WSS reversal. Reversed WSS is
present for the same cases for transient CFD simulations, but the exposed
area is a bit smaller. For the peak velocity steady state CFD simulations a
considerably smaller area is exposed to reversed WSS.
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(a) Anaesthesia (b) Rest1 (c) Rest2 (d) Active1 (e) Active2
Figure 9.6:e normalised TAWSS (divided by the mean value of respectively 2.85,
3.08, 5.12, 4.77 and 8.11 Pa) for mouse 3L under dierent circumstances: anaesthesia
(a: Anaesthesia), conscious-rest lower bound (b: Rest1), conscious-rest higher bound
(c: Rest2), high locomotor activity lower bound (d: Active1) and high locomotor
activity higher bound (e: Active2).ese circumstances were simulated by changing
the boundary conditions according to [27].
9.4 Discussion
9.4.1 Steady CFD vs. Transient CFD vs. Transient FSI
In this chapter, dierent possible modelling strategies to simulate the murine
carotid haemodynamics were compared.e focus of the comparison is on
the WSS and HWPs reecting oscillatory motion of ow. A second part of
this chapter dealt with the inuence of the activity state of the mouse on
these simulations.e inuence of anaesthesia and locomotor activity were
modelled.
From gure 9.3d it is clear that the (normalised) WSS pattern is the same
for all the modelling strategies, despite the clearly dierent BCs that were
applied. Even the inclusion of the pulsatile nature of the blood ow (in
transient CFD and FSI) and/or the inclusion of the buering capacity of the
carotid artery (CA) (FSI) had little eect.
Although the normalised WSS patterns are similar, the absolute values
for the dierent simulations dier because the total ow through the spe-
cic geometry dier between the dierent simulations. Moreover, the FSI
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(a) Anaesthesia (b) Rest1 (c) Rest2 (d) Active1 (e) Active2
Figure 9.7: e OSI for mouse 3L under dierent circumstances: anaesthesia (a:
Anaesthesia), conscious-rest lower bound (b: Rest1), conscious-rest higher bound (c:
Rest2), high locomotor activity lower bound (d: Active1) and high locomotor activity
higher bound (e: Active2). ese circumstances were simulated by changing the
boundary conditions according to [27].
geometry gets inated during the simulations (gure 9.11: CFD-FSIcase0),
resulting in the globally lower WSS for the FSI simulation compared to the
transient CFD simulation.
e larger impact is found for parameters reecting the oscillatory be-
haviour of the WSS. Obviously, the steady state simulations cannot assess
the oscillatory behaviour of the WSS. In gure 9.4 on page 185, the OSI is
compared for transient CFD and FSI simulations.e clearly higher oscillat-
ory character of the ECA ow for the FSI simulations is due to the buering
of the CA.is results in a net instantaneous ow imbalance and thus a net
in/outow dierence in the model.erefore, the FSI boundary condition is
a less restrictive condition for small oscillations to occur compared to the
CFD simulations. For the CFD simulations there is always an instantaneous
balance of mass.
9.4.2 Inuence of anaesthesia and activity
Mohri et al. showed that lower ow measurements due to anaesthesia can
have a big inuence on the simulation results[8]. Similar to their results,
we also observed the presence of ow recirculation (in the ECA) when the
inuence of anaesthesia and locomotor activity are taken into account.ese
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(a) Anaesthesia (b) Rest1 (c) Rest2 (d) Active1 (e) Active2
Figure 9.8:eWSS in the conscious and active state at the early deceleration phase
for mouse 3L.e LIC is used to visualise recirculation zones in the WSS at the
anterior side of the ECA.e dierent calculated circumstances are: anaesthesia (a:
Anaesthesia), conscious-rest lower bound (b: Rest1), conscious-rest higher bound (c:
Rest2), high locomotor activity lower bound (d: Active1) and high locomotor activity
higher bound (e: Active2). ese circumstances were simulated by changing the
boundary conditions according to [27].
ow recirculations were present at the outer sinus of the ECA for both the
steady state and transient simulations. For the transient simulations they
were mainly present during the deceleration phase. As a result of the changed
BC (see table 9.1 on page 180) the peak systolic Reynolds number for the
CCA changes from 13.38 to 39.57 for the anaesthesia to the high locomotor
activity case. For the same cases the Womersley number increases from 0.44
to 0.70, indicating the possibility of changes in ow behaviour. Due to this
changed ow behaviour, the results of the simulations assuming anaesthesia
conditions should be interpreted with caution.
Nonetheless, the normalised TAWSS patterns for all these dierent and
heavily adapted conditions did not show clear dierences. erefore we
can conclude that the normalised TAWSS patterns are rather robust with
regard to dierent activity levels of a mouse. erefore, it makes sense to
identify zones with high/low TAWSS compared to the remainder of the
bifurcation/vasculature, because the location of these zones is robust with
regard to changing physical activity levels. Reporting and comparing absolute
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Figure 9.9: Flow recirculation in the ECA when in high locomotor activity (Active2)
for mouse 3L.e LIC is used to visualise recirculation zones in the mid plane of the
ECA. a)e dierent time points at which the velocity eld is shown in subgures
b, c,d and e
190
9.4. Discussion
Figure 9.10: Reversed WSS area[mm2] for the dierent simulation types with dier-
ent sets of BC mimicking anaesthetic, conscious and active conditions. Close up of
the transient CFD case 4 condition with the 2 dierent zones with reversed WSS
present: stagnation point (blue) and the outer sinus of the ECA (red)
values of the WSS/TAWSS on the other hand is much more subject to the
precise boundary conditions and level of physical activity that were applied
On the other hand, OSI shows a dierent distribution in the dierent
simulations (gure 9.7 on page 188).e location of the region with elevated
OSI is the same for those simulations, but the shape and size of this location
diers. Caution should be taken when comparing the actual values. e
largest dierences were seen in when simulating extensive locomotor activity
(cases Active1 and Active2).
It should be noted, however that the increase in blood ow through the
CCA at locomotor activity is probably overestimated in these simulations and
thus results in an worst case scenario.e ow rescaling fractions were based
on an increase of cardiac output measured by Janssen et al. [27] (similar to
what Mohri et al. did [8]). At high locomotor activity, the cardiac output
increases but this is mainly because of an increase in blood ow towards the
skeletal muscles [33]. e main perfusion area of the CA is the brain. In
humans, the rise in cerebral blood ow only peaks at the onset of physical
activity and decreases during constant physical activity, while the cardiac
output is still at an elevated level [34]. Hiura et al. quantied the initial
increase due to physical exercise (steady-state cycling) for healthy humans to
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Figure 9.11: Cross-sectional area at the boundaries for the dierent simulation types.
e CFD simulations have a constant cross-sectional area. e FSI simulations
inate the artery, resulting in the sameminimal area but higher mean andmaximum
areas at higher distensions. For cases Anaesthesia, Rest1 and Rest2 the windkessel
pressure does not change, resulting in the same (not plotted) areas (within a 1%
margin). For cases Active1 and Active2 the pressure is increased, resulting in an even
further ination of the artery.
be 27.9±28.6% and the increase during prolonged exercise to be 2.6±13.5%.
Both of these changes are smaller than the increase in cardiac output with
respectively 92% and 118% [35].erefore, it is likely that in mice the change
in blood ow through the CA is smaller than the change in cardiac output
during exercise. If the blood ow to the brain is assumed to be constant
during this (prolonged) locomotor activity, cases Active1 and Active2 should
be ignored and Rest2 is the most extreme case. Rest2 is right at the border of
the initiation of recirculation in this geometry.erefore, under the constant
blood ow assumption it is dicult to say if recirculation will be present or
not (Rest2 is an upper bound for the inuence of anaesthesia).
9.4.3 Conclusion
Simple steady state CFD simulations can be used to assess the WSS pattern
in the murine carotid bifurcation. However, the average WSS value diers
between dierent simulation strategies. To be able to assess the oscillatory
behaviour (OSI) of the WSS, the buering eect of the elastic CA should
be taken into account and FSI simulations are indispensable.e eect of
anaesthesia and locomotor activity on the WSS patterns is minimal, but
absolute levels are likely dierent. Our simulations show that it is possible
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that ow recirculation and WSS reversal could occur when the mice are in a
high locomotor activity state.
193
9. Comparison of numerical methodologies to assessWSS
Bibliography Chapter 9
[1] V. Peier, S. J. Sherwin and P. D. Weinberg, ‘Does low and oscillatory
wall shear stress correlate spatially with early atherosclerosis? A sys-
tematic review’, Cardiovascular Research, vol. 99, no. 2, pp. 242–250,
2013.
[2] D. N. Ku, D. P. Giddens, C. K. Zarins and S. Glagov, ‘Pulsatile ow and
atherosclerosis in the human carotid bifurcation. Positive correlation
between plaque location and low oscillating shear stress.’ Arterioscler-
osis, vol. 5, no. 3, pp. 293–302, 1985.
[3] Y. S. Chatzizisis, A. U. Coskun,M. Jonas, E. R. Edelman, C. L. Feldman
and P. H. Stone, ‘Role of endothelial shear stress in the natural his-
tory of coronary atherosclerosis and vascular remodeling: molecular,
cellular, and vascular behavior.’ Journal of the American College of
Cardiology, vol. 49, no. 25, pp. 2379–93, 2007.
[4] T. Asakura and T. Karino, ‘Flow patterns and spatial distribution of ath-
erosclerotic lesions in human coronary arteries’, Circulation Research,
vol. 66, no. 4, pp. 1045–1066, 1990.
[5] A. Gnasso, C. Irace, C. Carallo,M. S. De Franceschi, C.Motti, P. L.Mat-
tioli and A. Pujia, ‘In Vivo Association Between LowWall Shear Stress
and Plaque in Subjects With Asymmetrical Carotid Atherosclerosis’,
Stroke, vol. 28, no. 5, pp. 993–998, 1997.
[6] Y. Nakashima, A. S. Plump, E. W. Raines, J. L. Breslow and R. Ross,
‘ApoE-decient mice develop lesions of all phases of atherosclerosis
throughout the arterial tree’,Arteriosclerosis,rombosis, and Vascular
Biology, vol. 14, no. 1, pp. 133–140, 1994.
[7] G. S. van Bochove, R. Straathof, R. Krams, K. Nicolay andG. J. Strijkers,
‘MRI-determined carotid artery ow velocities and wall shear stress
in a mouse model of vulnerable and stable atherosclerotic plaque.’
Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 23,
no. 2, pp. 77–84, 2010.
[8] Z. Mohri, E. M. Rowland, L. A. Clarke, A. De Luca, V. Peier, R.
Krams, S. J. Sherwin and P. D. Weinberg, ‘Elevated Uptake of Plasma
Macromolecules by Regions of Arterial Wall Predisposed to Plaque
Instability in a Mouse Model’, PLoS ONE, vol. 9, no. 12, e115728, 2014.
[9] C. Cheng, R. de Crom, R. van Haperen, F. Helderman, B. Mousavi
Gourabi, L. C. a. van Damme, S. W. Kirschbaum, C. J. Slager, A. F. W.
van der Steen and R. Krams, ‘e role of shear stress in atherosclerosis:
action through gene expression and inammation?’, Cell biochemistry
and biophysics, vol. 41, no. 2, pp. 279–294, 2004.
194
Bibliography Chapter 9
[10] A. Feintuch, P. Ruengsakulrach, A. Lin, J. Zhang, Y.-Q. Zhou, J. Bishop,
L. Davidson, D. Courtman, F. S. Foster, D. A. Steinman, R. M. Hen-
kelman and C. R. Ethier, ‘Hemodynamics in the mouse aortic arch
as assessed by MRI, ultrasound, and numerical modeling.’ American
journal of physiology. Heart and circulatory physiology, vol. 292, no. 2,
H884–H892, 2007.
[11] P. Ruengsakulrach, A. K. Joshi, S. Fremes, S. Foster, J. BUTANY, B.
Wiwatanapataphee and Y. Lenbury, ‘Wall shear stress and atherosclero-
sis: numerical blood ow simulations in the mouse aortic arch’,Wseas
Transactions on Fluid Mechanics, vol. 3, no. 2, pp. 90–100, 2008.
[12] H. Zhu, J. Zhang, J. Shih, F. Lopez-Bertoni, J. R. Hagaman, N. Maeda
and M. H. Friedman, ‘Dierences in aortic arch geometry, hemody-
namics, and plaque patterns between C57BL/6 and 129/SvEv mice.’
Journal of biomechanical engineering, vol. 131, no. 12, p. 121 005, 2009.
[13] B. Trachet, A. Swillens, D. Van Loo, C. Casteleyn, A. De Paepe, B.
Loeys and P. Segers, ‘e inuence of aortic dimensions on calcu-
lated wall shear stress in the mouse aortic arch.’ Computer methods in
biomechanics and biomedical engineering, vol. 12, no. 5, pp. 491–499,
2009.
[14] B. Trachet, A. Swillens, D. Loo, C. Casteleyn, A. De Paepe, B. Loeys
and P. Segers, ‘Wall shear stress in the mouse aortic arch: does size
matter?’, in 4th European Conference of the International Federation
for Medical and Biological Engineering, Springer, 2009, pp. 1994–1998.
[15] P. Assemat, J. A. Armitage, K. K. Siu, K. G. Contreras, A. M. Dart,
J. P. Chin-Dusting and K. Hourigan, ‘ree-dimensional numerical
simulation of blood ow in mouse aortic arch around atherosclerotic
plaques’, Applied Mathematical Modelling, vol. 38, no. 17-18, pp. 4175–
4185, 2014.
[16] P. Assemat, K. K. Siu, J. Armitage, S. N. Hokke, A. Dart, J. Chin-
Dusting and K. Hourigan, ‘Haemodynamical stress in mouse aortic
arch with atherosclerotic plaques: Preliminary study of plaque pro-
gression’, Computational and Structural Biotechnology Journal, vol. 10,
no. 17, pp. 98–106, 2014.
[17] J. Suo, D. E. Ferrara, D. Sorescu, R. E. Guldberg, W. R. Taylor and D. P.
Giddens, ‘Hemodynamic shear stresses in mouse aortas: implications
for atherogenesis.’ Arteriosclerosis, thrombosis, and vascular biology,
vol. 27, no. 2, pp. 346–51, 2007.
195
9. Comparison of numerical methodologies to assessWSS
[18] J. M. Greve, A. S. Les, B. T. Tang, M. T. Draney Blomme, N. M.Wilson,
R. L. Dalman, N. J. Pelc and C. a. Taylor, ‘Allometric scaling of wall
shear stress from mice to humans: quantication using cine phase-
contrast MRI and computational uid dynamics.’ American journal of
physiology. Heart and circulatory physiology, vol. 291, no. 4, H1700–8,
2006.
[19] B. Trachet, M. Renard, G. De Santis, S. Staelens, J. De Backer, L. Antiga,
B. Loeys and P. Segers, ‘An Integrated Framework to Quantitatively
Link Mouse-Specic Hemodynamics to Aneurysm Formation in An-
giotensin II-infused ApoE -/- mice.’ Annals of biomedical engineering,
vol. 39, no. 9, pp. 2430–2444, 2011.
[20] M. D. Ford, A. T. Black, R. Y. Cao, C. D. Funk and U. Piomelli, ‘Hemo-
dynamics of the mouse abdominal aortic aneurysm.’ Journal of bio-
mechanical engineering, vol. 133, no. 12, p. 121 008, 2011.
[21] Y. Huo, X. Guo and G. S. Kassab, ‘e ow eld along the entire
length of mouse aorta and primary branches.’ Annals of biomedical
engineering, vol. 36, no. 5, pp. 685–699, 2008.
[22] B. Trachet, J. Bols, G. De Santis, S. Vandenberghe, B. Loeys and P.
Segers, ‘e Impact of Simplied Boundary Conditions and Aortic
Arch Inclusion on CFD Simulations in the Mouse Aorta: A Compar-
ison With Mouse-specic Reference Data’, Journal of Biomechanical
Engineering, vol. 133, no. 12, p. 121 006, 2011.
[23] M. Van Doormaal, Y.-Q. Zhou, X. Zhang, D. a. Steinman and R. Mark
Henkelman, ‘Inputs for Subject-Specic Computational Fluid Dy-
namics Simulation of Blood Flow in the Mouse Aorta’, Journal of
Biomechanical Engineering, vol. 136, no. 10, p. 101 008, 2014.
[24] Y. Hoi, Y.-Q. Zhou, X. Zhang, R. M. Henkelman and D. A. Steinman,
‘Correlation between local hemodynamics and lesion distribution in a
novel aortic regurgitation murine model of atherosclerosis.’ Annals of
biomedical engineering, vol. 39, no. 5, pp. 1414–22, 2011.
[25] D. De Wilde, B. Trachet, N. Debusschere, F. Iannaccone, A. Swillens,
J. Degroote, J. Vierendeels, G. R. De Meyer and P. Segers, ‘Assessment
of shear stress related parameters in the carotid bifurcation using
mouse-specic FSI simulations’, Journal of Biomechanics, In press,
2015.
[26] B. Trachet, J. Bols, J. Degroote, B. Verhegghe, N. Stergiopulos, J. Vier-
endeels and P. Segers, ‘An Animal-Specic FSI Model of the Abdom-
inal Aorta in Anesthetized Mice’, Annals of Biomedical Engineering,
vol. 43, no. 6, pp. 1298–1309, 2015.
196
Bibliography Chapter 9
[27] B. J. a. Janssen, T. De Celle, J. J. M. Debets, A. E. Brouns, M. F. Callahan
and T. L. Smith, ‘Eects of anesthetics on systemic hemodynamics in
mice.’American journal of physiology. Heart and circulatory physiology,
vol. 287, no. 4, H1618–H1624, 2004.
[28] V. Komarek, ‘Normative Biology, Husbandry, and Models - Mouse
Physiology’, ine Mouse in Biomedical Research, II, vol. III, Elsevier,
2007, ch. 2, pp. 23–90.
[29] D. De Wilde, B. Trachet, C. Van der Donckt, B. Vandeghinste, B.
Descamps, C. Vanhove, G. R. Y. De Meyer and P. Segers, ‘Vulner-
able plaque detection and quantication with gold particle-enhanced
computed tomography in atherosclerotic mouse models.’Molecular
imaging, vol. 14, pp. 9–19, 2015.
[30] J. Bols, L. Taelman, G. De Santis, J. Degroote, B. Verhegghe, P. Segers
and J. Vierendeels, ‘Unstructured hexahedral mesh generation of com-
plex vascular trees using amulti-block grid-based approach’,Computer
Methods in Biomechanics and Biomedical Engineering, pp. 1–10, 2015.
[31] P. Moireau, N. Xiao, M. Astorino, C. A. Figueroa, D. Chapelle, C. A.
Taylor and J.-F. Gerbeau, ‘External tissue support and uid-structure
simulation in blood ows.’ Biomechanics and modeling in mechanobio-
logy, vol. 11, no. 1-2, pp. 1–18, 2012.
[32] J. L. Van Herck, G. R. De Meyer, W. Martinet, C. E. Van Hove, K.
Foubert, M. H.eunis, S. Apers, H. Bult, C. J. Vrints and A. G. Her-
man, ‘Impaired Fibrillin-1 Function Promotes Features of Plaque In-
stability in Apolipoprotein E-Decient Mice’, Circulation, vol. 120, no.
24, pp. 2478–2487, 2009.
[33] E. N. Marieb and K. Hoehn, ‘Anatomy & Physiology’, Pearson In.
Pearson Benjamin Cummings, 2008.
[34] J. S. Querido and a.W. Sheel, ‘Regulation of cerebral blood ow during
exercise.’ Sports medicine (Auckland, N.Z.), vol. 37, no. 9, pp. 765–82,
2007.
[35] M. Hiura, T. Nariai, K. Ishii, M. Sakata, K. Oda, J. Toyohara and K.
Ishiwata, ‘Changes in cerebral blood ow during steady-state cycling
exercise: a study using oxygen-15-labeled water with PET’, Journal of
Cerebral Blood Flow &Metabolism, vol. 34, no. 3, pp. 389–396, 2014.
197

C
h
a
p
t
e
r
10
Correlation between
atherosclerosis and shear
stress metrics in the carotid
arteries of mice developing
atherosclerosis ∗
10.1 Introduction
Atherosclerosis is a slowly progressing chronic inammatory disease of the
medium-sized and large arteries characterised by the development of athero-
sclerotic plaques.ese atherosclerotic plaques consist of lipids accumulating
in the arterial wall and inammatory cells (including macrophages) [1]–[4].
Haemodynamics is generally assumed to play a crucial role in the initialisa-
tion and development of atherosclerosis.is is mediated by the shear forces
that the blood ow exerts on the endothelial cells, with zones experiencing
low and oscillatory shear stresses being more prone to the development of
atherosclerosis [5], [6]. CFD allow researchers to obtain precise local shear
stress distributions. However, it is not straightforward to link shear stress
∗is chapter is based on the work: D. De Wilde, B. Trachet, G. R. Y. De Meyer
and P. Segers, ‘Shear stress metrics and their relation to atherosclerosis: an in vivo
follow-up study in atherosclerotic mice’, Annals of Biomedical Engineering, In press,
2016
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patterns calculated by CFD to atherosclerosis development, as described in
detail by Peier et al. in their systematic review [7].
A rst important problem is that atherosclerosis develops slowly with
the disease altering arterial geometry, hereby changing the shear stress dis-
tributions that occur. erefore two conicting types of data are needed
for within-subject association studies of shear stress patterns and plaque
initiation. First, measurements in a non-diseased condition (i.e. vascular geo-
metry and ow information for the boundary conditions) are indispensable
to set up an accurate CFD model of the reference state. Second, the plaque
distribution in the arteries needs to be quantied aer plaque initiation and
progression. Due to the slow progression of atherosclerosis in humans, it
is almost impossible to assess the pre- and post-disease state in the same
subject. A second limitation of the current scientic evidence with regard to
the association between atherosclerosis and (low and oscillatory) wall shear
stress, is that it is not straightforward to quantitatively link the shear stress
distribution with the plaque initiation metric. Regression analysis is most
commonly used to study their association [8], [9]. However, this analysis
presumes a linear relationship between both variables, which is not valid
a priori. Moreover, a linear regression analysis implicitly assumes that the
dierent observations are mutually independent. Peier et al. showed that
neither of these assumptions can be justied and proposed a novel method
for quantifying spatial correlations between shear stress distributions and
patterns of atherosclerosis: the surrogate sample data analysis [10]. With
this technique none of the assumptions that are required for the regression
analysis, have to be made. Rowland et al. showed that using this technique
the correlation coecient, including its condence interval (CI), can be
calculated [11].
Another challenge is to quantify the impact of the ow eld and to select
the appropriate HWP. Over the past decades, several metrics have been
introduced, ranging from simple time-averaged wall shear stress values to
more complex parameters accounting for the directionality of the shear stress.
To the best of our knowledge, there is no consensus on which HWP provides
the strongest association with the location of atherosclerosis. Most studies
focusing on the correlation between HWPs and atherosclerosis development
are limited to the classical magnitude-based HWPs (TAWSS, OSI and RRT),
but even for these parameters no consensus is reached [7].
Chapter 7 describes a novel methodology to quantify macrophage inlt-
ration in vivo in atherosclerotic plaques in the carotid bifurcation of ApoE−/−
andApoE−/− Fbn1C1039G+/−mice [4]. When fed aWestern type diet, ApoE−/−
mice develop stable atherosclerotic plaques, which are morphologically sim-
ilar to human plaques [12]–[14]. Our experimental protocol consisted of
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repeated gold-nanoparticle-enhanced µCT scans and we demonstrated that
the contrast agent accumulates in the macrophage rich regions of the plaque
over time [15]. In chapter 8 we performed FSI simulations in the carotid
bifurcation of ApoE−/− mice. We calculated detailed and realistic shear stress
metrics based on subject-specic in vivomeasurements that were acquired
before any atherosclerosis was present [16].e baseline data used for the
computational analysis were obtained in the same animals in which macro-
phage inltration and plaque formation were studied for the experimental
analysis.
In the present chapter, we link the results of the computational chapter (i.e.
FSI calculated shear stress patterns prior to plaque formation) to the results
of our experimental chapter (i.e. distribution of macrophage inltration as a
marker for plaque formation). At the individual bifurcation level we applied
the surrogate sample data analysis technique suggested by Peier et al. [10],
to test for a spatial correlation between the shear stress patterns occurring
before plaque development and the macrophage distribution within the
plaque aerwards. At the population level, a one sample t-test was applied
at the paired shear stress and lesion patterns to assess the correlation at the
population level as suggested by Rowland et al. [11]. We also compared some
of the most commonly used shear stress metrics with more recently dened
metrics such as transWSS [17] and harmonic-based indices [18], [19].
10.2 Materials andMethods
10.2.1 Mice
is study was performed on a subset (4 female ApoE−/− mice) of data
that was available from previous studies [15], [16], and we refer to these
studies for details regarding the experimental methods. All experiments
were conducted according to the EC guidelines and were approved by the
animal ethics committee of Ghent University (ECD 12/26). Animals were
fed a Western type diet (TD88137, Harlan Teklad, Madison, Wis, USA) from
the age of 6 to 26 weeks. At weeks 10, 15 and 20 aer the start of the diet
(mice aged 16, 21 and 26 weeks), the animals underwent an imaging protocol
consisting of µCT and US. HWPs were obtained from FSI simulations at
week 10 in all 4 animals, and for both the le and right carotid territory. As
for the contrast accumulation data, data from 2 out of 4 animals at week 15
had to be excluded due to motion artefacts during the µCT measurements.
At week 20, one of the 4 animals had developed a severe stenosis preventing
a correct segmentation of the right carotid bifurcation (ECA).
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10.2.2 In vivo measurements and FSI simulations
At the three time points, the µCT protocol consisted of a measurement before
and aer the injection of 100 µl/25g body weight Aurovist (Nanoprobes,
Yaphank, NY, USA), which accumulated over time in the macrophages of the
atherosclerotic plaques located near the carotid bifurcation. As such, µCT
measurements performed at weeks 15 and 20 enabled the visualisation of
contrast accumulation, and thus macrophage inltration, in the arterial wall.
To quantify contrast accumulation, the proportional length of the normal
(total length of 0.3 mm) was calculated with respect to the luminal surface
with contrast, as shown in gure 10.1 1G. Further details are provided in [15].
Mouse-specic FSI simulations in the le and right carotid bifurcation
were performed based on measurements at week 10. At this time, no signs
of inward remodelling could be detected, and we considered the blood ow
and haemodynamic wall parameters to be equivalent to the situation prior
to the onset of atherosclerosis.e segmented µCT geometry was used for
the vascular model, PW Doppler US provided velocity waveforms and M-
mode US measurements provided diameter curves that served as boundary
conditions. Further methodological details are provided in [16].
10.2.3 Derived haemodynamic wall parameters
We considered two groups of HWPs, proposed over the past decades in liter-
ature as quantitative markers capable of identifying “disturbed” blood ow:
the magnitude-based and the harmonic-based. Magnitude-based parameters
are TAWSS, OSI [20], RRT [21] and the transWSS [17]. In the group of the
harmonic-based parameters, the DH [18] and the HI [19] were calculated.
transWSS = 1
T ∫ T0 RRRRRRRRRRRτ⃗ ⋅ (n⃗ × τ⃗mean∥τ⃗mean∥)
RRRRRRRRRRR dt with τ⃗mean = ∫
T
0
τ⃗ dt
(10.1)
DH = n ∋ max (F (nω0)) , F ≡ FFT (∥τ⃗∥) , ω0 = 2piT (10.2a)
HI = ∑∞n=1 F (nω0)∑∞n=0 F (nω0) , F ≡ FFT (∥τ⃗∥) , ω0 = 2piT (10.2b)
In a previous chapter (chapter 8 on page 149), the TAWSS, the OSI and
RRT are already described in more detail for the current datasets and the
formulas are shown in equation (8.1). How to calculate the more recently
developed metrics is shown in equation (10.1) and equation (10.2). In these
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formulas τ⃗ is the instantaneous wall shear stress vector, τ⃗mean the cycle-av-
eraged wall shear stress vector and T the period of the cardiac cycle. e
movement of the arterial wall in the FSI simulations was taken into account
by expressing τ⃗ in a local frame of reference attached to the arterial wall.
For the fast Fourier transformation (FFT), the parameters are the funda-
mental frequency ω0 and the harmonic index n so that n ω0 indicates the
nth harmonic.
10.2.4 Mapping the carotid bifurcation
A rst step to correlate the FSI simulations with macrophage inltration was
to map the bifurcation surface, segmented from measurements at dierent
time points, onto a commonmesh. A centreline-based approach usingVMTK
(www.vmtk.org) was followed as proposed by Antiga and Steinman [22].
e bifurcation was split into its 3 main branches (CCA, ECA and ICA).
e distance to the bifurcation was chosen as longitudinal coordinate, while
the angle around the centreline was taken as circumferential coordinate
(ranging from –pi to +pi at the medial side of the bifurcation normal, from
medial to posterior, lateral, anterior and nally medial; gure 10.1 1). It is
important to keep in mind that for the le and right bifurcations, the rotation
is opposite (medial-lateral axis is ipped).en, the longitudinal and angular
coordinates were mapped onto a planar rectangular grid (gure 10.1 1D-1H).
e grid contained 100 cells in the circumferential direction (resolution
0.0628 rad) and in the longitudinal direction the resolution was 13.5 µm,
which resulted in square cells for the average CCA.e ow extensions of
the FSI simulations were cut o at the ECA (30 cells) and the CCA (10 cells)
to remove transient in/outow phenomena.
10.2.5 Statistical modelling
At the individual bifurcation level, a single lesion map was compared to
a single shear stress map. We applied the surrogate sample data analysis,
proposed by Peier et al. [10], to study correlations between the calculated
haemodynamic wall parameters and macrophage inltration maps. In short,
the similarity of the distribution of two dierent variables (HWP and contrast
accumulation) is described by Spearman’s rank correlation coecient ρs
(adapted from the algorithmdescribed byRowland et al. [11]).e correlation
is determined for the original values of the variables and for nsur scrambled
distributions of one of the variables (=surrogates).
For the interpretation of the data, a distinction needs to be made be-
tween TAWSS, where low values are associated with the susceptibility for
atherosclerosis (negative correlation expected), and the other HWP where
high values are associated with plaque susceptibility (positive correlation
expected). In the case of a negative correlation (TAWSS), one should test
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Figure 10.1: Virtually cutting open the 3D geometry of the carotid bifurcation:
the FSI (top: A-D) and week 20 µCT dataset contrast-enhancement map (bottom:
E-H) of an example mouse. e rst coordinate used for the cutting open is the
distance along the centreline (A/E).e second coordinate is the circumferential
angle ranging from –pi...pi (B/F). Both coordinates are mapped to the 2D space for
every branch.e cutting line is taken at the medial side and perpendicular to the
bifurcation. Next are example parameters for both cases: FSI - TAWSS (C) and week
20 – contrast presence (G). Figure D shows the opened TAWSS map.e horizontal
axis loops through consecutively the medial, posterior, lateral, anterior and medial
side while ranging from –pi to pi. e lateral side is indicated with a dashed line,
splitting the patch in the posterior and anterior side. Figure H shows the cut open
representation of the plaque presence map.
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whether the correlation coecient is below the 5% percentile of the random
distributions (i.e. the le-hand side of the histogram – le tailed test). For
positive correlations, the statistical test ascertains that the original correlation
coecient is higher than the 95% percentile of the random distributions (i.e.
the right-hand side of the histogram – right tailed test).
To take into account the spatial autocorrelation of the variables, extra
sampling steps (nsmp) were performed.e sample size ssmp was calculated for
every geometry using: ssmp = smap/ldec2. In this formula smap was the original
number of grid points and ldec the spatial de-correlation length, which was
determined with a tailored approach as described in [10] for all the branches
separately and all the dierent HWPs.is resulted in average values for the
ldec of 15.42±4.61, 14.90±2.76, 15.35±4.38, 19.05±6.35 and 16.57±5.46 for the
TAWSS, OSI, RRT, transWSS and HI respectively. A conservative value of
20 was used for ldec in all the surrogate sample data analysis calculations to
assure that all sample points were independent observations and that proper
statistical testing was conducted.e nal histogram was averaged over nsmp
histograms (one for each sampling step), with condence levels as shown in
gure 10.2. An error tolerance of 10−4 was used for the p-value resulting in
averaged values of: nsur = 2600 and nsmp=3300.is technique was used to
calculate the correlation between the distribution of the HWP (TAWSS, OSI,
RRT, transWSS, DH or HI) on the one hand and the macrophage inltration
distribution at weeks 15 or 20 on the other hand. From the correlations found
between the dierent samples, a condence interval could be calculated as
shown by Rowland et al. [11]. In the current study the condence bound
(CB) was used instead, which is more appropriate for a single tailed test.e
found correlation was deemed signicant at p<0.05 if the upper condence
bound (UCB)<0 for a le tailed test (expected ρs<0 - TAWSS) or the lower
condence bound (LCB) >0 for a right tailed test (expected ρs>0 – other
HWP).is was done both on an individual branch level, only considering
one branch for every statistical test, and on a bifurcation level, combining
the three branches into a single statistical test.
On the bifurcation level a correlation coecient was found for 7 indi-
vidual bifurcations (1 dataset was excluded). On the population level, we
studied both the Spearman’s rank correlation coecient (ρs)(assumingmono-
tonic relationship) and the Pearson’s correlations coecient (r) (assuming
linear relationship). First a Fisher r to z transformation was applied because
correlation coecients are not normally distributed [11]. A single tailed one
sample t-test was performed to assess if the found correlation was signicant.
Next to the previous ‘paired’ approach, an aggregate approach was per-
formed. Aggregated datasets were obtained by averaging the 7 datasets ob-
tained at week 20. Aerwards, the aggregated lesion map was compared to
the aggregated HWP maps using the surrogate sample data analysis method.
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Finally, we also tested the relationship between the dierent haemody-
namic wall parameters. A similar t-test method was applied to the HWP
maps to check the correlation between the several HWPs. Since the sign of
the expected correlations was unknown, a two tailed test was used in this
case.
10.3 Results
10.3.1 Contrast (plaque) accumulation
Limited contrast inltrationwas present at week 15. On average there was only
contrast present (contrast-enhancement over >25% of the normal length) for
0.47±0.58, 2.48±1.30 and 1.19±0.74 %area of the lumen area of the CCA, ECA
and ICA, respectively.is resulted in an average of 1.07±0.59%area for the
complete bifurcation. With exception of 1 animal and for one bifurcation (4R;
0.39%area), there was a clear increase in contrast accumulation from week 15
to week 20 with values at week 20 of 4.4±1.8, 40.2±12.0, 19.1±10.1 %area for
the CCA, ECA and ICA respectively.e extent of contrast accumulation is
thus relatively mild in the common carotid artery, and most outspoken in
the external carotid artery
10.3.2 Haemodynamics vs. atherosclerosis in individual branches
At week 15 no signicant correlations were found for the individual branches
for either of the HWPs.e average ρs for the RRT was: CCA = 0.020, ECA
= -0.145 and ICA= 0.118.e p-values were larger than: 0.12 (TAWSS), 0.12
(OSI), 0.14 (RRT), 0.25 (transWSS), 0.3 (HI) and 0.67 (DH).
At week 20, on an individual branch level, the surrogate data sample anal-
ysis revealed a signicant positive correlation (p<0.05 and LCB>0) between
RRT and the amount of plaque accumulation in 4 out of 7 cases in the CCA
(table 10.1). No statistically signicant results were found for either the ECA
or the ICA. In gure 10.4 a visual side by side comparison of (i) the amount
of macrophage inltration at week 20 and (ii) the RRT at week 10 is given for
the 7 bifurcations. In the CCA the visual comparison shows that high values
of macrophage inltration and RRT occur close to the bifurcation. In the
ECA and the ICA the spatial distribution is visually more dierent for both
metrics as shown by the statistical analysis.
e same statistical trend was observed for OSI (2 times p<0.05 and
LCB>0 – positive correlation) and TAWSS (4 times p<0.05 and UCB<0
–negative correlation) in the CCA. For both of these parameters, no signicant
correlation was found for the ECA or ICA branch in any of the animals.e
transWSS resulted in 2 CCA branches with p<0.05 but not LCB>0 and no
signicant correlation in any of the ECA or ICA branches. For neither DH
nor HI a signicant correlation was found in any of the branches.
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Table 10.1: Spearman’s rank correlation coecient (ρs) between the macrophage
inltration at week 20 and the calculated RRT for the three branches of the le and
right carotid bifurcation. Values showing signicance in the surrogate data analysis
for both conditions (p<0.05 and LCB>0) are indicated by a *. For the right carotid
bifurcation of mouse 1 (1R), severe stenosis inhibited the segmentation of the ECA
and consequently this bifurcation was removed from the analysis.
Mouse CCA ECA ICA
1L 0.285* 0.055 0.215
1R - - -
2L 0.275* 0.046 0.181
2R 0.331* 0.166 0.26
3L 0.073 -0.554 -0.178
3R 0.254* 0.107 -0.045
4L 0.134 0.114 -0.354
4R -0.175 -0.013 0.083
10.3.3 Haemodynamics vs. atherosclerosis in the complete bifurcation
At week 15, our ndings did not change when considering the complete bifur-
cation. None of the classical HWPs correlated signicantly with macrophage
inltration aer 15 weeks with p-values larger than: 0.39 (TAWSS), 0.23 (OSI),
0.35 (RRT), 0.057 (transWSS), 0.19 (HI) and 0.54 (DH).e DH only diered
from the ground harmonic (value = 1) for 0.65±0.67% of the surface, and
therefore had a constant value throughout almost the entire bifurcation.
In the second row of gure 10.2, the results at week 15 of the le bifur-
cation of mouse 1 are shown. e thick black line shows ρs between the
macrophage inltration at week 15 and the respective HWPs (TAWSS, OSI,
RRT, transWSS and HI).e signs of both ρs and its CB (dashed line) are
opposite to their theoretically expected values (negative values expected for
TAWSS and positive values for OSI, RRT, transWSS and HI) for all HWPs
except for the transWSS.us, ρs=0 is included in the interval conned by
the CB. Moreover, p>0.05 in these cases and thus none of the conditions for
signicance is met. For the transWSS ρs=0 is not included in the LCB but
still p>0.05, indicating that the correlation is not signicant.
However, aer 20 weeks a signicant negative correlation (p<0.05 and
UCB<0) was found in 4 cases (1L, 2L, 2R and 3R) for TAWSS (table 10.2).e
RRT yielded similar results but with a signicant positive correlation for the
same 4 cases. A visual comparison of the macrophage inltration at week
20 and the RRT for these bifurcations is given in gure 10.4.e OSI only
correlated for 2 cases (1L and 3R).e transWSS showed a signicant positive
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Table 10.2: Spearman’s rank correlation coecient (ρs) between the simulatedHWPs
at week 10 and the macrophage inltration at week 20 on the individual bifurcation
level. Values showing signicance (p<0.05 and UCB<0 for ρs<0 or LCB>0 for
ρs>0) are indicated by a *. It should be noted that in the bifurcation 4R almost no
atherosclerosis was present.
TAWSS OSI RRT transWSS HI DH
1L -0.203* 0.224* 0.197* 0.203* 0.068 -0.043
1R - - - - - -
2L -0.284* 0.157 0.288* 0.009 0.109 0.058
2R -0.244* 0.145 0.251* 0.119 0.056 0.016
3L 0 -0.108 0.007 0.068 -0.044 0.015
3R -0.337* 0.317* 0.338* 0.052 0.276* 0.004
4L 0.018 0.082 0.003 0.384* -0.034 0.028
4R 0.046 -0.003 -0.051 0.002 -0.027 0.035
correlation for mice 1L and 4L. Mouse 3R showed a positive correlation for
HI. No signicant correlation could be found for DH.
For mouse 1L the last row of gure 10.2 shows a signicant negative
correlation for TAWSS (p<0.05 and both ρs and its UCB are negative), as
evidenced by a 1-tailed test. For the OSI and the RRT on the other hand, a
signicant positive correlation was found (p<0.05 and both ρs and its LCB
are positive).
10.3.4 Haemodynamics vs. atherosclerosis on a population level
In table 10.3 the Spearman’s rank correlation coecient (ρs) and the Pearson’s
correlation coecient (r) are listed for the population (N=7) at week 20.
e correlation coecient is low (ρs < 0.15) for all wall shear stress metrics.
On average the TAWSS shows a negative correlation (-0.144) and the other
metrics show on average a positive correlation. For the TAWSS, OSI, RRT and
transWSS this correlation is signicant (p<0.05).e Pearson’s correlation
coecient (r) shows the same trends as ρs . In this case, a signicant positive
population correlation was found for OSI (0.160), RRT (0.232) and HI (0.129).
e statistical test on the aggregated datasets showed that the correlation was
higher, but still the same HWPs showed a signicant correlation (TAWSS,
OSI, RRT and transWSS).
10.3.5 Comparison of the HWPs
10.3.5.1 Visual comparison for a single bifurcation
A graphical overview of the interdependence of the HWPs for the carotid
bifurcation of mouse 3L is shown in gure 10.3. is gure is a slightly
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Table 10.3: Overview of the population average correlation between several HWPs
at week 10 and the macrophage inltration at week 20. Both ρs and r are listed. Sig-
nicant results (p<0.05) are annotated by *. Between brackets the p-value resulting
from a one sample single tailed t-test is shown.e last two row shows the results for
the surrogate sample data analysis applied to the aggregate datasets (-agg) for both
ρs and r. Signicant results meeting the two signicance conditions are annotated
by a *. For the ρs RRT, only one signicance condition is met (p<0.05 but LCB<0),
which is indicated by °.
TAWSS OSI RRT transWSS HI
ρs -0.144*
(0.027)
0.118*
(0.034)
0.148*
(0.024)
0.121*
(0.031)
0.057
(0.118)
r -0.080
(0.183)
0.160*
(0.006)
0.232*
(0.013)
0.039
(0.267)
0.129*
(0.049)
ρs-agg -0.200*
(0.024)
0.196*
(0.028)
0.201°
(0.025)
0.401*
(0.000)
-0.113
(0.863)
r-agg -0.134
(0.091)
0.489*
(0.000)
0.575*
(0.000)
0.132
(0.108)
0.236*
(0.009)
adapted scatterplot matrix. It contains three kinds of plots in structured way:
on the diagonal the histogram of a single HWP is shown, below the diagonal
scatterplots show the correlation between HWP-pairs and above the diagonal
this correlation between two HWPs is visualised using a hexbin plot.
Every plot on the diagonal shows the distribution of a dierent HWP
by plotting the histogram.e x-axis represents the range of values of the
HWP of the subsequent column (x-axes are shared for each column).e
CCA, ECA and ICA are shown in red, blue and green respectively as a
stacked barchart. As a result the histogram of the whole bifurcation (over all
three branches) is represented by the total length of each bar (adding up the
dierent colours/branches) and it is delineated by a small black line. For the
TAWSS (upper le corner) two clear peaks are visible in the histogram for
the ECA (lowest) and CCA (middle).e ICA does not really show a specic
peak but the highest TAWSS values are present in this branch. e x-axis
(that depicts TAWSS) is shared with for example the scatter plot comparing
TAWSSwithOSI (directly below the histogram: second row and rst column).
erefore, the points of the ECA (blue +) are located directly under the blue
ECA peak in the histogram. For both the OSI and RRTmost striking is a right
handed tail (high values) for the ECA branch.is indicates that the highest
values of the respective HWP is found in the ECA branch. e transWSS
shows a right handed tail for the ICA with lower values for both the ECA
and CCA.e HI clearly shows a peak for the three dierent branches with
high values of HI present in the ECA.
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Figure 10.3: Scatterplot matrix of the HWPs in the murine carotid bifurcation (3L):
TAWSS[Pa], OSI[-], RRT[-], transWSS[Pa] and HI[-]. On the diagonal of the matrix,
the histograms of the dierent HWPs are plotted for the three branches (CCA-red,
ECA-blue and ICA-green).e total histogram is delineated by a black line. Below
the diagonal, scatter plots are shown for 500 random points of the surface mesh.
On the x-axis, the HWP of the subsequent column is shown and the y-axis shows
the HWP according to the subsequent row. ese scatter plots can show a clear
correlation (example: scatter plot at row 3-RRT and column 1-TAWSS) or can show
the absence of a correlation (example: scatter plot at row 4-transWSS and column
2-OSI). Not all the points can be plotted in a scatter plot, the large amount would
render the scatter plot unreadable.erefore, above the diagonal 2D-histograms
(hexbin-plots) of all the points in the surface mesh are shown. e 2D-space is
divided in hexagons to form a honeycomb structure.e amount of points in every
hexagon is indicated by the colour scale.e regions with a higher point density are
shown in a darker colour. In the 2D-histograms, no distinction between the three
branches is made.e x-axis and y-axis are ordered in the same manner as for the
scatter plots.
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e plots below the diagonal are scatter plots in which 500 random points
of the surfacemesh are shown. In each of this scatter plots two dierentHWPs
are plotted against each other, according to the position of the scatter plot in
the matrix.e x-axes and the y-axes are the same within each column and
row respectively. In the scatter plots dierent markers dierentiate between
the three branches: red o - CCA, blue + - ECA and green x - ICA.ese plots
give a clear rst indication whether the two HWPs included in the plot are
linked or not. e most clearly (inversely) linked are the TAWSS and the
RRT, as evidenced by the clear hyperbolic shape. Also the TAWSS and the
OSI appear to be inversely dependent shown by a less obvious hyperbolic
shape of the plot. Between the OSI and RRT, this relation appears to be more
or less linear, although there is a lot of scatter. For the correlations between
the transWSS and the other HWPs, it is dicult to see a clear relationship
in these plots.e HI appears to be negatively correlated to the TAWSS and
positively with the OSI and RRT. For the HI, there is a lot of scatter present
so this relations are not very clear.
e plots above the diagonal show 2D-histograms (hexbin plots) of
the same HWP-pairs. In these plots, the dierentiation between the three
branches is lost, but in contrast to the scatter plots (below the diagonal) all
the points of the surface mesh were included.is kind of plot is a natural
extension of the normal 1D-histogram (see diagonal plots) to 2D.e do-
main is divided in hexagonal bins and every bin is coloured according to the
number of points present in that bin.erefore, a dierent point density is
more obvious in this representation.e same relations between the dierent
HWPs were found.
10.3.5.2 Comparison of the HWPs on a population level
e correlations between the dierent HWPs on a population level are listed
in table 10.4. As can be anticipated, there were strong correlations between
RRT and TAWSS and OSI. HI correlated reasonably well (correlation coe-
cient magnitude from 0.45 to 0.68) with the TAWSS, RRT, OSI and transWSS.
Lowest correlations were between transWSS and TAWSS, OSI and RRT (all
below 0.25).
10.4 Discussion
We present the rst study that assesses the spatial correlation between com-
monly used haemodynamic wall parameters and the location of contrast
accumulation in macrophages (∼atherosclerosis development), in paired as
well as aggregated data of the carotid arteries in ApoE−/− mice.
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Table 10.4: Heatmap of the dierent HWPs and the Spearman’s rank correlation
coecient between them for all bifurcations (N=7). For every correlation the 95%
condence interval is given in sub- and superscript.e cells are coloured according
to the mean value of the correlation coecient.
TAWSS OSI RRT transWSS HI
- -0.66−0.59−0.73 -0.97−0.95−0.98 0.250.370.14 -0.65−0.57−0.73 TAWSS
- 0.710.780.64 -0.07
0.05−0.19 0.560.660.46 OSI
- -0.22−0.10−0.33 0.680.770.59 RRT
- -0.45−0.37−0.54 transWSS
- HI
10.4.1 Week 15
No correlation was found between any of the studied HWPs and the macro-
phage inltration at week 15, neither on the single branch level nor on the
bifurcation level.e main reason is that almost no contrast accumulation
had occurred in the carotid bifurcation at this specic time point. Note that
the contrast accumulation measured at week 15 results from contrast injected
at week 10.erefore it is plausible that we missed the exact time point where
contrast accumulation signicantly speeds up. e radiation experienced
by the animals during the µCT measurements puts ethical constraints that
prevented us from performing more frequent (e.g. weekly) measurement of
macrophage inltration.
10.4.2 Week 20: individual branch level
When studying the association between haemodynamics and atherosclerosis
on the individual branch level, no correlation was found between the HWPs
and the macrophage inltration in both ECA and ICA.e HWPs display
rather smooth patterns while themacrophage inltration distribution is more
irregular (see e.g. gure 10.4 and extra gures in Appendix C on page 251).
For the CCA, the HWPs and macrophage inltration overlap in the region
closest to the bifurcation.is results in a positive correlation in 6 out of 7
cases (signicant for 4 cases) for the RRT. For both the OSI and TAWSS, the
same trends are visible.
10.4.3 Week 20: individual bifurcation level
On the individual bifurcation level, a clear correlation with the macrophage
inltration map was found for both RRT and TAWSS (4 out of 7 cases sig-
nicant) and a moderate correlation was found for both OSI and transWSS
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Figure 10.4: A side by side comparison between the contrast-enhancement related
tomacrophage inltration at week 20 and the calculated RRT.e cut open branches
of the le and right carotid bifurcations for the 4 mice are shown. e contrast-
enhancement measurement of the right carotid bifurcation of mouse 1 failed.
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(2 out of 7 cases signicant) (table 10.1).e limited correlation magnitude
(around 0.2 – 0.3) shows that processes other than the haemodynamics are
involved in the complex process of atherosclerotic plaque initiation. is
also shows when comparing the le with the right bifurcation for a single
mouse.e HWP distributions are similar for both sides in most mice but
the macrophage inltration oen diers between both sides (gure 10.4). In
this study, the haemodynamics cannot explain the dierence in plaque loca-
tion between the le and the right bifurcation and other processes are likely
involved. Important to note is the consistent negative correlation for TAWSS
and the positive correlation for RRT.is provides important evidence for
the low and oscillatory shear stress hypothesis, as we are (to the best of our
knowledge) the rst to compare pre-disease HWPs with a quantitative metric
for plaque development on a within-subject basis.
10.4.4 Week20: population level
For the whole population, a signicant Spearman’s rank correlationwas found
for the TAWSS, OSI, RRT and transWSS (table 10.3 and gure 10.5).ese
data conrm the results found on an individual bifurcation level and further
support the low and oscillatory shear stress hypothesis.e magnitude-based
HWPs prove to have predictive value with regard to atherosclerotic plaque
development.e harmonic-based parameters (HI and DH), do not seem
to add extra relevant information in this study given their low correlation
coecients. When assuming linearity and thus calculating the Pearson’s r,
the correlation for TAWSS and transWSS drops, indicating that those are
not linearly correlated with macrophage inltration. Aggregating the data
(last row in Table 3) leads to an overestimation of the correlation, conrming
data reported by Ku et al. [23] and Rowland et al. [11]. Especially for the
more irregular patterns of transWSS, aggregating leads to smoothing and an
overestimation of the correlation.is indicates the importance of taking the
individual correlations into account and suggests that the results of aggregated
data should be interpreted with caution.
10.4.5 Comparing comparisons: which HWP to choose?
It is not a trivial task to assess which of the proposed HWPs best captures
the relation between haemodynamics and atherosclerosis.e classical mag-
nitude-based HWPs (TAWSS, OSI and RRT) are highly correlated to each
other (table 10.4).is has been reported previously in the human carotid
bifurcation by Lee et al. [24].
In addition to the “traditional” parameters we calculated the recently
introduced transWSS metric, which was developed by Peier et al. to better
discriminate between uniaxial and multidirectional ow [17]. In the carotid
bifurcation of the ApoE−/− mice in this study, the correlation found for
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0.6 0.4 0.2 0.0 0.2 0.4 0.6
Correlation
TAWSS
OSI
RRT
transWSS
DH
HI
ρ r Aggregate ρ Aggregate r
Figure 10.5: A graphical representation of the data in table 10.3. For the dierent
HWPs, ρs and r are plotted together with their CB. Signicant results (both the
p-value and the CB conditions) are indicated by a star. For the aggregate ρs RRT,
only one signicance condition is met (p<0.05 but LCB<0), which is indicated by °.
transWSS was lower compared to TAWSS and RRT. A possible explanation
for this low correlation might be the specic haemodynamic conditions in
the mouse carotid, where ow is highly organised due to the low Reynolds
numbers (peak Re is in the order of 12).e correlation with the classical
HWPs is low, indicating that the transWSS indeed describes a dierent aspect
of blood ow induced shear forces on the arterial wall. We did not calculate
gradient-based haemodynamic wall parameters because of the reported high
correlation with magnitude-based HWPs [24].
We also calculated two harmonics-based indices: the dominant harmonic
(DH) introduced by Himburg et al. [18] and the harmonic index (HI) intro-
duced by Gelfand et al. [19]. Both metrics describe the frequency-dependent
response of the vascular endothelial cells with regard to atherosclerosis initi-
ation [25]. In the present study, DH did not provide any additional informa-
tion, because it only diered from the rst harmonic at a very small zone in
between the ECA and ICA branch; the stagnation point of the blood ow. HI
on the other hand showed a pattern similar to (the inverse of) the TAWSS.
Globally, HI is elevated in the ECA while its value is reduced in the CCA.
Compared to TAWSS, this pattern shows an even smoother distribution
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at the locations distant from the bifurcation. In the immediate vicinity of
the bifurcation HI is not particularly elevated, while TAWSS shows a more
outspoken drop. Overall, this results in a lower spatial correlation between
HI and contrast accumulation.
10.4.6 Statistical methodology
e surrogate sample data analysis test, which is extensively used in the
current work, is inherently a single tailed testing approach. For all the HWPs
it is known a priori if the correlation would be positive (OSI, RRT, transWSS,
HI and DH) or negative (TAWSS) and thus a single tailed approach can be
applied. For consistency, a single tail t-test was also applied at the population
level. A two tailed approach would result in p-values twice as large and would
thus yield values around (and just above) the 0.05 condence level.
e ldec is an important parameter for the surrogate sample data analysis.
We followed the same tailored approach as described by Peier et al. [10],
calculating the dissimilarity of the neighbouring pixels at dierent length
scales.e ldec, is the length for which this dissimilarity reaches a maximum
plateau value and the pixels become uncorrelated. In the CCA, where some of
the HWPs (OSI and HI) have a more or less constant value, no such plateau
value could be found in 11 (out of 14) cases. For the other branches and the
other parameters, a clear plateau value was found. Because an overestima-
tion of ldec reduces the specicity but has no implication for the statistical
correctness, the ldec was taken to be 20 in all cases. With this value, the ratio
of ldec to the number of circumferential pixels (20/100=1/5) is more or less
equal to the ratio proposed by Peier et al. (in their case ldec ranged from
2
√
2 to 3
√
2 for ∼20 circumferential pixels).
Rowland et al. dened a second condition for the surrogate data analysis
test: if the value ρs=0 is included in the condence interval for ρs, the result
is not signicant [11].is leads to an inconsistency: the rst condition of
the approach deals with an inherently single tailed p-value while the second
condition deals with a double tailed condence interval. In the current work
we have chosen to use the condence bounds for the second condition, which
is the single tailed equivalent of the condence interval.
When comparing dierent statistical methods for assessing spatial correl-
ations, Rowland et al. [11] described other possible statistical methods that
could replace the surrogate sample data analysis applied in the current work.
However, both the restricted randomisation and the bootstrap approach,
which were proposed as alternative methods, are computationally more de-
manding than the surrogate sample data analysis.e bootstrapped approach
was not used in this work due to the low amount of datasets (n=7).e Four-
ier-based restricted randomisation approach cannot be applied to the whole
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bifurcation due to the irregular shape of the bifurcation (not rectangular
because 3 branches are present). For the discrete wavelets-based restricted
randomisation, the computational cost and complexity are even higher and
rotations should be added to overcome poor directional selectivity, which
was judged too complex for the added benet.
10.4.7 Limitations
One of the main limitations in the current study was that we did not have
baselinemeasurements before themice were put on a diet. For ethical reasons
the amount of (high radiation) µCT measurements was restricted. At week
10 aer the start of the diet no narrowing of the carotid arteries was visible
and we assumed a pre-disease state. Nevertheless (small) plaques may have
been present that may have inuenced the local haemodynamics. Moreover,
even if the animals were 16 weeks old at this stage and thus fully grown, we
still measured at a single point in time and could not account for changes in
vascular functioning that may have occurred during the study.
ere are some technical considerations to be kept in mind when inter-
preting our data. Amajor potential source of inaccuracy is themapping of the
3D bifurcation geometry onto the 2D grid.is mapping should result in the
same 2D decomposition for the bifurcation geometry measured at 3 dierent
time points: week 10 (used for the FSI simulations and the assessment of
haemodynamic wall parameters), week 15 (macrophage inltration 1) and
week 20 (macrophage inltration 2) aer the start of the diet. To assess the
impact of potential angle misalignment, the macrophage inltration was shif-
ted in the circumferential direction with 5 pixels (angular shi of 18○) in both
directions with respect to the HWPs data.e inuence on the results was
minimal with a dierence in signicance level in 4 out of 35 calculated values
at week 20 (cases 2L/R: change for OSI from not signicant to signicant
with still LCB<0; case1L : for TAWSS and RRT still p<0.05 but respectively
UCB>0 and LCB<0). On average the dierence induced by the angle shi
for the correlation coecient was 3.73% with the highest values for the OSI
(on average 0.076: 7.65%). erefore, we can conclude that the method is
rather robust to small mapping misalignments.
Aer the mapping, both the HWP and the macrophage inltration data-
sets have been resampled to a common rectangular grid, and therefore our
results might depend on the chosen grid size parameters. e statistical
testing of the current methodology was recalculated with a rectangular grid
that had 50 circumferential cells instead of 100 (axial size of 27.0 µm) and
thus an ldec of 10 instead of 20 to validate the grid size dependency. Virtually
no dierence was found with the original results.e sampling-based on ldec
thus provides a good solution to acquire grid size independent results.
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We used mouse-specic FSI simulations to assess the spatial distribution
of haemodynamic wall parameters.is is a complex and time consuming
procedure. Given the low Reynolds numbers and highly organised ow in
the mouse carotid, we veried whether a simple estimation of the TAWSS for
every branch based on Poiseuille ow assumptions, omitting the need for FSI
simulations, would not suce to come to the same conclusion. Although the
same negative trends were visible compared to the FSI results, the correlation
was lower for ρs and comparable for r.is indicates that the Poiseuille ow
assumption can give a rst estimate, but that knowing the correct TAWSS
distribution using the FSI simulations has added value.
Finally, the correlations that were found were statistically signicant (on a
population level) but still remained low. Atherosclerosis is a complex process
involving dierent mechanisms and our results indicate that haemodynamics
provides only a partial explanation for its localized nature. For example, the
regions with high macrophage inltration (gure 10.4) dier much more
between dierent mice than the regions with high RRT.e rate of plaque
progression can also dier between animals and might be dierent from one
location to another. In combination with only 2 measured time points this
may partially explain the dierences found between animals and possibly
even between the le and the right bifurcation of a single mouse.
10.4.8 Conclusion
We investigated the spatial correlation between several pre-disease FSI calcu-
lated shear stress parameters and the macrophage inltration aer athero-
sclerotic plaque development. Overall, our study indicates that:
(i) e association between haemodynamics and atherosclerosis is most
apparent when assessed at the level of the entire carotid bifurcation;
the association is much weaker when assessed at the individual branch
level
(ii) e association is stronger for the data measured at week 20 than week
15
(iii) e association is stronger for the population compared to individual
carotid bifurcations
(iv) Of all parameters tested, the strongest spatial correlation between
haemodynamics and atherosclerosis development was observed for
RRT and TAWSS
(v) Aggregating the data led to an overestimation of the correlation.
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Conclusions and future
perspectives
In the current work the link between WSS and atherosclerosis development
was explored, integrating in vivo research in amousemodel of atherosclerosis
with imaging and compuatational techniques.e overall research question
we put forward was: “Is there an individual and quantitative link between
baseline wall shear stress and subsequent plaque development in mouse
models of atherosclerosis?”
11.1 Research Goals
ree dierent intermediate goals were stated that should lead to answering
the research question.
Goal 1. Development of an in vivo measurement technique to localise the
atherosclerotic plaques
It is indispensable to be able to in vivo identify atherosclerotic plaques in
mice during plaque progression. In chapter 7, a novel application of the gold
nanoparticle contrast agent Aurovist 15nm for µCT was described. Using
this contrast agent, we were able to in vivo visualise macrophage inltration
in atherosclerotic plaques using an µCT technique based on a pre- and a
post-contrast injection scan. Although MRI based methods were already
described in literature, the current µCT based technique enabled us to per-
form measurements at a superior resolution, which is required for murine
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applications. Moreover, macrophages are a very important marker for plaque
vulnerability that are dicult to image.
e importance of this imaging methodology should not be underestim-
ated.e in vivo aspect made it possible to follow up plaque progression at 2
time points.
Goal 2. Setup of a measurements-based computational model to calculate the
WSS without sacricing the mouse.
A computational FSI model of the blood ow in the murine carotid arteries
has been described in chapter 8. To the best of our knowledge, this is the
rst computational model describing the haemodynamics inside the murine
carotid arteries and bifurcation.
Stricto sensu, no signicant modications or additions were made to
the dierent existing models and methods that already have been described
and applied in literature, mainly oriented toward studies in humans. In the
current work several state-of-the-art existing models were combined and
integrated for the rst time by our group: external tissue support (using
springs), axial prestress (using the BI method) and diastolic inate prestress
(using a second run of the BI method). All these methods were necessary
to obtain a stable FSI model in the challenging environment of the murine
carotid bifurcation.e innovative methodological aspect of this work is in
the aggregation of the dierent methodologies into one coherent model.
Goal 3. Applying a statistical model to quantify the link between the
haemodynamic metrics and the plaque locations.
Finally, in chapter 10 a statistical model was applied to relate the shear stress
metric maps with the macrophage inltration on a within-subject basis. Fol-
lowing this methodology we demonstrated that a correlation exists between
WSS patterns and the plaque formation.is relation was stronger on the
population level compared to the individual bifurcation level. On the indi-
vidual branch level, only a weak correlation was found for the CCA branch,
while the correlation was absent for the ECA and the ICA branches.
Is there an individual and quantitative link between baseline wall shear
stress and subsequent plaque development in mouse models of
atherosclerosis?
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Answering the research question
e simple answer to the central research question is “Yes”. However, in
reality the answer is not as simple as that.
We did nd signicant correlations for our population (n=7 bifurcations)
between several HWPs (TAWSS, OSI, RRT and transWSS) and the macro-
phage inltration at a later stage, when this correlation was determined over
the whole carotid bifurcation.is is a most promising result, given that the
correlation is signicant (with p<0.05) for such a small sample size. However,
we do have to keep in mind that the statistical testing was a 1-tailed approach.
is is a valid approach due to the theoretical description of the HWPs that
already denes whether we are interested in a negative (TAWSS) or a positive
(other HWPs) correlation.
Although the found (bifurcation) correlations were deemed signicant,
one still has to remain critical.e absolute values of the correlation coe-
cients ranged from 0.118 to 0.148, which is still rather low. It is thus save to
state that these HWPs only describe a small part of the process leading to athe-
rosclerosis. Moreover, in recent years newer HWPs have been proposed that
have been claimed to provide stronger mechanistic links with atherosclerosis
development. In the current thesis, we tested the harmonic based HWPs, but
they did not provide a stronger association with atherosclerosis in the murine
carotid bifurcation. Moreover, most of the tested HWPs demonstrated high
degrees of collinearity.
Haemodynamics are only one factor contributing to the atherogenic pro-
cess and thus the magnitude of the correlation between both will likely never
be very high. Nonetheless, there are still other factors that (partially) explain
the relatively low correlations between haemodynamics and atherosclerosis
that were found in the current work. Some of these factors are inherent to the
methodology of imaging, modelling and statistics. To calculate the correla-
tion between the baseline state and the diseased state at a later time point, we
needed to map both geometries on a single grid. Especially when severe sten-
osis occurs, this mapping will never be perfect, even with the best mapping
algorithms, due to the high geometrical dierences between both geometries.
Moreover, macrophage inltration only highlights one part of atherosclerosis
formation. Next to this, we start from images with limited resolution and
artefacts. Furthermore, the pipeline to get to the correlation between the
HWPs and the macrophage inltration is long, possibly including extra arte-
facts. Although several physical processes are included in the modelling part,
model assumptions have to be made. In the current thesis the most stringing
ones are: the assumption of Newtonian behaviour of the blood and isotropy
of the arterial wall.erefore, reality is only approximated, possibly further
clouding the relation between WSS and atherosclerosis development.
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Other, statistical reasons for the relatively low correlationwere introduced
on purpose.e Spearman’s rank correlation coecient generally results in a
lower correlation coecient compared to the Pearson’s correlation coecient
but it is theoretically the better choice because the dierent HWPs are not
linearly correlated to macrophage inltration. Moreover, we showed that
aggregating of the data, which is commonly done in literature, overestimates
the correlation.
Another limitation of the current work are the “baseline” simulations.
e simulations were based on measurements done at 10 weeks aer the start
of the diet. Because there is not sign of plaque development (= no narrowing
of the arteries) visible yet, we assume that this is a valid model for the baseline
state. However, the absence of visible narrowing does not does not assure
that there is no inuence of (minor) plaque formation present yet.erefore,
our baseline measurements could be biased by initial plaque formation.
What about humans?
e current work was restricted to mouse models. Of course the nal goal
is still to better understand atherosclerosis in humans. We are, in my opin-
ion, still a long way from that nal goal. As explained in chapter 2, the
atherosclerotic plaques in the recently developed genetically modied mouse
models are morphologically similar to human plaques. However, there are
still dierences and the induced genetic defects may also aect the plaque
formation and the general health of the mouse in dierent ways, which are
not all well understood yet. e measurements described in this disserta-
tion show that in the ApoE−/− and ApoE−/− Fbn1C1039G+/− mouse models,
the atherosclerosis develops preferentially at the ECA compared to the ICA.
On the other hand in humans, clinical complications are commonly found
because of atherosclerotic plaques that developed in the ICA[1], [2].
More specically with regard to haemodynamics, there are still some
major dierences between mice and humans, the most prominent ones being
the higher heart rate and the smaller dimensions.is leads to much lower
Reynolds (∼25 times lower [3]) andWomersley (∼9 times lower [3]) numbers
in mice compared to humans and thus towards more laminar ow patterns.
In the carotid bifurcation this leads to the absence of ow recirculation
zones at the outer side of the sinus in the base model described in chapter 8,
while this phenomenon has been reported in numerously publications in
humans. Adaptation of the BCs to active, non-anaesthetised conditions was
necessary for limited recirculation to occur.ese very dierent temporal
WSS patterns between mice and humans make it more dicult to directly
compare or translate the results.e dierent HWPs that were calculated
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in the current thesis were, most of the time, dened in the human context
and they were dened in an attempt to describe the atheroprone eect of the
WSS.e fact that the murine haemodynamic environment is substantially
dierent from the human haemodynamic environment may hamper their
applicability for the setting of the mouse carotid artery. At the same time,
however, our ndings also questions the generalizability of the use of some
of these metrics.
Still, one has to keep in mind the main reason why in this work we chose
to set up these studies in a mouse model of atherosclerosis.e long time
span for atherosclerosis to develop in humans makes it almost impossible
to conduct a similar study in the human setting. Once the atherosclerotic
plaque has formed and stenosis is present, the haemodynamic environment
changes dramatically.e haemodynamic environment still has an important
inuence on the plaque development and possibly even on the vulnerability
or plaque rupture. However, the change in the haemodynamic environment
hampers studies aiming for a spatial correlation and/or a causal link between
baseline haemodynamics and plaque initiation. Some groups have tried to
virtually remove the atherosclerotic plaque to obtain a baseline setting, but
this is very challenging. Mice are already a step closer to the human case, in
comparison with the numerous in vitro studies linking WSS with dierent
molecular pathways towards atherosclerosis.erefore, future research could
be directed to animal models that mimic the human even more closely such
as pigs or non-human primates.
11.2 What about rupture?
Aer reading chapter 8, one might nd it somewhat disappointing that we
limited our focus on the haemodynamics. Aer all, this chapter distinguishes
itself from work done by other research groups by including the external
tissue and prestress, which allows for a more realistic simulation of the wall
mechanics. A logic next step for the current research is to include the me-
chanical behaviour of the arterial wall and the atherosclerotic plaque. A
rst step can be to model the atherosclerotic plaque together with a more
realistic arterial wall model, without the presence of blood ow in a purely
computational solid mechanics model (because the shear stresses exerted by
the blood are much lower compared to the mechanical stresses in the arterial
wall). A second step is to include this mechanical plaque and arterial wall
models in the FSI methodology described in the current thesis.
Both of these steps are not minor, mainly because even more challenging
imaging is required. For the current work, one of the main limitations was
that the thickness of the arterial wall was unknown and estimated to be 10%
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of the arterial diameter. To be able to build realistic CSM or FSI models, this
assumption should be avoided and preferentially the layered structure of the
arterial wall (intima, media and adventitia) should be included in the model.
To be able to build such models, the 3D-geometry of the arterial wall needs
to be known with high accuracy. To include the atherosclerotic plaque, the
requirements are even more demanding because of for example the small
thickness of the cap of the plaque. Next to this, the so tissue contrast that
is needed to image the plaque and the layered structure of the wall also
places a restriction on viable imaging techniques. Recent advances such as
synchrotron-based X-ray tomographic microscopy [4] and 3D cryo-imaging
[5] can provide sucient so tissue contrast at superior resolutions which
makes it feasible to construct a highly accurate 3Dmodel of the atherosclerotic
plaque and wall.e main disadvantage is that these techniques are ex vivo.
In future projects, the baseline haemodynamics could be assessed using the
methodological framework presented in the current thesis with at the end
stage a full FSI model including the plaque and more realistic wall mechanics
based on highly accurate ex vivo imaging.
11.3 Where to go from here?
Asmentioned above there are 2 main new directions that the current research
can take: (i) proceeding towards animal models such as pigs that are more
closely related to humans and (ii) extending the current framework to also
include more realistic models for the arterial wall and plaque to expand the
research eld towards plaque rupture.
e current thesis fused advancement made in dierent research elds
including: preclinical imaging, image processing, development of animal
models, statistics and computational modelling. Indispensable for the current
research were: (i) development of a murine vascular µCT contrast agent (ii)
better image reconstruction algorithms for CT (iii) development of robust
coupling code for FSI simulations (iv) development of advanced statistical
models to study spatial correlations. erefore, future opportunities will
present themselves when signicant advances are made in any of those re-
search elds.e inclusion of the atherosclerotic plaque in the computational
solid mechanics model has already become feasible due to recent advances
in (ex vivo) imaging.
Next to this, one should aim to render the proposed methodology more
ecient, reducing the manual labour needed.e two most labour intensive
steps were the high quality segmentation (needed for the FSI model) and a
high quality (uid and structural) mesh. Both are subject to a lot of scientic
interest and development. Large industrial companies, such as Materialise,
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Ansys or Simulia, provide newer and better performing algorithms every
year. In the coming years this will probably signicantly reduce the manual
labour, providing the opportunity to include more animals in similar studies,
needed to obtain statistically more robust results.
11.4 Take home message
In this work, we have shown that gold nanoparticle- enhanced µCT can be
applied to visualise macrophage inltration in vivo in the atherosclerotic
plaque of mice. Moreover, a methodology was presented to calculate the
haemodynamics in the carotid bifurcation of those mice. Most importantly,
we showed that the haemodynamic wall shear stress at the baseline stage
is linked to macrophage inltration in the atherosclerotic plaques at a later
stage on an individual mouse level.
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Linear mixed models
A.1 Introduction
Linear mixed models were used in chapter 6 (analysis of ultrasound data)
and chapter 7 (analysis of macrophage inltration data). All these datasets
are similarly structured and the same statistical methodology was followed.
Because this statistical model is not generally known, a short introduction is
described in this appendix.
A.2 Description of the numerical data
For all these datasets we want to study how a single numerical variable or
parameter, for example the velocity at peak systole, diers between groups of
animals, taking into account grouping variables such as the time on the diet,
measuring location or measuring side.e dierent subjects are grouped in
several ways. First, species (ApoE−/− or ApoE−/− Fbn1C1039G+/−), is taken as
a between-subjects grouping factor, because this is a factor that dierentiates
between the dierentmice (subjects). Side (le or right), location (CCA, ECA
or ICA) and time (weeks 0, 5, 10, 15 or 20) are within-subject grouping factors.
ese within-subject factors, dierentiate between several measurements
done in the same subject (mouse). Statistically the latter are dierent from
the between-subject measurements because they are repeated measurements
on the same mouse.erefore, they are in some degree correlated to each
other.us, they can not be included in the statistical model as independent
measurements. An overview of the dierent grouping factors, their nature
and possible values is given in table A.1.
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Table A.1: Grouping variables used in the linear mixed model analysis. Some of the
analyses take only 2 time points (weeks 15 and 20) into account while for others all 5
time points (weeks 0, 5, 10, 15 and 20) are taken into account.
factor nature possible values
species between-subjects ApoE−/−—ApoE−/− Fbn1C1039G+/−
time within-subject weeks 0 – 5 – 10 – 15 – 20
side within-subject le — right
location within-subject CCA – ECA – ICA
A.3 GLM: repeated measures ANOVA
e repeated measures analysis of variance (ANOVA) (a general linear model
(GLM)), is the more traditional approach used in the scientic world to
compare group means of dependent variables across repeated measurements
over time. Using an ANOVA procedure, the group means of more than 2
groups can be compared.erefore, this can be seen as a generalization of
the t-test. For analyzing a repeated measurements experiments, there are
some severe limitations related to the ANOVA analysis that are dicult to
meet [1], [2]:
• e datasets have to be complete (meaning subjects with at least one
missing data point have to be excluded)
• A common set of time periods is needed (time between measurements
exactly the same for all subjects)
A.4 LinearMixedModel (LMM)
A.4.1 Why LMM in the current PhD thesis?
In comparison with the GLM, the LMM has two main strengths for
(bio)medical data: (i) accommodate for missing data points (oen present in
longitudinal datasets) (ii) model individual, nonlinear characteristics [1].
Especially the ability of the test to deal with missing data is essential with
respect to the current research.
Missing data points are present in for some of the mice in all our datasets.
For the US data, this is mainly because the high amount of measurements
done on an individual mouse. For both the PWDoppler US and theM-mode
US measurements, the measurements include: 5 time points, 3 locations and
2 sides.is results in 30 measurements for both the PW Doppler US and
the M-mode US measurements. Next to this, the presence of atherosclerosis
made these measurements challenging and technically dicult to perform.
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Next to this, the limited time frame (duration of the anaesthesia was limited
to one hour) and irregular response to the anaesthesia of the sick animals
further complicated the measurements. For the µCT measurements, less
measurements are done although 4 measurements are needed for the macro-
phage-inltration visualization results in chapter 7 on page 117 (2 time points
but pre- and post-contrast injection). However, these measurements are
much more challenging with motion artifacts, dicult registration and seg-
mentation compromising accurate results.is leads to only a small amount
of measurements that are complete and that thus can be included in an GLM
analysis.
A.4.2 LMM: basic principles
is section gives a short overview of the principles behind the LMM, based
on three major literature sources∗,†,‡.
A linear model describes the responses of the model (y) in function of
xed eects and an error term (ε).e xed eects are eects that aect the
population mean.ey can be repeated and an example in the current PhD
thesis is the between-subject factor measuring location (CCA, ECA or ICA).
is eect is repeatable, in a next study it is possible to measure the same
locations again, and it could be possible that the location has an inuence on
the average value measured. More specically for this study the xed eects
are always considered to be factors (categorical, qualitative data). No xed
covariates (quantitative data) were studied in the current thesis.
A general linear model can be described by:
y = Xβ®
f ixed
+ ε®
residual
(A.1)
In this equation the vector y (n x 1 with n the number of responses) represents
the responses(=measurements) of the model and the term Xβ denotes the
xed eects. β (p x 1 with p the number of factors) is a vector representing the
unknown xed eects and X (n x p) the associated independent, grouping
variables (X is called the design matrix). ε (n x 1) represents a vector with the
errors.
In contrast to the general linear model, the LMM can deal with responses
that are described by both xed and random eects. e random eects
∗SPSS, ‘Linear mixed-eects modeling in SPSS: An introduction to the MIXED
procedure’, Technical Report, LMEMWP–1002, 2002.
†C. Kincaid, ‘Guidelines for Selecting the Covariance Structure in Mixed Model
Analysis’, in Proceedings of the irtieth Annual SAS Users Group International
Conference, SAS Institute Inc, Cary, NC: SAS Institute Inc, 2005.
‡W. A. Jensen, ‘Prole Monitoring for Mixed Model Data’, PhD, 2006.
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have no eect on the population mean but it they aect the mean of a single
subject (=mouse). As an example we will consider the PW Doppler US
measured blood velocity in section 6.2 on page 102.e LMM is able to take
into account both the xed eect of measurement location and the random
dierences between dierent mice into account. If the measured velocities
in a specic mouse are higher for all measurement locations, the random
eects include this in the model.
e tted LMM can be described as:
yi = Xiβ®
f ixed
+ Ziγi®
random
+ εi®
residual
(A.2)
e subscript i denotes dierent subjects (=mice). In this formula Yi is a
vector(ni x 1 with ni the number of measurements on mouse i) that gives the
responses of the model (=the measurements).e term Xiβ describes the
xed eects. In this term β denotes the dierent unknown xed eects (p x 1
with p the number of factors) and Xi is the xed eects design matrix (ni x
p).e design matrix X represents the independent variables in the model
(=grouping variables). In other words, for every measurement it describes to
which groups, according to the grouping variables, the measurement belongs.
It can be seen that the inuence of the xed eects β do not dier between
mice (no subscript i for β), the inuence of the xed eects is the same for all
subjects.e random eects are incorporated in the term Ziγi . γi (q x 1 with
q the number of random eects) denotes the unknown random eects and
Zi is the design matrix (ni x q) of the random eects. Another interpretation
of the random eects, is that they represent the subject-specic regression
coecients that characterize the natural heterogeneity in the population [4].
More specically in the current research, the (average) dierence between
dierentmice ismodelled as a random eect and thus included in the random
term Ziγi . Finally, εi (ni x 1)denotes the residual errors.
e described LMMwas tted to the measurements using SPSS Statistics
22 (IBM, Armonk, NY, US).e specic parameters are described in the
subsequent chapters when the analysis is performed. For more details on the
procedure the reader is referred to the manual of SPSS.
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Surrogate sample data analysis
B.1 Introduction
is appendix gives an overview of the surrogate sample data analysis (SSDA),
as this method is an important tool used in this thesis (in 10). e SSDA
was rst described by Peier et al.∗ and later further rened by Rowland et
al.†.is section is thus mainly an overview of their work with only minor
adaptations.
e SSDA was developed to quantify the correlation between (an aggreg-
ated) atherosclerotic plaque distribution (=lesion map) and (an aggregated)
haemodynamic wall parameter distribution (= haemodynamic map). As a
criterion to conclude that correlation is present, most early publications used
a linear regression analysis [3], [4]. However, there are twomain prerequisites
needed to do a linear regression analysis that are very strict and that are not
always valid in these kind of datasets:
1. a linear relationship between the variables
2. the data points are independent of each other
∗V. Peier, A. A. Bharath, S. J. Sherwin et al., ‘A novel method for quantifying
spatial correlations between patterns of atherosclerosis and hemodynamic factors.’
Journal of biomechanical engineering, vol. 135, no. 2, p. 021 023, 2013.
†E. M. Rowland, Y. Mohamied, K. Yean Chooi et al., ‘Comparison of Statistical
Methods for Assessing Spatial Correlations Between Maps of Dierent Arterial
Properties’, Journal of Biomechanical Engineering, vol. 137, no. 10, p. 101 003, 2015.
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e process that leads from disturbed blood ow to atherosclerosis devel-
opment, is complicated and includes a lot of interfering factors.erefore the
relationship between a lesion map and a haemodynamic map will most likely
not be linear. e HWPs are calculated in the grid points of the numeric
mesh. If all the grid points are included in the linear regression test, this
results in a problematic testing approach. Indeed, using a ner calculation
mesh will result in a higher number of data points and thus in a higher power
of the statistical test.e outcome of the test is thus mesh-size dependent,
although the mesh size is a pure numerical property.
Peier et al. [1] solved this dual problem with a dual solution. Both of
them are described below.
1. linear relationship→surrogate analysis
2. independence→sample analysis
When applying the SSDA to study the correlation between atherosclerosis
and haemodynamic maps, both distributions need to be known in the same
grid. is 2D-grid has to be spaced equally in both directions. erefore,
the luminal surface has to be mapped onto a 2D-grid. Several methods have
already been developed to do this; in the current work a VMTK (http:
//www.vmtk.org) based approach has been followed. More information
about themapping can be found in chapter 10 onpage 199 or in the publication
of Antiga and Steinman [5].
B.2 Surrogate analysis
e surrogate analysis is applied to overcome the limitation of the linear
relationship. First a quantitative measure describing the similarity between
two dierent maps is needed (a HWPmap and a lesion map), which is called
the discriminating statistic. is enables the algorithm to order dierent
(HWP) maps according to the similarity to a base map (lesion map). For
this discriminating statistic, Peier et al. proposed the sum of the absolute
dierences aer normalization (for example by division with the L2-norm)
of the maps (equation (B.1a) with x and y the values of both maps). Another
possibility is to use the correlation coecient as the discriminating statistic
as proposed by Rowland et al. [2]. Pearson’s correlation coecient r (equa-
tion (B.1b))can be used, but this assumes that the relation between the lesion
map and the haemodynamic map is linear. Spearman’s correlation coecient
ρs (equation (B.1c))on the other hand only assumes a monotonic relation
between the two variables. For the ρs, the pointwise values of both maps (x
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and y) are replaced by their ranks (r and s). When using either the absolute
dierences or ρs , the assumption of a linear relationship can be circumvented.
Discriminating Statistic = n∑
i=1∣xi − yi ∣ (B.1a)
r =
n∑
i=1(xi − x¯)(yi − y¯)√
n∑
i=1(xi − x¯)2
√
n∑
i=1(yi − y¯)2
(B.1b)
ρs =
n∑
i=1(ri − r¯)(si − s¯)√
n∑
i=1(ri − r¯)2
√
n∑
i=1(si − s¯)2
(B.1c)
In the current work and the remainder of this appendix, ρs is used by
default unless it is mentioned explicitly that r was calculated.
A owchart of the surrogate analysis is given in gure B.1.e rst step is
to calculate ρs between the lesion map and the haemodynamic map, which is
called the original ρs. Aerwards, the haemodynamic map is randomly
shued generating a surrogate haemodynamic map. For this surrogate
haemodynamic map a surrogate ρs is calculated, describing the similarity
between the original lesion map and the randomly shued haemodynamic
map. In the current work, this step was repeated for 250 times to generate
250 surrogate ρs values. Aerwards, a histogram is determined of the 250 (or
more) surrogate ρs values and the percentile of the original ρs value (for the
original maps) is determined. An extra 250 surrogate ρs values are calculated
as long as the resulting percentile is not below the convergence criterion of
10−4.
A simplied graphical illustration of this procedure is given in gure B.2.
In this illustration 3 surrogate pairs (right) are generated from the original
maps (le).e percentile of the original ρs is indicated on top of the histo-
gram of the surrogate values.
It is also clear from gure B.2 that the surrogate sample analysis is a
single tailed approach. For the example in the gure, the ρs value of the
originalmaps is smaller thanmost of the randomly shued surrogate datasets,
meaning that the negative correlation is more outspoken than in most of
the random shued distributions. If the original ρs is smaller than 95% of
the surrogates, we can conclude that the negative correlation is signicant
according to this test. us for the le tailed test, looking for a negative
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start:
calculate original ρs
shuﬄe dataset 2
(=take surrogate)
Calculate surrogate ρs
ΔP < 10-4
Calculate histogram of
surrogate ρs
get percentile (P) of 
original ρs in histogram
repeat 250x
Y
N
Percentile found
Figure B.1: Schematic drawing of the surrogate analysis. In the diagram nsur is the
number of surrogates taken (number of iterations) and isur the iterator (adapted
from [1]).
Figure B.2: Illustration of the surrogate data analysis (adapted from [1])
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correlation, the original ρs values has to be below the 5% percentile. e
p-value of the test is equal to the percentile of the original ρs in the surrogate
histogram. When looking for a positive correlation (right tailed test), the
original ρs has to be larger than 95% of the surrogate ρs values.is means
that the p-value of the right-tailed test equals the 1-percentile.
B.3 Sample analysis
Although the surrogate analysis eliminates the need for a linear relation be-
tween both maps, the independence of the data points is still not guaranteed.
erefore, Peier et al. introduced a second step of randomizations by tak-
ing random samples of the original maps[1], see owchart gure B.3. e
surrogate data analysis is applied for 250 random samples of the original
maps.is results in 250 percentile values for the original samples compared
to the surrogates of these samples. e resulting p-value for the SSDA, is
the median value of the individual surrogate data analysis. Extra surrogate
analyses are performed as long as the resulting median percentile diers
more than the convergence criterion of 10−4.
e sample and surrogate steps are illustrated in gure B.4 for 2 sample
steps (ismp) and 2 surrogate steps (isur). For both sample steps, a dierent
random sample of the original datasets was taken (coloured in black).
To ensure that the subsampling overcomes the spatial autocorrelation,
the number of points that is included in each subsample is critical. e
decorrelation length ldec, is the spatial distance for which two samples are
not correlated any more. For a given ldec, a given sample size (ssmp) of ssmp =
smap/ldec with smap the size of the map, ensures that on average one pixel
is selected from each ldec2 square subregion. To determine the length scale
ldec at which the autocorrelation diminishes, the same tailored approach as
described by Peier et al. was followed[1]. Rowland et al. [2]warn that more
than one ldec can be present in a dataset. Underestimating the ldec implies
that not all the spatial autocorrelation is removed and that the data points are
not mutually independent. Overestimating the ldec implies that the smaller
spatial scales are not included in the testing procedure and this results in a
lower specicity of the test. When applying the SSDA in chapter 10, we have
ensured to not underestimate the ldec in order to assure correct testing.
B.4 Confidence bound adaptation
Rowland et al. [2] made some further renements to the method of Peier et
al. [1]. A rst adaptation was the use of ρs instead of the sum of the absolute
dierences for the discriminating statistic, as described above. ey also
included the condence interval into the analysis.
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start
Take<a<random
sample
Surrogate<data<
analysis
Determine<median
percentile<(MP)
N
Y
repeat<250x
ΔMP<<<10-4
Percentile<found
Figure B.3: Schematic drawing of the surrogate sample data analysis. A schematic
of the surrogate analysis is given in gure B.1. In the current diagram, the sample
iterations are shown. Nsmp is the number of samples taken and ismp the iterator
(adapted from [1]).
Figure B.4: Illustration of the surrogate sample data analysis (adapted from [1])
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e SSDA described in the previous section results in a single tailed
p-value for the statistical test. e rst condition for signicance is: p-
value<0.05. is condition is graphically represented in gure B.5a for a
positive correlation.
As Rowland et al. mentioned, a part of the testing procedure is to obtain
the distribution of the ρs for several subsamples. From this distribution
one can then calculate the two tailed condence interval or the one tailed
condence bound (CB). In the current work, the upper condence bound
(UCB) was used for the le tailed tests (negative correlation) and the lower
condence bound (LCB) for the right tailed tests (positive correlation).is
ensures that both conditions, i.e. the condition for the p-value and the
condition for the CB, are one tailed and thus consistent.
For a negative correlation, this second condition stipulates that for 95%
of the subsamples that are analyzed, the found value for ρs has to be negative.
In a formula this becomes: UCBρs<0. For the positive correlation case the
test has to make sure that the found ρs is positive for at least 95% of the
subsamples: LCBρs>0.is second condition is plotted for an example case
in gure B.5b.
B.5 Other methods to account for spatial autocorrelation
When comparing dierent statistical methods for assessing spatial correla-
tions, Rowland et al. [2] described other possible statistical methods that
could replace the SSDA applied in the current work. However, both the
restricted randomization and the bootstrap approach, which were proposed
as alternative methods, are computationally more demanding than the SSDA.
In contrast to the previous authors [1], [2], the surrogate sample data anal-
ysis was applied to individual spatial maps (branch and bifurcation level)
instead of on aggregated spatial maps or groups of spatial maps.erefore,
the bootstrapped approach [6] could not be used, because we compare in-
dividual maps. At the population level, we could apply a paired t-test in
the current work, rendering the bootstrapped approach unnecessary.e
Fourier based restricted randomization approach [2] cannot be applied to the
current datasets due to their irregular shape. For the discrete wavelets based
restricted randomization [7], [8], the computational cost and complexity are
even higher and rotations should be added to overcome poor directional
selectivity, which was judged too complex for the added benet.
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Figure B.5: Graphical representation of the conditions for signicance for the SSDA.
In this example a one-tailed test for a positive correlation is illustrated, which relates
the OSI with the macrophage inltration at week 20 for mouse 1L (see chapter 10
on page 199). (a) the original condition for the SSDA proposed by Peier et al.
[1].For every sample, the p-value is equal to 1- the percentile of the original sample
compared to the surrogates. For signicance, the median p-value for all samples
(p=0.012, thick black line), has to be lower than 0.05 and thus has to be located in the
grey area. (b) for the second condition the histogram of the correlation coecients
of the original samples has to be calculated.e condition for signicance stipulates
that the LCB has to be higher than 0 (ρ has to be in the grey area) .
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C. Comparison macrophage infiltration and differentHWPs
Figure C.1: Overview of the three branches (CCA, ECA, ECA) of the 8 carotid
bifurcations (le and right) of the 4 ApoE−/− mice. For every bifurcation locations
with macrophage inltration at week 20 and the TAWSS pattern are placed side by
side.
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Figure C.2: Overview of the three branches (CCA, ECA, ECA) of the 8 carotid
bifurcations (le and right) of the 4 ApoE−/− mice. For every bifurcation locations
with macrophage inltration at week 20 and the OSI pattern are placed side by side.
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Figure C.3: Overview of the three branches (CCA, ECA, ECA) of the 8 carotid
bifurcations (le and right) of the 4 ApoE−/− mice. For every bifurcation locations
with macrophage inltration at week 20 and the transWSS pattern are placed side
by side.
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Figure C.4: Overview of the three branches (CCA, ECA, ECA) of the 8 carotid
bifurcations (le and right) of the 4 ApoE−/− mice. For every bifurcation locations
with macrophage inltration at week 20 and the HI pattern are placed side by side.
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(a) week 15 (b) week 20
Figure C.5:e aggregated macrophage inltration datasets for (a) week 15 and (b)
week 20.
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(a) TAWSS (Pa) (b)OSI
(c) RRT (d) transWSS (Pa)
(e)HI (f)DH
Figure C.6: Aggregated FSI caculated WSS metric datasets: (a) TAWSS, (b) OSI, (c)
RRT,(d) transWSS, (e) HI and (f) DH
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